<html lang="en" dir="ltr" xmlns="http://www.w3.org/1999/xhtml" xmlns:mml="http://www.w3.org/1998/Math/MathML">
 <head prefix="og: http://ogp.me/ns# article: http://ogp.me/ns/article# book: http://ogp.me/ns/book#">
  <link rel="dns-prefetch" href="//d33xdlntwy0kbs.cloudfront.net"/>
  <link rel="dns-prefetch" href="//www.google.com"/>
  <link rel="dns-prefetch" href="//scholar.google.com"/>
  <link rel="dns-prefetch" href="//www.google-analytics.com"/>
  <link rel="dns-prefetch" href="//stats.g.doubleclick.net"/>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
  <meta name="viewport" content="width=device-width, initial-scale=1"/>
  <link rel="shortcut icon" href="https://www.medrxiv.org/sites/default/files/images/favicon.ico" type="image/vnd.microsoft.icon"/>
  <link rel="alternate" type="application/pdf" title="Full Text (PDF)" href="/content/10.1101/2021.10.31.21265703v3.full.pdf"/>
  <link rel="alternate" type="text/plain" title="Full Text (Plain)" href="/content/10.1101/2021.10.31.21265703v3.full.txt"/>
  <link rel="alternate" type="application/vnd.ms-powerpoint" title="Powerpoint" href="/content/10.1101/2021.10.31.21265703v3.ppt"/>
  <meta name="type" content="article"/>
  <meta name="category" content="article"/>
  <meta name="HW.identifier" content="/medrxiv/early/2022/08/03/2021.10.31.21265703.atom"/>
  <meta name="HW.pisa" content="medrxiv;2021.10.31.21265703v3"/>
  <meta name="DC.Format" content="text/html"/>
  <meta name="DC.Language" content="en"/>
  <meta name="DC.Title" content="Safety and efficacy of the two doses conjugated protein-based SOBERANA-02 COVID-19 vaccine and of a heterologous three-dose combination with SOBERANA-PLUS: double-blind, randomised, placebo-controlled phase 3 clinical trial"/>
  <meta name="DC.Identifier" content="10.1101/2021.10.31.21265703"/>
  <meta name="DC.Date" content="2022-08-03"/>
  <meta name="DC.Publisher" content="Cold Spring Harbor Laboratory Press"/>
  <meta name="DC.Rights" content="© 2022, Posted by Cold Spring Harbor Laboratory. The copyright holder for this pre-print is the author. All rights reserved. The material may not be redistributed, re-used or adapted without the author's permission."/>
  <meta name="DC.AccessRights" content="restricted"/>
  <meta name="DC.Description" content="Background SOBERANA-02 is a COVID-19 conjugate vaccine (recombinant RBD conjugated to tetanus toxoid). Phases 1/2 clinical trials demonstrated high immunogenicity, promoting neutralizing IgG and specific T-cell response. A third heterologous dose of SOBERANA-Plus (RBD-dimer) further increased neutralizing antibodies.

Methods From March 8th to September 30th, 2021 we conducted in Havana, Cuba a multicentre randomized, double-blind, placebo-controlled, phase-3 trial evaluating two doses of SOBERANA-02 and a heterologous scheme with one dose SOBERANA-Plus added to it. Participants 19–80 years were randomly assigned to receiving 28 days apart either the two or three dose scheme or placebo. The main endpoint was vaccine efficacy in preventing the occurrence of RT-PCR confirmed symptomatic COVID-19 occurring at least 14 days after the second or third dose in the per-protocol population. We also assessed efficacy against severe disease and, in all participants receiving at least one vaccine/placebo dose, safety for 28 days after each dose.

Finding We included 44·031 participants in a context of Beta VOC predominance, with this variant being gradually replaced by Delta near the trial end. Vaccine efficacy in the heterologous combination was 92·0% (95%CI 80·4–96·7) against symptomatic and 100% against severe COVID-19. Two doses of SOBERANA-02 was 69·7% (95%CI 56·5-78·9) and 74·9% (95%CI 33·7-90·5) efficacious to protect against symptomatic and severe COVID-19, respectively. The occurrence of serious and severe AEs was very rare and equally distributed between placebo and vaccine groups. Solicited AEs were slightly more frequent in the vaccine group but predominantly local and mostly mild and transient.

Interpretation Our results indicate that the straightforward to manufacture SOBERANA vaccines are efficacious in a context of Beta and Delta VOC dominance and that they constitute an attractive, feasible option for low- and middle-income countries, where besides financial constraints ease of vaccine storage and distribution is of concern.

Funding This study received funds from Finlay Vaccine Institute and National Fund for Science and Technology (FONCI-CITMA-Cuba, contract 2020–20). of Ministry of Science, Technology and the Environment (Contract Project-2020-20) in Cuba.

### Competing Interest Statement

(M. M. P, M. C. R. G., B. P. M., R. G.M. R., E. L. M., E.C.G., S. F., Y. C., Y. V.B., D. G.R., V. V. B.) are from Finlay Vaccine Institute the sponsor of the trial

### Clinical Trial

RPCEC00000354 International Clinical Trials Registry Platform. Identifier

### Funding Statement

Supported by Finlay Vaccine Institute, Biocubafarma and by Fondo Nacional de Ciencia y Tecnica (FONCI-CITMA-Cuba, contract 2020-20).

### Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The Central Research Ethics Committee from the Cuban Ministry of Health was ad hoc appointed for this trial. They approved the protocol (Clinical Trials IFV/COR/09 number, RPCEC00000354) and the consent forms.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

All data produced in the present study are available upon reasonable request to the authors

<https://rpcec.sld.cu/en/trials/RPCEC00000354-En>"/>
  <meta name="DC.Contributor" content="María Eugenia Toledo-Romaní"/>
  <meta name="DC.Contributor" content="Mayra García-Carmenate"/>
  <meta name="DC.Contributor" content="Carmen Valenzuela-Silva"/>
  <meta name="DC.Contributor" content="Waldemar Baldoquín-Rodríguez"/>
  <meta name="DC.Contributor" content="Marisel Martínez-Pérez"/>
  <meta name="DC.Contributor" content="Meiby Rodríguez-González"/>
  <meta name="DC.Contributor" content="Beatriz Paredes-Moreno"/>
  <meta name="DC.Contributor" content="Ivis Mendoza-Hernández"/>
  <meta name="DC.Contributor" content="Raúl González-Mujica"/>
  <meta name="DC.Contributor" content="Oscar Samón-Tabio"/>
  <meta name="DC.Contributor" content="Pablo Velazco-Villares"/>
  <meta name="DC.Contributor" content="Juan Pablo Bacallao-Castillo"/>
  <meta name="DC.Contributor" content="Ernesto Licea-Martín"/>
  <meta name="DC.Contributor" content="Misladys Rodríguez-Ortega"/>
  <meta name="DC.Contributor" content="Nuris Herrera-Marrero"/>
  <meta name="DC.Contributor" content="Esperanza Caballero-González"/>
  <meta name="DC.Contributor" content="Liudmila Egües-Torres"/>
  <meta name="DC.Contributor" content="Reinaldo Duartes-González"/>
  <meta name="DC.Contributor" content="Serguey García-Blanco"/>
  <meta name="DC.Contributor" content="Suzette Pérez-Cabrera"/>
  <meta name="DC.Contributor" content="Santos Huete-Ferreira"/>
  <meta name="DC.Contributor" content="Kirenia Idalmis-Cisnero"/>
  <meta name="DC.Contributor" content="Omayda Fonte-Galindo"/>
  <meta name="DC.Contributor" content="Dania Meliá-Pérez"/>
  <meta name="DC.Contributor" content="Ivonne Rojas-Remedios"/>
  <meta name="DC.Contributor" content="Delaram Doroud"/>
  <meta name="DC.Contributor" content="Mohammad Mehdi Gouya"/>
  <meta name="DC.Contributor" content="Alireza Biglari"/>
  <meta name="DC.Contributor" content="Patrick Van der Stuyft"/>
  <meta name="DC.Contributor" content="Sonsire Fernández-Castillo"/>
  <meta name="DC.Contributor" content="Yanet Climent-Ruiz"/>
  <meta name="DC.Contributor" content="Yury Valdes-Balbín"/>
  <meta name="DC.Contributor" content="Dagmar García-Rivera"/>
  <meta name="DC.Contributor" content="Vicente Verez-Bencomo"/>
  <meta name="DC.Contributor" content="the SOBERANA Phase 3 team"/>
  <meta name="article:published_time" content="2022-08-03"/>
  <meta name="citation_title" content="Safety and efficacy of the two doses conjugated protein-based SOBERANA-02 COVID-19 vaccine and of a heterologous three-dose combination with SOBERANA-PLUS: double-blind, randomised, placebo-controlled phase 3 clinical trial"/>
  <meta name="citation_abstract" lang="en" content="<h3>SUMMARY</h3>
<h3>Background</h3>
<p>SOBERANA-02 is a COVID-19 conjugate vaccine (recombinant RBD conjugated to tetanus toxoid). Phases 1/2 clinical trials demonstrated high immunogenicity, promoting neutralizing IgG and specific T-cell response. A third heterologous dose of SOBERANA-Plus (RBD-dimer) further increased neutralizing antibodies.</p><h3>Methods</h3>
<p>From March 8<sup>th</sup> to September 30<sup>th</sup>, 2021 we conducted in Havana, Cuba a multicentre randomized, double-blind, placebo-controlled, phase-3 trial evaluating two doses of SOBERANA-02 and a heterologous scheme with one dose SOBERANA-Plus added to it. Participants 19–80 years were randomly assigned to receiving 28 days apart either the two or three dose scheme or placebo. The main endpoint was vaccine efficacy in preventing the occurrence of RT-PCR confirmed symptomatic COVID-19 occurring at least 14 days after the second or third dose in the per-protocol population. We also assessed efficacy against severe disease and, in all participants receiving at least one vaccine/placebo dose, safety for 28 days after each dose.</p><h3>Finding</h3>
<p>We included 44·031 participants in a context of Beta VOC predominance, with this variant being gradually replaced by Delta near the trial end. Vaccine efficacy in the heterologous combination was 92·0% (95%CI 80·4–96·7) against symptomatic and 100% against severe COVID-19. Two doses of SOBERANA-02 was 69·7% (95%CI 56·5-78·9) and 74·9% (95%CI 33·7-90·5) efficacious to protect against symptomatic and severe COVID-19, respectively. The occurrence of serious and severe AEs was very rare and equally distributed between placebo and vaccine groups. Solicited AEs were slightly more frequent in the vaccine group but predominantly local and mostly mild and transient.</p><h3>Interpretation</h3>
<p>Our results indicate that the straightforward to manufacture SOBERANA vaccines are efficacious in a context of Beta and Delta VOC dominance and that they constitute an attractive, feasible option for low- and middle-income countries, where besides financial constraints ease of vaccine storage and distribution is of concern.</p><h3>Funding</h3>
<p>This study received funds from Finlay Vaccine Institute and National Fund for Science and Technology (FONCI-CITMA-Cuba, contract 2020–20). of Ministry of Science, Technology and the Environment (Contract Project-2020-20) in Cuba.</p>"/>
  <meta name="citation_journal_title" content="medRxiv"/>
  <meta name="citation_publisher" content="Cold Spring Harbor Laboratory Press"/>
  <meta name="citation_publication_date" content="2022/01/01"/>
  <meta name="citation_mjid" content="medrxiv;2021.10.31.21265703v3"/>
  <meta name="citation_id" content="2021.10.31.21265703v3"/>
  <meta name="citation_public_url" content="https://www.medrxiv.org/content/10.1101/2021.10.31.21265703v3"/>
  <meta name="citation_abstract_html_url" content="https://www.medrxiv.org/content/10.1101/2021.10.31.21265703v3.abstract"/>
  <meta name="citation_full_html_url" content="https://www.medrxiv.org/content/10.1101/2021.10.31.21265703v3.full"/>
  <meta name="citation_pdf_url" content="https://www.medrxiv.org/content/medrxiv/early/2022/08/03/2021.10.31.21265703.full.pdf"/>
  <meta name="citation_doi" content="10.1101/2021.10.31.21265703"/>
  <meta name="citation_num_pages" content="43"/>
  <meta name="citation_article_type" content="Article"/>
  <meta name="citation_firstpage" content="2021.10.31.21265703"/>
  <meta name="citation_author" content="María Eugenia Toledo-Romaní"/>
  <meta name="citation_author_institution" content="“Pedro Kourí” Tropical Medicine Institute. Av “Novia del Mediodía”"/>
  <meta name="citation_author_email" content="mariaeugenia@ipk.sld.cu"/>
  <meta name="citation_author_email" content="vicente.verez@finlay.edu.cu"/>
  <meta name="citation_author" content="Mayra García-Carmenate"/>
  <meta name="citation_author_institution" content="Havana Hygiene and Epidemiology Center"/>
  <meta name="citation_author" content="Carmen Valenzuela-Silva"/>
  <meta name="citation_author_institution" content="Cybernetics, Mathematics and Physics Institute"/>
  <meta name="citation_author" content="Waldemar Baldoquín-Rodríguez"/>
  <meta name="citation_author_institution" content="“Pedro Kourí” Tropical Medicine Institute. Av “Novia del Mediodía”"/>
  <meta name="citation_author" content="Marisel Martínez-Pérez"/>
  <meta name="citation_author_institution" content="Finlay Vaccine Institute"/>
  <meta name="citation_author" content="Meiby Rodríguez-González"/>
  <meta name="citation_author_institution" content="Finlay Vaccine Institute"/>
  <meta name="citation_author" content="Beatriz Paredes-Moreno"/>
  <meta name="citation_author_institution" content="Finlay Vaccine Institute"/>
  <meta name="citation_author" content="Ivis Mendoza-Hernández"/>
  <meta name="citation_author_institution" content="National Coordinating Center for Clinical Trials"/>
  <meta name="citation_author" content="Raúl González-Mujica"/>
  <meta name="citation_author_institution" content="Finlay Vaccine Institute"/>
  <meta name="citation_author" content="Oscar Samón-Tabio"/>
  <meta name="citation_author_institution" content="“José Antonio Echevarría” Technological University"/>
  <meta name="citation_author" content="Pablo Velazco-Villares"/>
  <meta name="citation_author_institution" content="UCT Geocuba Research and Consulting"/>
  <meta name="citation_author" content="Juan Pablo Bacallao-Castillo"/>
  <meta name="citation_author_institution" content="UCT Geocuba Research and Consulting"/>
  <meta name="citation_author" content="Ernesto Licea-Martín"/>
  <meta name="citation_author_institution" content="Finlay Vaccine Institute"/>
  <meta name="citation_author" content="Misladys Rodríguez-Ortega"/>
  <meta name="citation_author_institution" content="“Pedro Kourí” Tropical Medicine Institute. Av “Novia del Mediodía”"/>
  <meta name="citation_author" content="Nuris Herrera-Marrero"/>
  <meta name="citation_author_institution" content="“Pedro Kourí” Tropical Medicine Institute. Av “Novia del Mediodía”"/>
  <meta name="citation_author" content="Esperanza Caballero-González"/>
  <meta name="citation_author_institution" content="Finlay Vaccine Institute"/>
  <meta name="citation_author" content="Liudmila Egües-Torres"/>
  <meta name="citation_author_institution" content="Havana Hygiene and Epidemiology Center"/>
  <meta name="citation_author" content="Reinaldo Duartes-González"/>
  <meta name="citation_author_institution" content="Municipal Health Department, Centro Habana"/>
  <meta name="citation_author" content="Serguey García-Blanco"/>
  <meta name="citation_author_institution" content="Municipal Health Department"/>
  <meta name="citation_author" content="Suzette Pérez-Cabrera"/>
  <meta name="citation_author_institution" content="Municipal Health Department"/>
  <meta name="citation_author" content="Santos Huete-Ferreira"/>
  <meta name="citation_author_institution" content="Municipal Health Department"/>
  <meta name="citation_author" content="Kirenia Idalmis-Cisnero"/>
  <meta name="citation_author_institution" content="Municipal Health Department"/>
  <meta name="citation_author" content="Omayda Fonte-Galindo"/>
  <meta name="citation_author_institution" content="Municipal Health Department"/>
  <meta name="citation_author" content="Dania Meliá-Pérez"/>
  <meta name="citation_author_institution" content="Municipal Health Department"/>
  <meta name="citation_author" content="Ivonne Rojas-Remedios"/>
  <meta name="citation_author_institution" content="Municipal Health Department"/>
  <meta name="citation_author" content="Delaram Doroud"/>
  <meta name="citation_author_institution" content="Pasteur Institute of Iran"/>
  <meta name="citation_author_orcid" content="http://orcid.org/0000-0003-4167-9921"/>
  <meta name="citation_author" content="Mohammad Mehdi Gouya"/>
  <meta name="citation_author_institution" content="Iran University of Medical Science"/>
  <meta name="citation_author" content="Alireza Biglari"/>
  <meta name="citation_author_institution" content="Pasteur Institute of Iran"/>
  <meta name="citation_author" content="Patrick Van der Stuyft"/>
  <meta name="citation_author_institution" content="Gent University"/>
  <meta name="citation_author" content="Sonsire Fernández-Castillo"/>
  <meta name="citation_author_institution" content="Finlay Vaccine Institute"/>
  <meta name="citation_author" content="Yanet Climent-Ruiz"/>
  <meta name="citation_author_institution" content="Finlay Vaccine Institute"/>
  <meta name="citation_author" content="Yury Valdes-Balbín"/>
  <meta name="citation_author_institution" content="Finlay Vaccine Institute"/>
  <meta name="citation_author" content="Dagmar García-Rivera"/>
  <meta name="citation_author_institution" content="Finlay Vaccine Institute"/>
  <meta name="citation_author" content="Vicente Verez-Bencomo"/>
  <meta name="citation_author_institution" content="Finlay Vaccine Institute"/>
  <meta name="citation_author_email" content="mariaeugenia@ipk.sld.cu"/>
  <meta name="citation_author_email" content="vicente.verez@finlay.edu.cu"/>
  <meta name="citation_author_orcid" content="http://orcid.org/0000-0001-5596-6847"/>
  <meta name="citation_author" content="the SOBERANA Phase 3 team"/>
  <meta name="citation_reference" content="Krause PR, Fleming TR, Longini IM, et al. SARS-CoV-2 Variants and Vaccines. N Engl J Med 2021; 385:179–186 DOI: 10.1056/NEJMsr2105280"/>
  <meta name="citation_reference" content="Rotshild V, Hirsh-Raccah B, Miskin I, et al. Comparing the clinical efficacy of COVID-19 vaccines: a systematic review and network meta-analysis. Scientific Reports 2021; 11:22777 https://doi.org/10.1038/s41598-021-02321-z"/>
  <meta name="citation_reference" content="WHO. Vaccine Equity. https://www.who.int/campaigns/vaccine-equity (Accessed 22 February 2021)"/>
  <meta name="citation_reference" content="Valdes-Balbin Y, Santana-Medero D, Quintero L, et al. SARS-CoV-2 RBD-Tetanus Toxoid Conjugate Vaccine Induces a Strong Neutralizing Immunity in Preclinical Studies. ACS Chem. Biol 2021; 16: 1223–1233 https://doi.org/10.1101/2021.02.08.430146."/>
  <meta name="citation_reference" content="Schneerson R, Robbins JB, Barrera O, et al. Haemophilus influenzae type B polysaccharide-protein conjugates: Model for a new generation of capsular polysaccharide vaccines. Prog Clin Biol Res 1980; 47: 77–94"/>
  <meta name="citation_reference" content="Goldblatt D. The indirect effect of pneumococcal conjugate vaccine. Lancet Glob Health 2017; 5: e6–7 https://doi.org/10.1016/S2214-109X(16)30338-2"/>
  <meta name="citation_reference" content="Gasparini R, Panatto D. Meningococcal glycoconjugate vaccines. Hum Vaccin 2011; 7:170–82 doi: 10.4161/hv.7.2.13717"/>
  <meta name="citation_reference" content="Toledo-Romani ME, Verdecia-Sánchez L, Rodríguez-González M, et al. Safety and immunogenicity of anti-SARS CoV-2 vaccine SOBERANA 02 in homologous or heterologous scheme: Open label phase I and phase IIa clinical trials, Vaccine 2022; 40: 4220–4230 https://doi.org/10.1016/j.vaccine.2022.05.082"/>
  <meta name="citation_reference" content="Chang-Monteagudo A, Ochoa-Azze R, Climent-Ruiz Y, et al. A single dose of SARS-CoV-2 FINLAY-FR-1A vaccine enhances neutralization response in COVID-19 convalescents, with a very good safety profile: An open-label phase 1 clinical trial, Lancet Reg Health Am 2021; 4:100079 https://doi.org/10.1016/j.lana.2021.100079"/>
  <meta name="citation_reference" content="Bates TA, Mcbride SK, Leier HC, et al. Vaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variants. Sci. Immunol 2022; 7: eabn8014 DOI: 10.1126/sciimmunol.abn801"/>
  <meta name="citation_reference" content="Toledo-Romani ME, García-Carmenate M, Verdecia-Sánchez L, et al. Safety and immunogenicity of anti-SARS-CoV-2 heterologous scheme with SOBERANA 02 and SOBERANA Plus vaccines: Phase IIb clinical trial in adults. Med 2022. (accepted). Preprint: https://doi.org/10.1101/2022.01.01.21268271."/>
  <meta name="citation_reference" content="Food and Drug Administration. E6(R2) Good Clinical Practice: Integrated Addendum to ICH E6(R1). Guidance for Industry. 2018; https://www.fda.gov/regulatory-information/search-fda-guidance-documents/e6r2-good-clinical-practice-integrated-addendum-ich-e6r1 (Accessed February 2021)"/>
  <meta name="citation_reference" content="Pérez-Caballero MD, León-Álvarez JL, Dueñas-Herrera A, et al. Cuban guide for hypertension diagnosis, evaluation and treatment. Rev Cub. Med 2017, 56: 242–321. Available: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75232017000400001&lng=es"/>
  <meta name="citation_reference" content="Ochoa-Azze R, Chang-Monteagudo A, Climent-Ruiz Y et al. Safety and immunogenicity of the FINLAY-FR-1A vaccine in COVID-19 convalescent participants: an open-label phase 2a and double-blind, randomised, placebo-controlled, phase 2b, seamless, clinical trial. Lancet Respir Med 2022; https://doi.org/10.1016/S2213-2600(22)00100-X"/>
  <meta name="citation_reference" content="Pérez-Rodríguez S, Rodríguez-González MC, Ochoa-Azze R, et al. A randomized, double-blind phase I clinical trial of two recombinant dimeric RBD COVID-19 vaccine candidates: Safety, reactogenicity and immunogenicity. Vaccine 2022: 40: 2068–2075 doi: 10.1016/j.vaccine.2022.02.029"/>
  <meta name="citation_reference" content="US Department of Health and Human Services. Common Terminology Criteria for Adverse Events (CTCAE). Version 5.0. Washington: HHS; 2017; https://ctep.cancer.gov/protocoldevelopment/electronic_applications/ctc.htm#ctc_50 (accessed February, 2021)."/>
  <meta name="citation_reference" content="World Health Organization. Causality Assessment of an Adverse Event Following Immunization (AEFI). 2nd ed. Geneva: WHO; 2018. https://apps.who.int/iris/bitstream/handle/10665/259959/9789241513654-eng.pdf (accessed Dec 10, 2020)."/>
  <meta name="citation_reference" content="WHO consideration for an evaluation of COVID19 Vaccines. Point to consider for manufacturers of COVID-19 vaccines, Sept 2020; https://www.who.int/default-source/COVID19. Accessed February 2021"/>
  <meta name="citation_reference" content="Pollet J, Chen WH, Strych U. Recombinant protein vaccines, a proven approach against coronavirus pandemics. Advanced Drug Delivery Reviews 2021; 170: 71–82 doi: 10.1016/j.addr.2021.01.001."/>
  <meta name="citation_reference" content="Ying W, Pak-Hang P. Effectiveness of heterologous and homologous covid-19 vaccine regimens: living systematic review with network meta-analysis. BMJ 2022; 377:e069989.doi: 10.1136/bmj-2022-069989"/>
  <meta name="citation_reference" content="Shaw R, Stuart A, Greenland M, Liu X, Nguyen JVT, Snape M, Com-COV Study Group. Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data. Lancet 2021; 397:2043–2046 doi: 10.1016/S0140-6736(21)01115-6."/>
  <meta name="citation_reference" content="Stuart A, Shaw R, Liu X, et al. Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial. Lancet 2022; 399:36–49. doi: 10.1016/S0140-6736(21)02718-5."/>
  <meta name="citation_reference" content="Jin P, Guo X, Chen W et al. Safety and immunogenicity of heterologous boost immunization with an adenovirus type-5-vectored and protein-subunit-based COVID-19 vaccine (Convidecia/ZF2001): A randomized, observer-blinded, placebo-controlled trial. PLoS Med 2022; 19: e1003953. doi: 10.1371/journal.pmed.1003953."/>
  <meta name="citation_reference" content="Korang SK, von Rohden E, Veroniki AA, et al. Vaccines to prevent COVID-19: A living systematic review with Trial Sequential Analysis and network meta-analysis of randomized clinical trials. PLoS ONE 2022; 17(1): 1–23 e0260733 https://doi.org/10.1371/journal.pone.0260733"/>
  <meta name="citation_reference" content="Jangra S. Ye C, Rathnasinghe R et al. SARS-CoV-2 spike E484K mutation reduces antibody neutralization. The Lancet Microbe 202; 2: 283–284, https://doi.org/10.1016/S2666-5247(21)00068-9"/>
  <meta name="citation_reference" content="Thomas SJ, Moreira ED, Kitchin N et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months. N Engl J Med 2021; 385:1761–1773 doi: 10.1056/NEJMoa2110345"/>
  <meta name="citation_reference" content="Madhi SA, Baillie V, Cutland CL, et al. Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant. N Engl J Med 2021; 384:1885–98. doi: 10.1056/NEJMoa2102214"/>
  <meta name="citation_reference" content="Sadoff J, Gray G, Vandebosch A. Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19. Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19. N Engl J Med 2021; 384: 2187–2201 doi: 10.1056/NEJMoa2101544."/>
  <meta name="citation_reference" content="Shinde V, Bhikha S., Hoosain Z, et al. Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant. N Engl J Med 2021, 384: 1899–1909 doi: 10.1056/NEJMoa210305"/>
  <meta name="twitter:title" content="Safety and efficacy of the two doses conjugated protein-based SOBERANA-02 COVID-19 vaccine and of a heterologous three-dose combination with SOBERANA-PLUS: double-blind, randomised, placebo-controlled phase 3 clinical trial"/>
  <meta name="twitter:site" content="@medrxivpreprint"/>
  <meta name="twitter:card" content="summary"/>
  <meta name="twitter:image" content="https://www.medrxiv.org/sites/default/files/images/medrxiv_logo_homepage7-5-small-test-up.png"/>
  <meta name="twitter:description" content="Background SOBERANA-02 is a COVID-19 conjugate vaccine (recombinant RBD conjugated to tetanus toxoid). Phases 1/2 clinical trials demonstrated high immunogenicity, promoting neutralizing IgG and specific T-cell response. A third heterologous dose of SOBERANA-Plus (RBD-dimer) further increased neutralizing antibodies.

Methods From March 8th to September 30th, 2021 we conducted in Havana, Cuba a multicentre randomized, double-blind, placebo-controlled, phase-3 trial evaluating two doses of SOBERANA-02 and a heterologous scheme with one dose SOBERANA-Plus added to it. Participants 19–80 years were randomly assigned to receiving 28 days apart either the two or three dose scheme or placebo. The main endpoint was vaccine efficacy in preventing the occurrence of RT-PCR confirmed symptomatic COVID-19 occurring at least 14 days after the second or third dose in the per-protocol population. We also assessed efficacy against severe disease and, in all participants receiving at least one vaccine/placebo dose, safety for 28 days after each dose.

Finding We included 44·031 participants in a context of Beta VOC predominance, with this variant being gradually replaced by Delta near the trial end. Vaccine efficacy in the heterologous combination was 92·0% (95%CI 80·4–96·7) against symptomatic and 100% against severe COVID-19. Two doses of SOBERANA-02 was 69·7% (95%CI 56·5-78·9) and 74·9% (95%CI 33·7-90·5) efficacious to protect against symptomatic and severe COVID-19, respectively. The occurrence of serious and severe AEs was very rare and equally distributed between placebo and vaccine groups. Solicited AEs were slightly more frequent in the vaccine group but predominantly local and mostly mild and transient.

Interpretation Our results indicate that the straightforward to manufacture SOBERANA vaccines are efficacious in a context of Beta and Delta VOC dominance and that they constitute an attractive, feasible option for low- and middle-income countries, where besides financial constraints ease of vaccine storage and distribution is of concern.

Funding This study received funds from Finlay Vaccine Institute and National Fund for Science and Technology (FONCI-CITMA-Cuba, contract 2020–20). of Ministry of Science, Technology and the Environment (Contract Project-2020-20) in Cuba.

### Competing Interest Statement

(M. M. P, M. C. R. G., B. P. M., R. G.M. R., E. L. M., E.C.G., S. F., Y. C., Y. V.B., D. G.R., V. V. B.) are from Finlay Vaccine Institute the sponsor of the trial

### Clinical Trial

RPCEC00000354 International Clinical Trials Registry Platform. Identifier

### Funding Statement

Supported by Finlay Vaccine Institute, Biocubafarma and by Fondo Nacional de Ciencia y Tecnica (FONCI-CITMA-Cuba, contract 2020-20).

### Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The Central Research Ethics Committee from the Cuban Ministry of Health was ad hoc appointed for this trial. They approved the protocol (Clinical Trials IFV/COR/09 number, RPCEC00000354) and the consent forms.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

All data produced in the present study are available upon reasonable request to the authors

<https://rpcec.sld.cu/en/trials/RPCEC00000354-En>"/>
  <meta name="og-title" property="og:title" content="Safety and efficacy of the two doses conjugated protein-based SOBERANA-02 COVID-19 vaccine and of a heterologous three-dose combination with SOBERANA-PLUS: double-blind, randomised, placebo-controlled phase 3 clinical trial"/>
  <meta name="og-url" property="og:url" content="https://www.medrxiv.org/content/10.1101/2021.10.31.21265703v3"/>
  <meta name="og-site-name" property="og:site_name" content="medRxiv"/>
  <meta name="og-description" property="og:description" content="Background SOBERANA-02 is a COVID-19 conjugate vaccine (recombinant RBD conjugated to tetanus toxoid). Phases 1/2 clinical trials demonstrated high immunogenicity, promoting neutralizing IgG and specific T-cell response. A third heterologous dose of SOBERANA-Plus (RBD-dimer) further increased neutralizing antibodies.

Methods From March 8th to September 30th, 2021 we conducted in Havana, Cuba a multicentre randomized, double-blind, placebo-controlled, phase-3 trial evaluating two doses of SOBERANA-02 and a heterologous scheme with one dose SOBERANA-Plus added to it. Participants 19–80 years were randomly assigned to receiving 28 days apart either the two or three dose scheme or placebo. The main endpoint was vaccine efficacy in preventing the occurrence of RT-PCR confirmed symptomatic COVID-19 occurring at least 14 days after the second or third dose in the per-protocol population. We also assessed efficacy against severe disease and, in all participants receiving at least one vaccine/placebo dose, safety for 28 days after each dose.

Finding We included 44·031 participants in a context of Beta VOC predominance, with this variant being gradually replaced by Delta near the trial end. Vaccine efficacy in the heterologous combination was 92·0% (95%CI 80·4–96·7) against symptomatic and 100% against severe COVID-19. Two doses of SOBERANA-02 was 69·7% (95%CI 56·5-78·9) and 74·9% (95%CI 33·7-90·5) efficacious to protect against symptomatic and severe COVID-19, respectively. The occurrence of serious and severe AEs was very rare and equally distributed between placebo and vaccine groups. Solicited AEs were slightly more frequent in the vaccine group but predominantly local and mostly mild and transient.

Interpretation Our results indicate that the straightforward to manufacture SOBERANA vaccines are efficacious in a context of Beta and Delta VOC dominance and that they constitute an attractive, feasible option for low- and middle-income countries, where besides financial constraints ease of vaccine storage and distribution is of concern.

Funding This study received funds from Finlay Vaccine Institute and National Fund for Science and Technology (FONCI-CITMA-Cuba, contract 2020–20). of Ministry of Science, Technology and the Environment (Contract Project-2020-20) in Cuba.

### Competing Interest Statement

(M. M. P, M. C. R. G., B. P. M., R. G.M. R., E. L. M., E.C.G., S. F., Y. C., Y. V.B., D. G.R., V. V. B.) are from Finlay Vaccine Institute the sponsor of the trial

### Clinical Trial

RPCEC00000354 International Clinical Trials Registry Platform. Identifier

### Funding Statement

Supported by Finlay Vaccine Institute, Biocubafarma and by Fondo Nacional de Ciencia y Tecnica (FONCI-CITMA-Cuba, contract 2020-20).

### Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The Central Research Ethics Committee from the Cuban Ministry of Health was ad hoc appointed for this trial. They approved the protocol (Clinical Trials IFV/COR/09 number, RPCEC00000354) and the consent forms.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

All data produced in the present study are available upon reasonable request to the authors

<https://rpcec.sld.cu/en/trials/RPCEC00000354-En>"/>
  <meta name="og-type" property="og:type" content="article"/>
  <meta name="og-image" property="og:image" content="https://www.medrxiv.org/sites/default/files/images/medrxiv_logo_homepage7-5-small-test-up.png"/>
  <meta name="citation_date" content="2022-08-03"/>
  <meta name="description" content="medRxiv - The Preprint Server for Health Sciences"/>
  <meta name="generator" content="Drupal 7 (http://drupal.org)"/>
  <link rel="canonical" href="https://www.medrxiv.org/content/10.1101/2021.10.31.21265703v3"/>
  <link rel="shortlink" href="https://www.medrxiv.org/node/545164"/>
  <title>
   Safety and efficacy of the two doses conjugated protein-based SOBERANA-02 COVID-19 vaccine and of a heterologous three-dose combination with SOBERANA-PLUS: double-blind, randomised, placebo-controlled phase 3 clinical trial | medRxiv
  </title>
  <link type="text/css" rel="stylesheet" href="https://www.medrxiv.org/sites/default/files/advagg_css/css__7SC0i-kTgUlQGKuqbmyS18Sez8FDO-aG9FSHkGrLGl8__9Xf-fJpmF9h8tvWywQTaOzJzFLt4sEfx108Wh1gYmm0__yDRjOTiBnSnu2tzh2xbnVTigKcZk0CFMqnf6m8vMg3M.css" media="all"/>
  <link type="text/css" rel="stylesheet" href="//cdn.jsdelivr.net/qtip2/2.2.1/jquery.qtip.min.css" media="all"/>
  <link type="text/css" rel="stylesheet" href="https://www.medrxiv.org/sites/default/files/advagg_css/css__JbFqFjYGp4Zx8gvmj6v5YmfNmbiFphGHPblyC9bfG5Y__OScmsb_1nSVmm_Ax3cJ5Rq7p081PahYkvF_YWQd5GtE__yDRjOTiBnSnu2tzh2xbnVTigKcZk0CFMqnf6m8vMg3M.css" media="all"/>
  <style type="text/css" media="all">
   /* &lt;![CDATA[ */
.panels-flexible-new .panels-flexible-region{padding:0}.panels-flexible-new .panels-flexible-region-inside{padding-right:.5em;padding-left:.5em}.panels-flexible-new .panels-flexible-region-inside-first{padding-left:0}.panels-flexible-new .panels-flexible-region-inside-last{padding-right:0}.panels-flexible-new .panels-flexible-column{padding:0}.panels-flexible-new .panels-flexible-column-inside{padding-right:.5em;padding-left:.5em}.panels-flexible-new .panels-flexible-column-inside-first{padding-left:0}.panels-flexible-new .panels-flexible-column-inside-last{padding-right:0}.panels-flexible-new .panels-flexible-row{padding:0 0 .5em;margin:0}.panels-flexible-new .panels-flexible-row-last{padding-bottom:0}.panels-flexible-column-new-main{float:left;width:99.0000%}.panels-flexible-new-inside{padding-right:0}.panels-flexible-new{width:auto}.panels-flexible-region-new-center{float:left;width:99.0000%}.panels-flexible-row-new-main-row-inside{padding-right:0}
/* ]]&gt; */
  </style>
  <link type="text/css" rel="stylesheet" href="https://www.medrxiv.org/sites/default/files/advagg_css/css__PWuQ_RYRTJ4BLEKsbWQeHysPg0gOQ3571ruQa_rXvAo__cj81oxtSGUe-AIO3tlkSBJPNpKP5ZgLdB8f8awBQsWU__yDRjOTiBnSnu2tzh2xbnVTigKcZk0CFMqnf6m8vMg3M.css" media="all"/>
  <style type="text/css" media="all">
   /* &lt;![CDATA[ */
#sliding-popup.sliding-popup-bottom,#sliding-popup.sliding-popup-bottom .eu-cookie-withdraw-banner,.eu-cookie-withdraw-tab{background:gray}#sliding-popup.sliding-popup-bottom.eu-cookie-withdraw-wrapper{background:transparent}#sliding-popup .popup-content #popup-text h1,#sliding-popup .popup-content #popup-text h2,#sliding-popup .popup-content #popup-text h3,#sliding-popup .popup-content #popup-text p,.eu-cookie-compliance-secondary-button,.eu-cookie-withdraw-tab{color:#fff !important}.eu-cookie-withdraw-tab{border-color:#fff}.eu-cookie-compliance-more-button{color:#fff !important}
/* ]]&gt; */
  </style>
  <link type="text/css" rel="stylesheet" href="https://www.medrxiv.org/sites/default/files/advagg_css/css__Wnlyen9qEpwh_Qaf9okEu4QdVGM0BDothxeqA6Nbvo8__EJmw6SZD9bYoS8jocCpPYS3JFRURpdzmuvJoAUNiI-g__yDRjOTiBnSnu2tzh2xbnVTigKcZk0CFMqnf6m8vMg3M.css" media="all"/>
  <link type="text/css" rel="stylesheet" href="https://www.medrxiv.org/sites/default/files/advagg_css/css__MF4P_i8lKWP7DQR7GmjDAVTRBKLnzxvs1Dvton-Awi0__yi5OflfckG_G8-Li4dDQQ3wO9cGIcdPx_YQ7ZZDuj5w__yDRjOTiBnSnu2tzh2xbnVTigKcZk0CFMqnf6m8vMg3M.css" media="all"/>
  <link type="text/css" rel="stylesheet" href="https://www.medrxiv.org/sites/default/files/advagg_css/css__2WBMox6sOrN42ss5lCnH7WWVRdFdJCxtTKnQJYRwTE4__yqNvNYLvMpjy3ffuJrjjm9uW2i-Me1c23KLYuWHaqio__yDRjOTiBnSnu2tzh2xbnVTigKcZk0CFMqnf6m8vMg3M.css" media="all"/>
  <link type="text/css" rel="stylesheet" href="https://www.medrxiv.org/sites/default/files/advagg_css/css__5mxrBK4DuyvC2MR5irx_TzVn9c8vr4vIjmBXjunHfxE__rtQnXv8GOc-AsynbhzSlQBD_2lVxAkB6XEFUCK72qXc__yDRjOTiBnSnu2tzh2xbnVTigKcZk0CFMqnf6m8vMg3M.css" media="all"/>
  <link type="text/css" rel="stylesheet" href="https://d33xdlntwy0kbs.cloudfront.net/cshl_custom_medrxiv.css" media="all"/>
  <script type="text/javascript" src="https://www.medrxiv.org/sites/default/files/advagg_js/js__BKYqkKToQ7EjirB7eIdMEH5521EU3da9IpoOs8Ex2XI__aSjVoX8giBmLhN2EbCgIGQJNu89Mh5aVu1LvI_gkJ7Y__yDRjOTiBnSnu2tzh2xbnVTigKcZk0CFMqnf6m8vMg3M.js">
  </script>
  <script type="text/javascript" src="//cdn.jsdelivr.net/qtip2/2.2.1/jquery.qtip.min.js">
  </script>
  <script type="text/javascript" src="https://www.medrxiv.org/sites/default/files/advagg_js/js__4Cn2dxvNlsJ-sHe6QOTLREaQvcqb0Yh0Zm9tTOHtQow__JeZEUjzbaj_yX6UjCI8eBbXy_J64ZVuoWmc2fSpLZHo__yDRjOTiBnSnu2tzh2xbnVTigKcZk0CFMqnf6m8vMg3M.js">
  </script>
  <script type="text/javascript" src="https://www.google.com/recaptcha/api.js?hl=en&render=explicit&onload=drupalRecaptchaOnload">
  </script>
  <script type="text/javascript" src="https://www.medrxiv.org/sites/default/files/advagg_js/js__dGWpV57YWu3sX6UOe04RMH-iP9jSkEP7Ajt0caYXZZk__u2clNMaOO3LCM0tpFNpsQhnHrJ4_SUXG1gFb00eB1iU__yDRjOTiBnSnu2tzh2xbnVTigKcZk0CFMqnf6m8vMg3M.js">
  </script>
  <script type="text/javascript" async="async" src="https://scholar.google.com/scholar_js/casa.js">
  </script>
  <script type="text/javascript">
   &lt;!--//--&gt;&lt;![CDATA[//&gt;&lt;!--
/*!
 * yepnope1.5.4
 * (c) WTFPL, GPLv2
 */
(function(a,b,c){function d(a){return"[object Function]"==o.call(a)}function e(a){return"string"==typeof a}function f(){}function g(a){return!a||"loaded"==a||"complete"==a||"uninitialized"==a}function h(){var a=p.shift();q=1,a?a.t?m(function(){("c"==a.t?B.injectCss:B.injectJs)(a.s,0,a.a,a.x,a.e,1)},0):(a(),h()):q=0}function i(a,c,d,e,f,i,j){function k(b){if(!o&amp;&amp;g(l.readyState)&amp;&amp;(u.r=o=1,!q&amp;&amp;h(),l.onload=l.onreadystatechange=null,b)){"img"!=a&amp;&amp;m(function(){t.removeChild(l)},50);for(var d in y[c])y[c].hasOwnProperty(d)&amp;&amp;y[c][d].onload()}}var j=j||B.errorTimeout,l=b.createElement(a),o=0,r=0,u={t:d,s:c,e:f,a:i,x:j};1===y[c]&amp;&amp;(r=1,y[c]=[]),"object"==a?l.data=c:(l.src=c,l.type=a),l.width=l.height="0",l.onerror=l.onload=l.onreadystatechange=function(){k.call(this,r)},p.splice(e,0,u),"img"!=a&amp;&amp;(r||2===y[c]?(t.insertBefore(l,s?null:n),m(k,j)):y[c].push(l))}function j(a,b,c,d,f){return q=0,b=b||"j",e(a)?i("c"==b?v:u,a,b,this.i++,c,d,f):(p.splice(this.i++,0,a),1==p.length&amp;&amp;h()),this}function k(){var a=B;return a.loader={load:j,i:0},a}var l=b.documentElement,m=a.setTimeout,n=b.getElementsByTagName("script")[0],o={}.toString,p=[],q=0,r="MozAppearance"in l.style,s=r&amp;&amp;!!b.createRange().compareNode,t=s?l:n.parentNode,l=a.opera&amp;&amp;"[object Opera]"==o.call(a.opera),l=!!b.attachEvent&amp;&amp;!l,u=r?"object":l?"script":"img",v=l?"script":u,w=Array.isArray||function(a){return"[object Array]"==o.call(a)},x=[],y={},z={timeout:function(a,b){return b.length&amp;&amp;(a.timeout=b[0]),a}},A,B;B=function(a){function b(a){var a=a.split("!"),b=x.length,c=a.pop(),d=a.length,c={url:c,origUrl:c,prefixes:a},e,f,g;for(f=0;f&lt;d;f++)g=a[f].split("="),(e=z[g.shift()])&amp;&amp;(c=e(c,g));for(f=0;f&lt;b;f++)c=x[f](c);return c}function g(a,e,f,g,h){var i=b(a),j=i.autoCallback;i.url.split(".").pop().split("?").shift(),i.bypass||(e&amp;&amp;(e=d(e)?e:e[a]||e[g]||e[a.split("/").pop().split("?")[0]]),i.instead?i.instead(a,e,f,g,h):(y[i.url]?i.noexec=!0:y[i.url]=1,f.load(i.url,i.forceCSS||!i.forceJS&amp;&amp;"css"==i.url.split(".").pop().split("?").shift()?"c":c,i.noexec,i.attrs,i.timeout),(d(e)||d(j))&amp;&amp;f.load(function(){k(),e&amp;&amp;e(i.origUrl,h,g),j&amp;&amp;j(i.origUrl,h,g),y[i.url]=2})))}function h(a,b){function c(a,c){if(a){if(e(a))c||(j=function(){var a=[].slice.call(arguments);k.apply(this,a),l()}),g(a,j,b,0,h);else if(Object(a)===a)for(n in m=function(){var b=0,c;for(c in a)a.hasOwnProperty(c)&amp;&amp;b++;return b}(),a)a.hasOwnProperty(n)&amp;&amp;(!c&amp;&amp;!--m&amp;&amp;(d(j)?j=function(){var a=[].slice.call(arguments);k.apply(this,a),l()}:j[n]=function(a){return function(){var b=[].slice.call(arguments);a&amp;&amp;a.apply(this,b),l()}}(k[n])),g(a[n],j,b,n,h))}else!c&amp;&amp;l()}var h=!!a.test,i=a.load||a.both,j=a.callback||f,k=j,l=a.complete||f,m,n;c(h?a.yep:a.nope,!!i),i&amp;&amp;c(i)}var i,j,l=this.yepnope.loader;if(e(a))g(a,0,l,0);else if(w(a))for(i=0;i&lt;a.length;i++)j=a[i],e(j)?g(j,0,l,0):w(j)?B(j):Object(j)===j&amp;&amp;h(j,l);else Object(a)===a&amp;&amp;h(a,l)},B.addPrefix=function(a,b){z[a]=b},B.addFilter=function(a){x.push(a)},B.errorTimeout=1e4,null==b.readyState&amp;&amp;b.addEventListener&amp;&amp;(b.readyState="loading",b.addEventListener("DOMContentLoaded",A=function(){b.removeEventListener("DOMContentLoaded",A,0),b.readyState="complete"},0)),a.yepnope=k(),a.yepnope.executeStack=h,a.yepnope.injectJs=function(a,c,d,e,i,j){var k=b.createElement("script"),l,o,e=e||B.errorTimeout;k.src=a;for(o in d)k.setAttribute(o,d[o]);c=j?h:c||f,k.onreadystatechange=k.onload=function(){!l&amp;&amp;g(k.readyState)&amp;&amp;(l=1,c(),k.onload=k.onreadystatechange=null)},m(function(){l||(l=1,c(1))},e),i?k.onload():n.parentNode.insertBefore(k,n)},a.yepnope.injectCss=function(a,c,d,e,g,i){var e=b.createElement("link"),j,c=i?h:c||f;e.href=a,e.rel="stylesheet",e.type="text/css";for(j in d)e.setAttribute(j,d[j]);g||(n.parentNode.insertBefore(e,n),m(c,0))}})(this,document);

//--&gt;&lt;!]]&gt;
  </script>
  <script type="text/javascript">
   &lt;!--//--&gt;&lt;![CDATA[//&gt;&lt;!--
yepnope({
  test: Modernizr.matchmedia,
  nope: '/sites/all/libraries/media-match/media.match.min.js'
});
//--&gt;&lt;!]]&gt;
  </script>
  <script type="text/javascript">
   &lt;!--//--&gt;&lt;![CDATA[//&gt;&lt;!--
var _prum=[['id', '52e95df3abe53d2e33000000'], ['mark', 'firstbyte',
      (new Date()).getTime()]]; (function() {
      var s=document.getElementsByTagName('script')[0],
      p=document.createElement('script');
      p.async='async'; p.src='//rum-static.pingdom.net/prum.min.js';s.parentNode.insertBefore(p,s);})();
//--&gt;&lt;!]]&gt;
  </script>
  <script type="text/javascript">
   &lt;!--//--&gt;&lt;![CDATA[//&gt;&lt;!--
if(typeof window.MathJax === "undefined") window.MathJax = { menuSettings: { zoom: "Click" } };
//--&gt;&lt;!]]&gt;
  </script>
  <script type="text/javascript">
   &lt;!--//--&gt;&lt;![CDATA[//&gt;&lt;!--
(function(i,s,o,g,r,a,m){i["GoogleAnalyticsObject"]=r;i[r]=i[r]||function(){(i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)})(window,document,"script","//www.google-analytics.com/analytics.js","ga");ga("create", "UA-141606356-1", {"cookieDomain":"auto"});ga("set", "page", location.pathname + location.search + location.hash);ga("send", "pageview");ga('create', 'UA-189672-38', 'auto', {'name': 'hwTracker'});
ga('set', 'anonymizeIp', true);
ga('hwTracker.send', 'pageview');
//--&gt;&lt;!]]&gt;
  </script>
  <script type="text/javascript">
   &lt;!--//--&gt;&lt;![CDATA[//&gt;&lt;!--
jQuery.extend(Drupal.settings,{"basePath":"\/","pathPrefix":"","ajaxPageState":{"theme":"jcore_1","theme_token":"R1ndTyWzeyHigWNEtuv_Zm8VEBdHLVMpvGYR8fgoGDk"},"colorbox":{"opacity":"0.85","current":"{current} of {total}","previous":"\u00ab Prev","next":"Next \u00bb","close":"Close","maxWidth":"98%","maxHeight":"98%","fixed":true,"mobiledetect":true,"mobiledevicewidth":"480px"},"highwire":{"nid":"545164","apath":"\/medrxiv\/early\/2022\/08\/03\/2021.10.31.21265703.atom","pisa":"medrxiv;2021.10.31.21265703v3","processed":["highwire_math"],"markup":[{"requested":"full-text","variant":"full-text","view":"full","pisa":"medrxiv;2021.10.31.21265703v3"}],"modal_window_width":"560","share_modal_width":"560","share_modal_title":"Share this Article"},"jcarousel":{"ajaxPath":"\/jcarousel\/ajax\/views"},"instances":"{\u0022highwire_abstract_tooltip\u0022:{\u0022content\u0022:{\u0022text\u0022:\u0022\u0022},\u0022style\u0022:{\u0022tip\u0022:{\u0022width\u0022:20,\u0022height\u0022:20,\u0022border\u0022:1,\u0022offset\u0022:0,\u0022corner\u0022:true},\u0022classes\u0022:\u0022qtip-custom hw-tooltip hw-abstract-tooltip qtip-shadow qtip-rounded\u0022,\u0022classes_custom\u0022:\u0022hw-tooltip hw-abstract-tooltip\u0022},\u0022position\u0022:{\u0022at\u0022:\u0022right center\u0022,\u0022my\u0022:\u0022left center\u0022,\u0022viewport\u0022:true,\u0022adjust\u0022:{\u0022method\u0022:\u0022shift\u0022}},\u0022show\u0022:{\u0022event\u0022:\u0022mouseenter click \u0022,\u0022solo\u0022:true},\u0022hide\u0022:{\u0022event\u0022:\u0022mouseleave \u0022,\u0022fixed\u0022:1,\u0022delay\u0022:\u0022100\u0022}},\u0022highwire_author_tooltip\u0022:{\u0022content\u0022:{\u0022text\u0022:\u0022\u0022},\u0022style\u0022:{\u0022tip\u0022:{\u0022width\u0022:15,\u0022height\u0022:15,\u0022border\u0022:1,\u0022offset\u0022:0,\u0022corner\u0022:true},\u0022classes\u0022:\u0022qtip-custom hw-tooltip hw-author-tooltip qtip-shadow qtip-rounded\u0022,\u0022classes_custom\u0022:\u0022hw-tooltip hw-author-tooltip\u0022},\u0022position\u0022:{\u0022at\u0022:\u0022top center\u0022,\u0022my\u0022:\u0022bottom center\u0022,\u0022viewport\u0022:true,\u0022adjust\u0022:{\u0022method\u0022:\u0022\u0022}},\u0022show\u0022:{\u0022event\u0022:\u0022mouseenter \u0022,\u0022solo\u0022:true},\u0022hide\u0022:{\u0022event\u0022:\u0022mouseleave \u0022,\u0022fixed\u0022:1,\u0022delay\u0022:\u0022100\u0022}},\u0022highwire_reflinks_tooltip\u0022:{\u0022content\u0022:{\u0022text\u0022:\u0022\u0022},\u0022style\u0022:{\u0022tip\u0022:{\u0022width\u0022:15,\u0022height\u0022:15,\u0022border\u0022:1,\u0022mimic\u0022:\u0022top center\u0022,\u0022offset\u0022:0,\u0022corner\u0022:true},\u0022classes\u0022:\u0022qtip-custom hw-tooltip hw-ref-link-tooltip qtip-shadow qtip-rounded\u0022,\u0022classes_custom\u0022:\u0022hw-tooltip hw-ref-link-tooltip\u0022},\u0022position\u0022:{\u0022at\u0022:\u0022bottom left\u0022,\u0022my\u0022:\u0022top left\u0022,\u0022viewport\u0022:true,\u0022adjust\u0022:{\u0022method\u0022:\u0022flip\u0022}},\u0022show\u0022:{\u0022event\u0022:\u0022mouseenter \u0022,\u0022solo\u0022:true},\u0022hide\u0022:{\u0022event\u0022:\u0022mouseleave \u0022,\u0022fixed\u0022:1,\u0022delay\u0022:\u0022100\u0022}}}","qtipDebug":"{\u0022leaveElement\u0022:0}","panel_ajax_tab":{"path":"sites\/all\/modules\/contrib\/panels_ajax_tab"},"disqus":{"domain":"medRxiv","url":"https:\/\/www.medrxiv.org\/content\/10.1101\/2021.10.31.21265703v3","title":"Safety and efficacy of the two doses conjugated protein-based SOBERANA-02 COVID-19 vaccine and of a heterologous three-dose combination with SOBERANA-PLUS: double-blind, randomised, placebo-controlled phase 3 clinical trial","identifier":"node\/545164"},"panels_ajax_pane":{"new-28877068-b9cb-4641-830b-b6b4638c98bb":"{\u0022encrypted\u0022:\u0022{\\\u0022encrypted\\\u0022:\\\u0022rg5fuuQW9pUkfrp9lCZvFB9P8Zf1jNnpIlTmpV14rOlGK6Sll3lDdvV2GMhOqrxOo3gvKqwwRpi1+xB\\\\\\\/10Wo+P\\\\\\\/yxtb8xYu7sJrVvghbC7jLPRH5Ehd3\\\\\\\/6ujIbx0BUFILehogJ1PbbgURXSrRaXtgazNYEpXni+Uud6aPGWO1xhk5rwPwatmNHq\\\\\\\/K0Oyor0TiqA\\\\\\\/zR27qPE65Ad16fkhZ11yL5RizQyYnab5yqvcYPT2iH7+Z63QxAC+VjRL7sFTgDQi4wswLJSDESdcJfYSY0FfKNZOeADcwf8RJDCfuRHANRtFON9jBe0GUsx+O3WaqEU7EV29qvM7TUKOswRpwYyoET8ka35B0Vz2GUogiB4ggEWB3Il9FffW7OyyHFiHseLIJjww5p1zNVng8VsriUockhfq9YOHlkQ+Udb919L9X4iikxbgAu6Tid4jImKUBfLxTSwHIFKA87cjyolMFcTHKlpDcjhspHZuLge7PtaGP3g+Y48mo4XO9WmDRl2aN9Eg2dIYfHAokWl9qLvoHRORGTKbyUlaacWe0CRZhsKP5myHgquvJHhueTHPYr+dMLhgRRab2qp\\\\\\\/YHpc5dyhr6W81eWC8GvqcI9hGUvO8irCkUBbcEr9LbwGlQ0XehI33tFpyGuRvbCXzPrluuCzpRsOk+gRGJq+oLpVGu1wSrkdXO4ZxdcBp8s+o1BWJL2L1Uq5cbXOFgO32RWYrsGr2LjOuDomw9yhjwBEpALO9Gjazs43jA1ZyjjWidBR3Xm0WTmcLnHBJQCn2k7Pv2yVHm0d0\\\\\\\/ZXIt7kqbda2RMsccXxJIvtMPqei9E93TNxffaaHShiIHvBLI7EyMseYKCX6iYbdK1rH+gnowr1R4JRSMczxo4sIRj4NZeFESzWJ5ekBW0fXcEEso2fMhYREzorvcVLyYLzfmIC9eBGBibGPg+I3vVnBHCEhrmLy3WSYZBag6SUtrnVXdfl28n7BE8U0JeZzcvkQ5ZegrbffVBUU\\\\\\\/5APvpyktRepRGGCVFnQVg4ms0xIYuXkSPuUkXWFGTEWLrCwIToynNaFL8De9w4FwF5Itoo8MflLpK6I+8iXU81atn22Ncor4xPJWss3gVJbD7nzEVOu2DcZoKoXKkuym3+XPu8OYlcOVzBCApVPEXfwZMrZEb62eSuGW4WeakXLmuVo0qsSVEuDWwTChIDahDeqaVPDSV8YaYyy9nwVFjQD1Thy6gguBJ3ejlojXNaD4f\\\\\\\/khbZfrVPRLT32fkkDeT85GDb96pz\\\\\\\/KVoG0u+i34z+dm9wTeW2J3Y6zlrrBW7C4XBA1rbVF\\\\\\\/Bkbu6J98FwlMz6RhRTd5YUJ94a6d0vH0k\\\\\\\/mGw4HNlskkUKUCh1+SOk+O2b63tkw68bHGU5aCkPDQ=\\\u0022,\\\u0022iv\\\u0022:\\\u0022N8Am7bLkc7RZrQ1WvcrU9g==\\\u0022,\\\u0022salt\\\u0022:\\\u0022f9d8845712f72c9fee5db7d9ff111eab\\\u0022}\u0022,\u0022hmac\u0022:\u0022081d144d02e78868ff790375fe13a21c066fcd64d29d0bad5299731e91eaf37c\u0022}"},"urlIsAjaxTrusted":{"\/content\/10.1101\/2021.10.31.21265703v3.full":true},"ws_fl":{"width":100,"height":21},"ws_gpo":{"size":"","annotation":"","lang":"","callback":"","width":300},"color":{"logo":"https:\/\/www.medrxiv.org\/sites\/default\/files\/medrxiv_internal_logo.png"},"highwire_list_expand":{"is_collapsed":"1"},"highwireResponsive":{"enquire_enabled":1,"breakpoints_configured":1,"breakpoints":{"zero":"all and (min-width: 0px)","xsmall":"all and (min-width: 380px)","narrow":"all and (min-width: 768px) and (min-device-width: 768px), (max-device-width: 800px) and (min-width: 768px) and (orientation:landscape)","normal":"all and (min-width: 980px) and (min-device-width: 980px), all and (max-device-width: 1024px) and (min-width: 1024px) and (orientation:landscape)","wide":"all and (min-width: 1220px)"}},"eu_cookie_compliance":{"popup_enabled":1,"popup_agreed_enabled":0,"popup_hide_agreed":0,"popup_clicking_confirmation":1,"popup_scrolling_confirmation":false,"popup_html_info":"\u003Cdiv\u003E\n  \u003Cdiv class =\u0022popup-content info\u0022\u003E\n    \u003Cdiv id=\u0022popup-text\u0022\u003E\n      \u003Cp\u003EWe use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.\u003C\/p\u003E\n    \u003C\/div\u003E\n    \u003Cdiv id=\u0022popup-buttons\u0022\u003E\n      \u003Cbutton type=\u0022button\u0022 class=\u0022agree-button eu-cookie-compliance-default-button\u0022\u003EContinue\u003C\/button\u003E\n                    \u003Cbutton type=\u0022button\u0022 class=\u0022find-more-button eu-cookie-compliance-more-button\u0022\u003EFind out more\u003C\/button\u003E\n          \u003C\/div\u003E\n  \u003C\/div\u003E\n\u003C\/div\u003E","use_mobile_message":false,"mobile_popup_html_info":"\u003Cdiv\u003E\n  \u003Cdiv class =\u0022popup-content info\u0022\u003E\n    \u003Cdiv id=\u0022popup-text\u0022\u003E\n          \u003C\/div\u003E\n    \u003Cdiv id=\u0022popup-buttons\u0022\u003E\n      \u003Cbutton type=\u0022button\u0022 class=\u0022agree-button eu-cookie-compliance-default-button\u0022\u003EContinue\u003C\/button\u003E\n                    \u003Cbutton type=\u0022button\u0022 class=\u0022find-more-button eu-cookie-compliance-more-button\u0022\u003EFind out more\u003C\/button\u003E\n          \u003C\/div\u003E\n  \u003C\/div\u003E\n\u003C\/div\u003E\n","mobile_breakpoint":"768","popup_html_agreed":"\u003Cdiv\u003E\n  \u003Cdiv class=\u0022popup-content agreed\u0022\u003E\n    \u003Cdiv id=\u0022popup-text\u0022\u003E\n      \u003Ch2\u003EThank you for accepting cookies\u003C\/h2\u003E\u003Cp\u003EYou can now hide this message or find out more about cookies.\u003C\/p\u003E    \u003C\/div\u003E\n    \u003Cdiv id=\u0022popup-buttons\u0022\u003E\n      \u003Cbutton type=\u0022button\u0022 class=\u0022hide-popup-button eu-cookie-compliance-hide-button\u0022\u003EHide\u003C\/button\u003E\n              \u003Cbutton type=\u0022button\u0022 class=\u0022find-more-button eu-cookie-compliance-more-button-thank-you\u0022 \u003EMore info\u003C\/button\u003E\n          \u003C\/div\u003E\n  \u003C\/div\u003E\n\u003C\/div\u003E","popup_use_bare_css":false,"popup_height":"auto","popup_width":"100%","popup_delay":1000,"popup_link":"\/help\/cookie-policy","popup_link_new_window":1,"popup_position":null,"popup_language":"en","store_consent":false,"better_support_for_screen_readers":0,"reload_page":0,"domain":"","popup_eu_only_js":0,"cookie_lifetime":"365","cookie_session":false,"disagree_do_not_show_popup":0,"method":"default","whitelisted_cookies":"","withdraw_markup":"\u003Cbutton type=\u0022button\u0022 class=\u0022eu-cookie-withdraw-tab\u0022\u003EPrivacy settings\u003C\/button\u003E\n\u003Cdiv class=\u0022eu-cookie-withdraw-banner\u0022\u003E\n  \u003Cdiv class=\u0022popup-content info\u0022\u003E\n    \u003Cdiv id=\u0022popup-text\u0022\u003E\n      \u003Cp\u003E\u0026lt;h2\u0026gt;We use cookies on this site to enhance your user experience\u0026lt;\/h2\u0026gt;\u0026lt;p\u0026gt;You have given your consent for us to set cookies.\u0026lt;\/p\u0026gt;\u003C\/p\u003E\n    \u003C\/div\u003E\n    \u003Cdiv id=\u0022popup-buttons\u0022\u003E\n      \u003Cbutton type=\u0022button\u0022 class=\u0022eu-cookie-withdraw-button\u0022\u003EWithdraw consent\u003C\/button\u003E\n    \u003C\/div\u003E\n  \u003C\/div\u003E\n\u003C\/div\u003E\n","withdraw_enabled":false},"googleanalytics":{"trackOutbound":1,"trackMailto":1,"trackDownload":1,"trackDownloadExtensions":"7z|aac|arc|arj|asf|asx|avi|bin|csv|doc(x|m)?|dot(x|m)?|exe|flv|gif|gz|gzip|hqx|jar|jpe?g|js|mp(2|3|4|e?g)|mov(ie)?|msi|msp|pdf|phps|png|ppt(x|m)?|pot(x|m)?|pps(x|m)?|ppam|sld(x|m)?|thmx|qtm?|ra(m|r)?|sea|sit|tar|tgz|torrent|txt|wav|wma|wmv|wpd|xls(x|m|b)?|xlt(x|m)|xlam|xml|z|zip","trackColorbox":1,"trackUrlFragments":1},"jnl_biorxiv_styles":{"defaultJCode":"medrxiv"},"omega":{"layouts":{"primary":"normal","order":["narrow","normal","wide"],"queries":{"narrow":"all and (min-width: 768px) and (min-device-width: 768px), (max-device-width: 800px) and (min-width: 768px) and (orientation:landscape)","normal":"all and (min-width: 980px) and (min-device-width: 980px), all and (max-device-width: 1024px) and (min-width: 1024px) and (orientation:landscape)","wide":"all and (min-width: 1220px)"}}}});
//--&gt;&lt;!]]&gt;
  </script>
 </head>
 <body class="html not-front not-logged-in page-node page-node- page-node-545164 node-type-highwire-article context-content hw-default-jcode-medrxiv hw-article-type-article">
  <noscript>
   <iframe src="//www.googletagmanager.com/ns.html?id=GTM-P4HH5NV" height="0" width="0" style="display:none;visibility:hidden">
   </iframe>
  </noscript>
  <script type="text/javascript">
   (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0];var j=d.createElement(s);var dl=l!='dataLayer'?'&amp;l='+l:'';j.src='//www.googletagmanager.com/gtm.js?id='+i+dl;j.type='text/javascript';j.async=true;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-P4HH5NV');
  </script>
  <div id="skip-link">
   <a href="#main-content" class="element-invisible element-focusable">
    Skip to main content
   </a>
  </div>
  <div class="page clearfix page-box-shadows footer-borders panels-page panels-layout-jcore_2col" id="page">
   <header id="section-header" class="section section-header">
    <div id="zone-branding" class="zone zone-branding clearfix print-display-block container-30">
     <div class="grid-15 prefix-1 region region-branding print-display-block" id="region-branding">
      <div class="region-inner region-branding-inner">
       <div class="branding-data clearfix">
        <div class="logo-img">
         <a href="/" rel="home" class="" data-icon-position="" data-hide-link-title="0">
          <img alt="medRxiv" src="https://www.medrxiv.org/sites/default/files/medrxiv_internal_logo.png"/>
         </a>
        </div>
       </div>
      </div>
     </div>
     <div class="grid-11 suffix-1 region region-branding-second print-hidden" id="region-branding-second">
      <div class="region-inner region-branding-second-inner">
       <div class="block block-system block-menu block-main-menu block-system-main-menu odd block-without-title" id="block-system-main-menu">
        <div class="block-inner clearfix">
         <div class="content clearfix">
          <nav class="menubar-nav">
           <ul class="menu" role="menu">
            <li class="first leaf" role="menuitem">
             <a href="/" title="" class="" data-icon-position="" data-hide-link-title="0">
              Home
             </a>
            </li>
            <li class="leaf" role="menuitem">
             <a href="/content/about-medrxiv" class="" data-icon-position="" data-hide-link-title="0">
              About
             </a>
            </li>
            <li class="leaf" role="menuitem">
             <a href="/submit-a-manuscript" class="" data-icon-position="" data-hide-link-title="0">
              Submit
             </a>
            </li>
            <li class="last leaf" role="menuitem">
             <a href="/content/alertsrss" title="" class="" data-icon-position="" data-hide-link-title="0">
              ALERTS / RSS
             </a>
            </li>
           </ul>
          </nav>
         </div>
        </div>
       </div>
       <div class="block block-panels-mini block-biorxiv-search-box block-panels-mini-biorxiv-search-box even block-without-title" id="block-panels-mini-biorxiv-search-box">
        <div class="block-inner clearfix">
         <div class="content clearfix">
          <div class="panel-display panel-1col clearfix" id="mini-panel-biorxiv_search_box">
           <div class="panel-panel panel-col">
            <div>
             <div class="panel-pane pane-highwire-seach-quicksearch">
              <div class="pane-content">
               <form class="highwire-quicksearch button-style-mini button-style-mini" action="/content/10.1101/2021.10.31.21265703v3.full" method="post" id="highwire-search-quicksearch-form-0" accept-charset="UTF-8">
                <div>
                 <div class="form-item form-item-label-invisible form-type-textfield form-item-keywords">
                  <label class="element-invisible" for="search_rightsidebar_keywords_1457085778">
                   Search for this keyword
                  </label>
                  <input placeholder="Search" type="text" id="search_rightsidebar_keywords_1457085778" name="keywords" value="" size="60" maxlength="128" class="form-text"/>
                 </div>
                 <div class="button-wrapper button-mini">
                  <span class="icon-search">
                  </span>
                  <input data-icon-only="1" data-font-icon="icon-search" data-icon-position="after" type="submit" id="search_rightsidebar_submit_478557131" name="op" value="Search" class="form-submit"/>
                 </div>
                 <input type="hidden" name="form_build_id" value="form-AuqObX0eXyJZVO86hg8xsZXrfR5q2vHMAZ-DGq3Ko_8"/>
                 <input type="hidden" name="form_id" value="highwire_search_quicksearch_form_0"/>
                </div>
               </form>
              </div>
             </div>
             <div class="panel-separator">
             </div>
             <div class="panel-pane pane-custom pane-2 advanced-search-link">
              <div class="pane-content">
               <a href="/search">
                Advanced Search
               </a>
              </div>
             </div>
            </div>
           </div>
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
    <div id="zone-header" class="zone zone-header clearfix container-30">
    </div>
   </header>
   <section id="section-content" class="section section-content">
    <div id="zone-content" class="zone zone-content clearfix container-30">
     <div class="grid-28 suffix-1 prefix-1 region region-content" id="region-content">
      <div class="region-inner region-content-inner">
       <a id="main-content">
       </a>
       <div class="block block-system block-main block-system-main odd block-without-title" id="block-system-main">
        <div class="block-inner clearfix">
         <div class="content clearfix">
          <div class="panel-display panels-960-layout jcore-2col-layout">
           <div class="panel-row-wrapper clearfix">
            <div class="main-content-wrapper grid-17 suffix-1 alpha">
             <div class="panel-panel panel-region-content">
              <div class="inside">
               <div class="panel-pane pane-highwire-article-citation">
                <div class="pane-content">
                 <div class="highwire-article-citation highwire-citation-type-highwire-article node545164" data-node-nid="545164" id="node-545164--21263208816" data-pisa="medrxiv;2021.10.31.21265703v3" data-pisa-master="medrxiv;2021.10.31.21265703" data-apath="/medrxiv/early/2022/08/03/2021.10.31.21265703.atom" data-hw-author-tooltip-instance="">
                  <div class="highwire-cite highwire-cite-highwire-article highwire-citation-medrxiv-article-top clearfix has-author-tooltip">
                   <h1 class="highwire-cite-title" id="page-title">
                    Safety and efficacy of the two doses conjugated protein-based SOBERANA-02 COVID-19 vaccine and of a heterologous three-dose combination with SOBERANA-PLUS: double-blind, randomised, placebo-controlled phase 3 clinical trial
                   </h1>
                   <div class="highwire-cite-authors">
                    <span class="highwire-citation-authors">
                     <span class="highwire-citation-author first" data-delta="0">
                      <span class="nlm-given-names">
                       María
                      </span>
                      <span class="nlm-surname">
                       Eugenia Toledo-Romaní
                      </span>
                     </span>
                     ,
                     <span class="highwire-citation-author" data-delta="1">
                      <span class="nlm-given-names">
                       Mayra
                      </span>
                      <span class="nlm-surname">
                       García-Carmenate
                      </span>
                     </span>
                     ,
                     <span class="highwire-citation-author" data-delta="2">
                      <span class="nlm-given-names">
                       Carmen
                      </span>
                      <span class="nlm-surname">
                       Valenzuela-Silva
                      </span>
                     </span>
                     ,
                     <span class="highwire-citation-author" data-delta="3">
                      <span class="nlm-given-names">
                       Waldemar
                      </span>
                      <span class="nlm-surname">
                       Baldoquín-Rodríguez
                      </span>
                     </span>
                     ,
                     <span class="highwire-citation-author" data-delta="4">
                      <span class="nlm-given-names">
                       Marisel
                      </span>
                      <span class="nlm-surname">
                       Martínez-Pérez
                      </span>
                     </span>
                     ,
                     <span class="highwire-citation-author" data-delta="5">
                      <span class="nlm-given-names">
                       Meiby
                      </span>
                      <span class="nlm-surname">
                       Rodríguez-González
                      </span>
                     </span>
                     ,
                     <span class="highwire-citation-author" data-delta="6">
                      <span class="nlm-given-names">
                       Beatriz
                      </span>
                      <span class="nlm-surname">
                       Paredes-Moreno
                      </span>
                     </span>
                     ,
                     <span class="highwire-citation-author" data-delta="7">
                      <span class="nlm-given-names">
                       Ivis
                      </span>
                      <span class="nlm-surname">
                       Mendoza-Hernández
                      </span>
                     </span>
                     ,
                     <span class="highwire-citation-author" data-delta="8">
                      <span class="nlm-given-names">
                       Raúl
                      </span>
                      <span class="nlm-surname">
                       González-Mujica
                      </span>
                     </span>
                     ,
                     <span class="highwire-citation-author" data-delta="9">
                      <span class="nlm-given-names">
                       Oscar
                      </span>
                      <span class="nlm-surname">
                       Samón-Tabio
                      </span>
                     </span>
                     ,
                     <span class="highwire-citation-author" data-delta="10">
                      <span class="nlm-given-names">
                       Pablo
                      </span>
                      <span class="nlm-surname">
                       Velazco-Villares
                      </span>
                     </span>
                     ,
                     <span class="highwire-citation-author" data-delta="11">
                      <span class="nlm-given-names">
                       Juan Pablo
                      </span>
                      <span class="nlm-surname">
                       Bacallao-Castillo
                      </span>
                     </span>
                     ,
                     <span class="highwire-citation-author" data-delta="12">
                      <span class="nlm-given-names">
                       Ernesto
                      </span>
                      <span class="nlm-surname">
                       Licea-Martín
                      </span>
                     </span>
                     ,
                     <span class="highwire-citation-author" data-delta="13">
                      <span class="nlm-given-names">
                       Misladys
                      </span>
                      <span class="nlm-surname">
                       Rodríguez-Ortega
                      </span>
                     </span>
                     ,
                     <span class="highwire-citation-author" data-delta="14">
                      <span class="nlm-given-names">
                       Nuris
                      </span>
                      <span class="nlm-surname">
                       Herrera-Marrero
                      </span>
                     </span>
                     ,
                     <span class="highwire-citation-author" data-delta="15">
                      <span class="nlm-given-names">
                       Esperanza
                      </span>
                      <span class="nlm-surname">
                       Caballero-González
                      </span>
                     </span>
                     ,
                     <span class="highwire-citation-author" data-delta="16">
                      <span class="nlm-given-names">
                       Liudmila
                      </span>
                      <span class="nlm-surname">
                       Egües-Torres
                      </span>
                     </span>
                     ,
                     <span class="highwire-citation-author" data-delta="17">
                      <span class="nlm-given-names">
                       Reinaldo
                      </span>
                      <span class="nlm-surname">
                       Duartes-González
                      </span>
                     </span>
                     ,
                     <span class="highwire-citation-author" data-delta="18">
                      <span class="nlm-given-names">
                       Serguey
                      </span>
                      <span class="nlm-surname">
                       García-Blanco
                      </span>
                     </span>
                     ,
                     <span class="highwire-citation-author" data-delta="19">
                      <span class="nlm-given-names">
                       Suzette
                      </span>
                      <span class="nlm-surname">
                       Pérez-Cabrera
                      </span>
                     </span>
                     ,
                     <span class="highwire-citation-author" data-delta="20">
                      <span class="nlm-given-names">
                       Santos
                      </span>
                      <span class="nlm-surname">
                       Huete-Ferreira
                      </span>
                     </span>
                     ,
                     <span class="highwire-citation-author" data-delta="21">
                      <span class="nlm-given-names">
                       Kirenia
                      </span>
                      <span class="nlm-surname">
                       Idalmis-Cisnero
                      </span>
                     </span>
                     ,
                     <span class="highwire-citation-author" data-delta="22">
                      <span class="nlm-given-names">
                       Omayda
                      </span>
                      <span class="nlm-surname">
                       Fonte-Galindo
                      </span>
                     </span>
                     ,
                     <span class="highwire-citation-author" data-delta="23">
                      <span class="nlm-given-names">
                       Dania
                      </span>
                      <span class="nlm-surname">
                       Meliá-Pérez
                      </span>
                     </span>
                     ,
                     <span class="highwire-citation-author" data-delta="24">
                      <span class="nlm-given-names">
                       Ivonne
                      </span>
                      <span class="nlm-surname">
                       Rojas-Remedios
                      </span>
                     </span>
                     ,
                     <span class="highwire-citation-author hw-author-orcid-logo-wrapper" data-delta="25">
                      <a href="http://orcid.org/0000-0003-4167-9921" target="_blank" class="hw-author-orcid-logo link-icon-only link-icon">
                       <span class="hw-icon-orcid hw-icon-color-orcid">
                       </span>
                       <span class="title element-invisible">
                        View ORCID Profile
                       </span>
                      </a>
                      <span class="nlm-given-names">
                       Delaram
                      </span>
                      <span class="nlm-surname">
                       Doroud
                      </span>
                     </span>
                     ,
                     <span class="highwire-citation-author" data-delta="26">
                      <span class="nlm-given-names">
                       Mohammad Mehdi
                      </span>
                      <span class="nlm-surname">
                       Gouya
                      </span>
                     </span>
                     ,
                     <span class="highwire-citation-author" data-delta="27">
                      <span class="nlm-given-names">
                       Alireza
                      </span>
                      <span class="nlm-surname">
                       Biglari
                      </span>
                     </span>
                     ,
                     <span class="highwire-citation-author" data-delta="28">
                      <span class="nlm-given-names">
                       Patrick
                      </span>
                      <span class="nlm-surname">
                       Van der Stuyft
                      </span>
                     </span>
                     ,
                     <span class="highwire-citation-author" data-delta="29">
                      <span class="nlm-given-names">
                       Sonsire
                      </span>
                      <span class="nlm-surname">
                       Fernández-Castillo
                      </span>
                     </span>
                     ,
                     <span class="highwire-citation-author" data-delta="30">
                      <span class="nlm-given-names">
                       Yanet
                      </span>
                      <span class="nlm-surname">
                       Climent-Ruiz
                      </span>
                     </span>
                     ,
                     <span class="highwire-citation-author" data-delta="31">
                      <span class="nlm-given-names">
                       Yury
                      </span>
                      <span class="nlm-surname">
                       Valdes-Balbín
                      </span>
                     </span>
                     ,
                     <span class="highwire-citation-author" data-delta="32">
                      <span class="nlm-given-names">
                       Dagmar
                      </span>
                      <span class="nlm-surname">
                       García-Rivera
                      </span>
                     </span>
                     ,
                     <span class="highwire-citation-author hw-author-orcid-logo-wrapper" data-delta="33">
                      <a href="http://orcid.org/0000-0001-5596-6847" target="_blank" class="hw-author-orcid-logo link-icon-only link-icon">
                       <span class="hw-icon-orcid hw-icon-color-orcid">
                       </span>
                       <span class="title element-invisible">
                        View ORCID Profile
                       </span>
                      </a>
                      <span class="nlm-given-names">
                       Vicente
                      </span>
                      <span class="nlm-surname">
                       Verez-Bencomo
                      </span>
                     </span>
                     ,
                     <span class="highwire-citation-author" data-delta="34">
                      <span class="nlm-collab" data-hwp-id="collab-1">
                       the SOBERANA Phase 3 team
                      </span>
                     </span>
                    </span>
                   </div>
                   <div class="highwire-cite-metadata">
                    <span class="highwire-cite-metadata-doi highwire-cite-metadata">
                     <span class="label">
                      doi:
                     </span>
                     https://doi.org/10.1101/2021.10.31.21265703
                    </span>
                   </div>
                  </div>
                  <div id="hw-article-author-popups-node-545164--21263208816" style="display: none;">
                   <div class="author-tooltip-0">
                    <div class="author-tooltip-name">
                     María Eugenia Toledo-Romaní
                    </div>
                    <div class="author-tooltip-affiliation">
                     <span class="author-tooltip-text">
                      <div class="author-affiliation">
                       <span class="nlm-sup">
                        1
                       </span>
                       <span class="nlm-institution">
                        “Pedro Kourí” Tropical Medicine Institute. Av “Novia del Mediodía”
                       </span>
                       , Kv 6 1/2, La Lisa, Habana, 11400,
                       <span class="nlm-country">
                        Cuba
                       </span>
                      </div>
                     </span>
                    </div>
                    <ul class="author-tooltip-find-more">
                     <li class="author-tooltip-gs-link first">
                      <a href="/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Mar%C3%ADa%2BEugenia%2BToledo-Roman%C3%AD%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on Google Scholar
                      </a>
                     </li>
                     <li class="author-tooltip-pubmed-link">
                      <a href="/lookup/external-ref?access_num=Eugenia%20Toledo-Roman%C3%AD%20M&link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on PubMed
                      </a>
                     </li>
                     <li class="author-site-search-link">
                      <a href="/search/author1%3AMar%25C3%25ADa%2BEugenia%2BToledo-Roman%25C3%25AD%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">
                       Search for this author on this site
                      </a>
                     </li>
                     <li class="author-corresp-email-link last">
                      <span>
                       For correspondence:
                       <a href="mailto:mariaeugenia@ipk.sld.cu" class="" data-icon-position="" data-hide-link-title="0">
                        mariaeugenia@ipk.sld.cu
                       </a>
                       <a href="mailto:vicente.verez@finlay.edu.cu" class="" data-icon-position="" data-hide-link-title="0">
                        vicente.verez@finlay.edu.cu
                       </a>
                      </span>
                     </li>
                    </ul>
                   </div>
                   <div class="author-tooltip-1">
                    <div class="author-tooltip-name">
                     Mayra García-Carmenate
                    </div>
                    <div class="author-tooltip-affiliation">
                     <span class="author-tooltip-text">
                      <div class="author-affiliation">
                       <span class="nlm-sup">
                        2
                       </span>
                       <span class="nlm-institution">
                        Havana Hygiene and Epidemiology Center
                       </span>
                       , Havana,
                       <span class="nlm-country">
                        Cuba
                       </span>
                      </div>
                     </span>
                    </div>
                    <ul class="author-tooltip-find-more">
                     <li class="author-tooltip-gs-link first">
                      <a href="/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Mayra%2BGarc%C3%ADa-Carmenate%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on Google Scholar
                      </a>
                     </li>
                     <li class="author-tooltip-pubmed-link">
                      <a href="/lookup/external-ref?access_num=Garc%C3%ADa-Carmenate%20M&link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on PubMed
                      </a>
                     </li>
                     <li class="author-site-search-link last">
                      <a href="/search/author1%3AMayra%2BGarc%25C3%25ADa-Carmenate%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">
                       Search for this author on this site
                      </a>
                     </li>
                    </ul>
                   </div>
                   <div class="author-tooltip-2">
                    <div class="author-tooltip-name">
                     Carmen Valenzuela-Silva
                    </div>
                    <div class="author-tooltip-affiliation">
                     <span class="author-tooltip-text">
                      <div class="author-affiliation">
                       <span class="nlm-sup">
                        3
                       </span>
                       <span class="nlm-institution">
                        Cybernetics, Mathematics and Physics Institute
                       </span>
                       . 15th St #55, Vedado, Plaza de la Revolución, Havana10400,
                       <span class="nlm-country">
                        Cuba
                       </span>
                      </div>
                     </span>
                    </div>
                    <ul class="author-tooltip-find-more">
                     <li class="author-tooltip-gs-link first">
                      <a href="/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Carmen%2BValenzuela-Silva%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on Google Scholar
                      </a>
                     </li>
                     <li class="author-tooltip-pubmed-link">
                      <a href="/lookup/external-ref?access_num=Valenzuela-Silva%20C&link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on PubMed
                      </a>
                     </li>
                     <li class="author-site-search-link last">
                      <a href="/search/author1%3ACarmen%2BValenzuela-Silva%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">
                       Search for this author on this site
                      </a>
                     </li>
                    </ul>
                   </div>
                   <div class="author-tooltip-3">
                    <div class="author-tooltip-name">
                     Waldemar Baldoquín-Rodríguez
                    </div>
                    <div class="author-tooltip-affiliation">
                     <span class="author-tooltip-text">
                      <div class="author-affiliation">
                       <span class="nlm-sup">
                        1
                       </span>
                       <span class="nlm-institution">
                        “Pedro Kourí” Tropical Medicine Institute. Av “Novia del Mediodía”
                       </span>
                       , Kv 6 1/2, La Lisa, Habana, 11400,
                       <span class="nlm-country">
                        Cuba
                       </span>
                      </div>
                     </span>
                    </div>
                    <ul class="author-tooltip-find-more">
                     <li class="author-tooltip-gs-link first">
                      <a href="/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Waldemar%2BBaldoqu%C3%ADn-Rodr%C3%ADguez%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on Google Scholar
                      </a>
                     </li>
                     <li class="author-tooltip-pubmed-link">
                      <a href="/lookup/external-ref?access_num=Baldoqu%C3%ADn-Rodr%C3%ADguez%20W&link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on PubMed
                      </a>
                     </li>
                     <li class="author-site-search-link last">
                      <a href="/search/author1%3AWaldemar%2BBaldoqu%25C3%25ADn-Rodr%25C3%25ADguez%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">
                       Search for this author on this site
                      </a>
                     </li>
                    </ul>
                   </div>
                   <div class="author-tooltip-4">
                    <div class="author-tooltip-name">
                     Marisel Martínez-Pérez
                    </div>
                    <div class="author-tooltip-affiliation">
                     <span class="author-tooltip-text">
                      <div class="author-affiliation">
                       <span class="nlm-sup">
                        4
                       </span>
                       <span class="nlm-institution">
                        Finlay Vaccine Institute
                       </span>
                       . 21st Ave. Nº 19810 between 198 and 200 St, Atabey, Playa, Havana,
                       <span class="nlm-country">
                        Cuba
                       </span>
                      </div>
                     </span>
                    </div>
                    <ul class="author-tooltip-find-more">
                     <li class="author-tooltip-gs-link first">
                      <a href="/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Marisel%2BMart%C3%ADnez-P%C3%A9rez%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on Google Scholar
                      </a>
                     </li>
                     <li class="author-tooltip-pubmed-link">
                      <a href="/lookup/external-ref?access_num=Mart%C3%ADnez-P%C3%A9rez%20M&link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on PubMed
                      </a>
                     </li>
                     <li class="author-site-search-link last">
                      <a href="/search/author1%3AMarisel%2BMart%25C3%25ADnez-P%25C3%25A9rez%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">
                       Search for this author on this site
                      </a>
                     </li>
                    </ul>
                   </div>
                   <div class="author-tooltip-5">
                    <div class="author-tooltip-name">
                     Meiby Rodríguez-González
                    </div>
                    <div class="author-tooltip-affiliation">
                     <span class="author-tooltip-text">
                      <div class="author-affiliation">
                       <span class="nlm-sup">
                        4
                       </span>
                       <span class="nlm-institution">
                        Finlay Vaccine Institute
                       </span>
                       . 21st Ave. Nº 19810 between 198 and 200 St, Atabey, Playa, Havana,
                       <span class="nlm-country">
                        Cuba
                       </span>
                      </div>
                     </span>
                    </div>
                    <ul class="author-tooltip-find-more">
                     <li class="author-tooltip-gs-link first">
                      <a href="/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Meiby%2BRodr%C3%ADguez-Gonz%C3%A1lez%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on Google Scholar
                      </a>
                     </li>
                     <li class="author-tooltip-pubmed-link">
                      <a href="/lookup/external-ref?access_num=Rodr%C3%ADguez-Gonz%C3%A1lez%20M&link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on PubMed
                      </a>
                     </li>
                     <li class="author-site-search-link last">
                      <a href="/search/author1%3AMeiby%2BRodr%25C3%25ADguez-Gonz%25C3%25A1lez%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">
                       Search for this author on this site
                      </a>
                     </li>
                    </ul>
                   </div>
                   <div class="author-tooltip-6">
                    <div class="author-tooltip-name">
                     Beatriz Paredes-Moreno
                    </div>
                    <div class="author-tooltip-affiliation">
                     <span class="author-tooltip-text">
                      <div class="author-affiliation">
                       <span class="nlm-sup">
                        4
                       </span>
                       <span class="nlm-institution">
                        Finlay Vaccine Institute
                       </span>
                       . 21st Ave. Nº 19810 between 198 and 200 St, Atabey, Playa, Havana,
                       <span class="nlm-country">
                        Cuba
                       </span>
                      </div>
                     </span>
                    </div>
                    <ul class="author-tooltip-find-more">
                     <li class="author-tooltip-gs-link first">
                      <a href="/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Beatriz%2BParedes-Moreno%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on Google Scholar
                      </a>
                     </li>
                     <li class="author-tooltip-pubmed-link">
                      <a href="/lookup/external-ref?access_num=Paredes-Moreno%20B&link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on PubMed
                      </a>
                     </li>
                     <li class="author-site-search-link last">
                      <a href="/search/author1%3ABeatriz%2BParedes-Moreno%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">
                       Search for this author on this site
                      </a>
                     </li>
                    </ul>
                   </div>
                   <div class="author-tooltip-7">
                    <div class="author-tooltip-name">
                     Ivis Mendoza-Hernández
                    </div>
                    <div class="author-tooltip-affiliation">
                     <span class="author-tooltip-text">
                      <div class="author-affiliation">
                       <span class="nlm-sup">
                        5
                       </span>
                       <span class="nlm-institution">
                        National Coordinating Center for Clinical Trials
                       </span>
                       . 5th Ave and 62, Miramar, Playa, Havana,
                       <span class="nlm-country">
                        Cuba
                       </span>
                      </div>
                     </span>
                    </div>
                    <ul class="author-tooltip-find-more">
                     <li class="author-tooltip-gs-link first">
                      <a href="/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Ivis%2BMendoza-Hern%C3%A1ndez%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on Google Scholar
                      </a>
                     </li>
                     <li class="author-tooltip-pubmed-link">
                      <a href="/lookup/external-ref?access_num=Mendoza-Hern%C3%A1ndez%20I&link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on PubMed
                      </a>
                     </li>
                     <li class="author-site-search-link last">
                      <a href="/search/author1%3AIvis%2BMendoza-Hern%25C3%25A1ndez%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">
                       Search for this author on this site
                      </a>
                     </li>
                    </ul>
                   </div>
                   <div class="author-tooltip-8">
                    <div class="author-tooltip-name">
                     Raúl González-Mujica
                    </div>
                    <div class="author-tooltip-affiliation">
                     <span class="author-tooltip-text">
                      <div class="author-affiliation">
                       <span class="nlm-sup">
                        4
                       </span>
                       <span class="nlm-institution">
                        Finlay Vaccine Institute
                       </span>
                       . 21st Ave. Nº 19810 between 198 and 200 St, Atabey, Playa, Havana,
                       <span class="nlm-country">
                        Cuba
                       </span>
                      </div>
                     </span>
                    </div>
                    <ul class="author-tooltip-find-more">
                     <li class="author-tooltip-gs-link first">
                      <a href="/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Ra%C3%BAl%2BGonz%C3%A1lez-Mujica%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on Google Scholar
                      </a>
                     </li>
                     <li class="author-tooltip-pubmed-link">
                      <a href="/lookup/external-ref?access_num=Gonz%C3%A1lez-Mujica%20R&link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on PubMed
                      </a>
                     </li>
                     <li class="author-site-search-link last">
                      <a href="/search/author1%3ARa%25C3%25BAl%2BGonz%25C3%25A1lez-Mujica%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">
                       Search for this author on this site
                      </a>
                     </li>
                    </ul>
                   </div>
                   <div class="author-tooltip-9">
                    <div class="author-tooltip-name">
                     Oscar Samón-Tabio
                    </div>
                    <div class="author-tooltip-affiliation">
                     <span class="author-tooltip-text">
                      <div class="author-affiliation">
                       <span class="nlm-sup">
                        6
                       </span>
                       <span class="nlm-institution">
                        “José Antonio Echevarría” Technological University
                       </span>
                       , Havana,
                       <span class="nlm-country">
                        Cuba
                       </span>
                      </div>
                     </span>
                    </div>
                    <ul class="author-tooltip-find-more">
                     <li class="author-tooltip-gs-link first">
                      <a href="/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Oscar%2BSam%C3%B3n-Tabio%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on Google Scholar
                      </a>
                     </li>
                     <li class="author-tooltip-pubmed-link">
                      <a href="/lookup/external-ref?access_num=Sam%C3%B3n-Tabio%20O&link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on PubMed
                      </a>
                     </li>
                     <li class="author-site-search-link last">
                      <a href="/search/author1%3AOscar%2BSam%25C3%25B3n-Tabio%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">
                       Search for this author on this site
                      </a>
                     </li>
                    </ul>
                   </div>
                   <div class="author-tooltip-10">
                    <div class="author-tooltip-name">
                     Pablo Velazco-Villares
                    </div>
                    <div class="author-tooltip-affiliation">
                     <span class="author-tooltip-text">
                      <div class="author-affiliation">
                       <span class="nlm-sup">
                        7
                       </span>
                       <span class="nlm-institution">
                        UCT Geocuba Research and Consulting
                       </span>
                       , Havana,
                       <span class="nlm-country">
                        Cuba
                       </span>
                      </div>
                     </span>
                    </div>
                    <ul class="author-tooltip-find-more">
                     <li class="author-tooltip-gs-link first">
                      <a href="/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Pablo%2BVelazco-Villares%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on Google Scholar
                      </a>
                     </li>
                     <li class="author-tooltip-pubmed-link">
                      <a href="/lookup/external-ref?access_num=Velazco-Villares%20P&link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on PubMed
                      </a>
                     </li>
                     <li class="author-site-search-link last">
                      <a href="/search/author1%3APablo%2BVelazco-Villares%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">
                       Search for this author on this site
                      </a>
                     </li>
                    </ul>
                   </div>
                   <div class="author-tooltip-11">
                    <div class="author-tooltip-name">
                     Juan Pablo Bacallao-Castillo
                    </div>
                    <div class="author-tooltip-affiliation">
                     <span class="author-tooltip-text">
                      <div class="author-affiliation">
                       <span class="nlm-sup">
                        7
                       </span>
                       <span class="nlm-institution">
                        UCT Geocuba Research and Consulting
                       </span>
                       , Havana,
                       <span class="nlm-country">
                        Cuba
                       </span>
                      </div>
                     </span>
                    </div>
                    <ul class="author-tooltip-find-more">
                     <li class="author-tooltip-gs-link first">
                      <a href="/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Juan%2BPablo%2BBacallao-Castillo%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on Google Scholar
                      </a>
                     </li>
                     <li class="author-tooltip-pubmed-link">
                      <a href="/lookup/external-ref?access_num=Bacallao-Castillo%20JP&link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on PubMed
                      </a>
                     </li>
                     <li class="author-site-search-link last">
                      <a href="/search/author1%3AJuan%2BPablo%2BBacallao-Castillo%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">
                       Search for this author on this site
                      </a>
                     </li>
                    </ul>
                   </div>
                   <div class="author-tooltip-12">
                    <div class="author-tooltip-name">
                     Ernesto Licea-Martín
                    </div>
                    <div class="author-tooltip-affiliation">
                     <span class="author-tooltip-text">
                      <div class="author-affiliation">
                       <span class="nlm-sup">
                        4
                       </span>
                       <span class="nlm-institution">
                        Finlay Vaccine Institute
                       </span>
                       . 21st Ave. Nº 19810 between 198 and 200 St, Atabey, Playa, Havana,
                       <span class="nlm-country">
                        Cuba
                       </span>
                      </div>
                     </span>
                    </div>
                    <ul class="author-tooltip-find-more">
                     <li class="author-tooltip-gs-link first">
                      <a href="/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Ernesto%2BLicea-Mart%C3%ADn%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on Google Scholar
                      </a>
                     </li>
                     <li class="author-tooltip-pubmed-link">
                      <a href="/lookup/external-ref?access_num=Licea-Mart%C3%ADn%20E&link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on PubMed
                      </a>
                     </li>
                     <li class="author-site-search-link last">
                      <a href="/search/author1%3AErnesto%2BLicea-Mart%25C3%25ADn%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">
                       Search for this author on this site
                      </a>
                     </li>
                    </ul>
                   </div>
                   <div class="author-tooltip-13">
                    <div class="author-tooltip-name">
                     Misladys Rodríguez-Ortega
                    </div>
                    <div class="author-tooltip-affiliation">
                     <span class="author-tooltip-text">
                      <div class="author-affiliation">
                       <span class="nlm-sup">
                        1
                       </span>
                       <span class="nlm-institution">
                        “Pedro Kourí” Tropical Medicine Institute. Av “Novia del Mediodía”
                       </span>
                       , Kv 6 1/2, La Lisa, Habana, 11400,
                       <span class="nlm-country">
                        Cuba
                       </span>
                      </div>
                     </span>
                    </div>
                    <ul class="author-tooltip-find-more">
                     <li class="author-tooltip-gs-link first">
                      <a href="/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Misladys%2BRodr%C3%ADguez-Ortega%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on Google Scholar
                      </a>
                     </li>
                     <li class="author-tooltip-pubmed-link">
                      <a href="/lookup/external-ref?access_num=Rodr%C3%ADguez-Ortega%20M&link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on PubMed
                      </a>
                     </li>
                     <li class="author-site-search-link last">
                      <a href="/search/author1%3AMisladys%2BRodr%25C3%25ADguez-Ortega%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">
                       Search for this author on this site
                      </a>
                     </li>
                    </ul>
                   </div>
                   <div class="author-tooltip-14">
                    <div class="author-tooltip-name">
                     Nuris Herrera-Marrero
                    </div>
                    <div class="author-tooltip-affiliation">
                     <span class="author-tooltip-text">
                      <div class="author-affiliation">
                       <span class="nlm-sup">
                        1
                       </span>
                       <span class="nlm-institution">
                        “Pedro Kourí” Tropical Medicine Institute. Av “Novia del Mediodía”
                       </span>
                       , Kv 6 1/2, La Lisa, Habana, 11400,
                       <span class="nlm-country">
                        Cuba
                       </span>
                      </div>
                     </span>
                    </div>
                    <ul class="author-tooltip-find-more">
                     <li class="author-tooltip-gs-link first">
                      <a href="/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Nuris%2BHerrera-Marrero%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on Google Scholar
                      </a>
                     </li>
                     <li class="author-tooltip-pubmed-link">
                      <a href="/lookup/external-ref?access_num=Herrera-Marrero%20N&link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on PubMed
                      </a>
                     </li>
                     <li class="author-site-search-link last">
                      <a href="/search/author1%3ANuris%2BHerrera-Marrero%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">
                       Search for this author on this site
                      </a>
                     </li>
                    </ul>
                   </div>
                   <div class="author-tooltip-15">
                    <div class="author-tooltip-name">
                     Esperanza Caballero-González
                    </div>
                    <div class="author-tooltip-affiliation">
                     <span class="author-tooltip-text">
                      <div class="author-affiliation">
                       <span class="nlm-sup">
                        4
                       </span>
                       <span class="nlm-institution">
                        Finlay Vaccine Institute
                       </span>
                       . 21st Ave. Nº 19810 between 198 and 200 St, Atabey, Playa, Havana,
                       <span class="nlm-country">
                        Cuba
                       </span>
                      </div>
                     </span>
                    </div>
                    <ul class="author-tooltip-find-more">
                     <li class="author-tooltip-gs-link first">
                      <a href="/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Esperanza%2BCaballero-Gonz%C3%A1lez%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on Google Scholar
                      </a>
                     </li>
                     <li class="author-tooltip-pubmed-link">
                      <a href="/lookup/external-ref?access_num=Caballero-Gonz%C3%A1lez%20E&link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on PubMed
                      </a>
                     </li>
                     <li class="author-site-search-link last">
                      <a href="/search/author1%3AEsperanza%2BCaballero-Gonz%25C3%25A1lez%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">
                       Search for this author on this site
                      </a>
                     </li>
                    </ul>
                   </div>
                   <div class="author-tooltip-16">
                    <div class="author-tooltip-name">
                     Liudmila Egües-Torres
                    </div>
                    <div class="author-tooltip-affiliation">
                     <span class="author-tooltip-text">
                      <div class="author-affiliation">
                       <span class="nlm-sup">
                        2
                       </span>
                       <span class="nlm-institution">
                        Havana Hygiene and Epidemiology Center
                       </span>
                       , Havana,
                       <span class="nlm-country">
                        Cuba
                       </span>
                      </div>
                     </span>
                    </div>
                    <ul class="author-tooltip-find-more">
                     <li class="author-tooltip-gs-link first">
                      <a href="/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Liudmila%2BEg%C3%BCes-Torres%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on Google Scholar
                      </a>
                     </li>
                     <li class="author-tooltip-pubmed-link">
                      <a href="/lookup/external-ref?access_num=Eg%C3%BCes-Torres%20L&link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on PubMed
                      </a>
                     </li>
                     <li class="author-site-search-link last">
                      <a href="/search/author1%3ALiudmila%2BEg%25C3%25BCes-Torres%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">
                       Search for this author on this site
                      </a>
                     </li>
                    </ul>
                   </div>
                   <div class="author-tooltip-17">
                    <div class="author-tooltip-name">
                     Reinaldo Duartes-González
                    </div>
                    <div class="author-tooltip-affiliation">
                     <span class="author-tooltip-text">
                      <div class="author-affiliation">
                       <span class="nlm-sup">
                        8
                       </span>
                       <span class="nlm-institution">
                        Municipal Health Department, Centro Habana
                       </span>
                       , Havana,
                       <span class="nlm-country">
                        Cuba
                       </span>
                      </div>
                     </span>
                    </div>
                    <ul class="author-tooltip-find-more">
                     <li class="author-tooltip-gs-link first">
                      <a href="/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Reinaldo%2BDuartes-Gonz%C3%A1lez%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on Google Scholar
                      </a>
                     </li>
                     <li class="author-tooltip-pubmed-link">
                      <a href="/lookup/external-ref?access_num=Duartes-Gonz%C3%A1lez%20R&link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on PubMed
                      </a>
                     </li>
                     <li class="author-site-search-link last">
                      <a href="/search/author1%3AReinaldo%2BDuartes-Gonz%25C3%25A1lez%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">
                       Search for this author on this site
                      </a>
                     </li>
                    </ul>
                   </div>
                   <div class="author-tooltip-18">
                    <div class="author-tooltip-name">
                     Serguey García-Blanco
                    </div>
                    <div class="author-tooltip-affiliation">
                     <span class="author-tooltip-text">
                      <div class="author-affiliation">
                       <span class="nlm-sup">
                        9
                       </span>
                       <span class="nlm-institution">
                        Municipal Health Department
                       </span>
                       , La Lisa, Havana,
                       <span class="nlm-country">
                        Cuba
                       </span>
                      </div>
                     </span>
                    </div>
                    <ul class="author-tooltip-find-more">
                     <li class="author-tooltip-gs-link first">
                      <a href="/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Serguey%2BGarc%C3%ADa-Blanco%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on Google Scholar
                      </a>
                     </li>
                     <li class="author-tooltip-pubmed-link">
                      <a href="/lookup/external-ref?access_num=Garc%C3%ADa-Blanco%20S&link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on PubMed
                      </a>
                     </li>
                     <li class="author-site-search-link last">
                      <a href="/search/author1%3ASerguey%2BGarc%25C3%25ADa-Blanco%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">
                       Search for this author on this site
                      </a>
                     </li>
                    </ul>
                   </div>
                   <div class="author-tooltip-19">
                    <div class="author-tooltip-name">
                     Suzette Pérez-Cabrera
                    </div>
                    <div class="author-tooltip-affiliation">
                     <span class="author-tooltip-text">
                      <div class="author-affiliation">
                       <span class="nlm-sup">
                        10
                       </span>
                       <span class="nlm-institution">
                        Municipal Health Department
                       </span>
                       , 10 de Octubre, Havana,
                       <span class="nlm-country">
                        Cuba
                       </span>
                      </div>
                     </span>
                    </div>
                    <ul class="author-tooltip-find-more">
                     <li class="author-tooltip-gs-link first">
                      <a href="/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Suzette%2BP%C3%A9rez-Cabrera%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on Google Scholar
                      </a>
                     </li>
                     <li class="author-tooltip-pubmed-link">
                      <a href="/lookup/external-ref?access_num=P%C3%A9rez-Cabrera%20S&link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on PubMed
                      </a>
                     </li>
                     <li class="author-site-search-link last">
                      <a href="/search/author1%3ASuzette%2BP%25C3%25A9rez-Cabrera%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">
                       Search for this author on this site
                      </a>
                     </li>
                    </ul>
                   </div>
                   <div class="author-tooltip-20">
                    <div class="author-tooltip-name">
                     Santos Huete-Ferreira
                    </div>
                    <div class="author-tooltip-affiliation">
                     <span class="author-tooltip-text">
                      <div class="author-affiliation">
                       <span class="nlm-sup">
                        11
                       </span>
                       <span class="nlm-institution">
                        Municipal Health Department
                       </span>
                       , Habana Vieja Havana,
                       <span class="nlm-country">
                        Cuba
                       </span>
                      </div>
                     </span>
                    </div>
                    <ul class="author-tooltip-find-more">
                     <li class="author-tooltip-gs-link first">
                      <a href="/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Santos%2BHuete-Ferreira%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on Google Scholar
                      </a>
                     </li>
                     <li class="author-tooltip-pubmed-link">
                      <a href="/lookup/external-ref?access_num=Huete-Ferreira%20S&link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on PubMed
                      </a>
                     </li>
                     <li class="author-site-search-link last">
                      <a href="/search/author1%3ASantos%2BHuete-Ferreira%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">
                       Search for this author on this site
                      </a>
                     </li>
                    </ul>
                   </div>
                   <div class="author-tooltip-21">
                    <div class="author-tooltip-name">
                     Kirenia Idalmis-Cisnero
                    </div>
                    <div class="author-tooltip-affiliation">
                     <span class="author-tooltip-text">
                      <div class="author-affiliation">
                       <span class="nlm-sup">
                        12
                       </span>
                       <span class="nlm-institution">
                        Municipal Health Department
                       </span>
                       , Cerro, Havana,
                       <span class="nlm-country">
                        Cuba
                       </span>
                      </div>
                     </span>
                    </div>
                    <ul class="author-tooltip-find-more">
                     <li class="author-tooltip-gs-link first">
                      <a href="/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Kirenia%2BIdalmis-Cisnero%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on Google Scholar
                      </a>
                     </li>
                     <li class="author-tooltip-pubmed-link">
                      <a href="/lookup/external-ref?access_num=Idalmis-Cisnero%20K&link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on PubMed
                      </a>
                     </li>
                     <li class="author-site-search-link last">
                      <a href="/search/author1%3AKirenia%2BIdalmis-Cisnero%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">
                       Search for this author on this site
                      </a>
                     </li>
                    </ul>
                   </div>
                   <div class="author-tooltip-22">
                    <div class="author-tooltip-name">
                     Omayda Fonte-Galindo
                    </div>
                    <div class="author-tooltip-affiliation">
                     <span class="author-tooltip-text">
                      <div class="author-affiliation">
                       <span class="nlm-sup">
                        13
                       </span>
                       <span class="nlm-institution">
                        Municipal Health Department
                       </span>
                       , Marianao, Havana,
                       <span class="nlm-country">
                        Cuba
                       </span>
                      </div>
                     </span>
                    </div>
                    <ul class="author-tooltip-find-more">
                     <li class="author-tooltip-gs-link first">
                      <a href="/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Omayda%2BFonte-Galindo%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on Google Scholar
                      </a>
                     </li>
                     <li class="author-tooltip-pubmed-link">
                      <a href="/lookup/external-ref?access_num=Fonte-Galindo%20O&link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on PubMed
                      </a>
                     </li>
                     <li class="author-site-search-link last">
                      <a href="/search/author1%3AOmayda%2BFonte-Galindo%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">
                       Search for this author on this site
                      </a>
                     </li>
                    </ul>
                   </div>
                   <div class="author-tooltip-23">
                    <div class="author-tooltip-name">
                     Dania Meliá-Pérez
                    </div>
                    <div class="author-tooltip-affiliation">
                     <span class="author-tooltip-text">
                      <div class="author-affiliation">
                       <span class="nlm-sup">
                        14
                       </span>
                       <span class="nlm-institution">
                        Municipal Health Department
                       </span>
                       , Playa, Havana,
                       <span class="nlm-country">
                        Cuba
                       </span>
                      </div>
                     </span>
                    </div>
                    <ul class="author-tooltip-find-more">
                     <li class="author-tooltip-gs-link first">
                      <a href="/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Dania%2BMeli%C3%A1-P%C3%A9rez%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on Google Scholar
                      </a>
                     </li>
                     <li class="author-tooltip-pubmed-link">
                      <a href="/lookup/external-ref?access_num=Meli%C3%A1-P%C3%A9rez%20D&link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on PubMed
                      </a>
                     </li>
                     <li class="author-site-search-link last">
                      <a href="/search/author1%3ADania%2BMeli%25C3%25A1-P%25C3%25A9rez%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">
                       Search for this author on this site
                      </a>
                     </li>
                    </ul>
                   </div>
                   <div class="author-tooltip-24">
                    <div class="author-tooltip-name">
                     Ivonne Rojas-Remedios
                    </div>
                    <div class="author-tooltip-affiliation">
                     <span class="author-tooltip-text">
                      <div class="author-affiliation">
                       <span class="nlm-sup">
                        15
                       </span>
                       <span class="nlm-institution">
                        Municipal Health Department
                       </span>
                       , Plaza Havana,
                       <span class="nlm-country">
                        Cuba
                       </span>
                      </div>
                     </span>
                    </div>
                    <ul class="author-tooltip-find-more">
                     <li class="author-tooltip-gs-link first">
                      <a href="/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Ivonne%2BRojas-Remedios%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on Google Scholar
                      </a>
                     </li>
                     <li class="author-tooltip-pubmed-link">
                      <a href="/lookup/external-ref?access_num=Rojas-Remedios%20I&link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on PubMed
                      </a>
                     </li>
                     <li class="author-site-search-link last">
                      <a href="/search/author1%3AIvonne%2BRojas-Remedios%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">
                       Search for this author on this site
                      </a>
                     </li>
                    </ul>
                   </div>
                   <div class="author-tooltip-25">
                    <div class="author-tooltip-name">
                     Delaram Doroud
                    </div>
                    <div class="author-tooltip-affiliation">
                     <span class="author-tooltip-text">
                      <div class="author-affiliation">
                       <span class="nlm-sup">
                        16
                       </span>
                       <span class="nlm-institution">
                        Pasteur Institute of Iran
                       </span>
                       . No. 69, Pasteur Ave., Tehran 1316943551,
                       <span class="nlm-country">
                        Islamic Republic of Iran
                       </span>
                      </div>
                     </span>
                    </div>
                    <ul class="author-tooltip-find-more">
                     <li class="author-tooltip-gs-link first">
                      <a href="/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Delaram%2BDoroud%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on Google Scholar
                      </a>
                     </li>
                     <li class="author-tooltip-pubmed-link">
                      <a href="/lookup/external-ref?access_num=Doroud%20D&link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on PubMed
                      </a>
                     </li>
                     <li class="author-site-search-link">
                      <a href="/search/author1%3ADelaram%2BDoroud%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">
                       Search for this author on this site
                      </a>
                     </li>
                     <li class="author-orcid-link last">
                      <a href="http://orcid.org/0000-0003-4167-9921" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       ORCID record for Delaram Doroud
                      </a>
                     </li>
                    </ul>
                   </div>
                   <div class="author-tooltip-26">
                    <div class="author-tooltip-name">
                     Mohammad Mehdi Gouya
                    </div>
                    <div class="author-tooltip-affiliation">
                     <span class="author-tooltip-text">
                      <div class="author-affiliation">
                       <span class="nlm-sup">
                        17
                       </span>
                       <span class="nlm-institution">
                        Iran University of Medical Science
                       </span>
                       , Teheran,
                       <span class="nlm-country">
                        Iran
                       </span>
                      </div>
                     </span>
                    </div>
                    <ul class="author-tooltip-find-more">
                     <li class="author-tooltip-gs-link first">
                      <a href="/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Mohammad%2BMehdi%2BGouya%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on Google Scholar
                      </a>
                     </li>
                     <li class="author-tooltip-pubmed-link">
                      <a href="/lookup/external-ref?access_num=Gouya%20MM&link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on PubMed
                      </a>
                     </li>
                     <li class="author-site-search-link last">
                      <a href="/search/author1%3AMohammad%2BMehdi%2BGouya%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">
                       Search for this author on this site
                      </a>
                     </li>
                    </ul>
                   </div>
                   <div class="author-tooltip-27">
                    <div class="author-tooltip-name">
                     Alireza Biglari
                    </div>
                    <div class="author-tooltip-affiliation">
                     <span class="author-tooltip-text">
                      <div class="author-affiliation">
                       <span class="nlm-sup">
                        16
                       </span>
                       <span class="nlm-institution">
                        Pasteur Institute of Iran
                       </span>
                       . No. 69, Pasteur Ave., Tehran 1316943551,
                       <span class="nlm-country">
                        Islamic Republic of Iran
                       </span>
                      </div>
                     </span>
                    </div>
                    <ul class="author-tooltip-find-more">
                     <li class="author-tooltip-gs-link first">
                      <a href="/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Alireza%2BBiglari%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on Google Scholar
                      </a>
                     </li>
                     <li class="author-tooltip-pubmed-link">
                      <a href="/lookup/external-ref?access_num=Biglari%20A&link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on PubMed
                      </a>
                     </li>
                     <li class="author-site-search-link last">
                      <a href="/search/author1%3AAlireza%2BBiglari%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">
                       Search for this author on this site
                      </a>
                     </li>
                    </ul>
                   </div>
                   <div class="author-tooltip-28">
                    <div class="author-tooltip-name">
                     Patrick Van der Stuyft
                    </div>
                    <div class="author-tooltip-affiliation">
                     <span class="author-tooltip-text">
                      <div class="author-affiliation">
                       <span class="nlm-sup">
                        18
                       </span>
                       <span class="nlm-institution">
                        Gent University
                       </span>
                       , Gent,
                       <span class="nlm-country">
                        Belgium
                       </span>
                      </div>
                     </span>
                    </div>
                    <ul class="author-tooltip-find-more">
                     <li class="author-tooltip-gs-link first">
                      <a href="/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Patrick%2BVan%2Bder%2BStuyft%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on Google Scholar
                      </a>
                     </li>
                     <li class="author-tooltip-pubmed-link">
                      <a href="/lookup/external-ref?access_num=Van%20der%20Stuyft%20P&link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on PubMed
                      </a>
                     </li>
                     <li class="author-site-search-link last">
                      <a href="/search/author1%3APatrick%2BVan%2Bder%2BStuyft%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">
                       Search for this author on this site
                      </a>
                     </li>
                    </ul>
                   </div>
                   <div class="author-tooltip-29">
                    <div class="author-tooltip-name">
                     Sonsire Fernández-Castillo
                    </div>
                    <div class="author-tooltip-affiliation">
                     <span class="author-tooltip-text">
                      <div class="author-affiliation">
                       <span class="nlm-sup">
                        4
                       </span>
                       <span class="nlm-institution">
                        Finlay Vaccine Institute
                       </span>
                       . 21st Ave. Nº 19810 between 198 and 200 St, Atabey, Playa, Havana,
                       <span class="nlm-country">
                        Cuba
                       </span>
                      </div>
                     </span>
                    </div>
                    <ul class="author-tooltip-find-more">
                     <li class="author-tooltip-gs-link first">
                      <a href="/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Sonsire%2BFern%C3%A1ndez-Castillo%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on Google Scholar
                      </a>
                     </li>
                     <li class="author-tooltip-pubmed-link">
                      <a href="/lookup/external-ref?access_num=Fern%C3%A1ndez-Castillo%20S&link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on PubMed
                      </a>
                     </li>
                     <li class="author-site-search-link last">
                      <a href="/search/author1%3ASonsire%2BFern%25C3%25A1ndez-Castillo%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">
                       Search for this author on this site
                      </a>
                     </li>
                    </ul>
                   </div>
                   <div class="author-tooltip-30">
                    <div class="author-tooltip-name">
                     Yanet Climent-Ruiz
                    </div>
                    <div class="author-tooltip-affiliation">
                     <span class="author-tooltip-text">
                      <div class="author-affiliation">
                       <span class="nlm-sup">
                        4
                       </span>
                       <span class="nlm-institution">
                        Finlay Vaccine Institute
                       </span>
                       . 21st Ave. Nº 19810 between 198 and 200 St, Atabey, Playa, Havana,
                       <span class="nlm-country">
                        Cuba
                       </span>
                      </div>
                     </span>
                    </div>
                    <ul class="author-tooltip-find-more">
                     <li class="author-tooltip-gs-link first">
                      <a href="/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Yanet%2BCliment-Ruiz%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on Google Scholar
                      </a>
                     </li>
                     <li class="author-tooltip-pubmed-link">
                      <a href="/lookup/external-ref?access_num=Climent-Ruiz%20Y&link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on PubMed
                      </a>
                     </li>
                     <li class="author-site-search-link last">
                      <a href="/search/author1%3AYanet%2BCliment-Ruiz%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">
                       Search for this author on this site
                      </a>
                     </li>
                    </ul>
                   </div>
                   <div class="author-tooltip-31">
                    <div class="author-tooltip-name">
                     Yury Valdes-Balbín
                    </div>
                    <div class="author-tooltip-affiliation">
                     <span class="author-tooltip-text">
                      <div class="author-affiliation">
                       <span class="nlm-sup">
                        4
                       </span>
                       <span class="nlm-institution">
                        Finlay Vaccine Institute
                       </span>
                       . 21st Ave. Nº 19810 between 198 and 200 St, Atabey, Playa, Havana,
                       <span class="nlm-country">
                        Cuba
                       </span>
                      </div>
                     </span>
                    </div>
                    <ul class="author-tooltip-find-more">
                     <li class="author-tooltip-gs-link first">
                      <a href="/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Yury%2BValdes-Balb%C3%ADn%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on Google Scholar
                      </a>
                     </li>
                     <li class="author-tooltip-pubmed-link">
                      <a href="/lookup/external-ref?access_num=Valdes-Balb%C3%ADn%20Y&link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on PubMed
                      </a>
                     </li>
                     <li class="author-site-search-link last">
                      <a href="/search/author1%3AYury%2BValdes-Balb%25C3%25ADn%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">
                       Search for this author on this site
                      </a>
                     </li>
                    </ul>
                   </div>
                   <div class="author-tooltip-32">
                    <div class="author-tooltip-name">
                     Dagmar García-Rivera
                    </div>
                    <div class="author-tooltip-affiliation">
                     <span class="author-tooltip-text">
                      <div class="author-affiliation">
                       <span class="nlm-sup">
                        4
                       </span>
                       <span class="nlm-institution">
                        Finlay Vaccine Institute
                       </span>
                       . 21st Ave. Nº 19810 between 198 and 200 St, Atabey, Playa, Havana,
                       <span class="nlm-country">
                        Cuba
                       </span>
                      </div>
                     </span>
                    </div>
                    <ul class="author-tooltip-find-more">
                     <li class="author-tooltip-gs-link first">
                      <a href="/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Dagmar%2BGarc%C3%ADa-Rivera%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on Google Scholar
                      </a>
                     </li>
                     <li class="author-tooltip-pubmed-link">
                      <a href="/lookup/external-ref?access_num=Garc%C3%ADa-Rivera%20D&link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on PubMed
                      </a>
                     </li>
                     <li class="author-site-search-link last">
                      <a href="/search/author1%3ADagmar%2BGarc%25C3%25ADa-Rivera%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">
                       Search for this author on this site
                      </a>
                     </li>
                    </ul>
                   </div>
                   <div class="author-tooltip-33">
                    <div class="author-tooltip-name">
                     Vicente Verez-Bencomo
                    </div>
                    <div class="author-tooltip-affiliation">
                     <span class="author-tooltip-text">
                      <div class="author-affiliation">
                       <span class="nlm-sup">
                        4
                       </span>
                       <span class="nlm-institution">
                        Finlay Vaccine Institute
                       </span>
                       . 21st Ave. Nº 19810 between 198 and 200 St, Atabey, Playa, Havana,
                       <span class="nlm-country">
                        Cuba
                       </span>
                      </div>
                     </span>
                    </div>
                    <ul class="author-tooltip-find-more">
                     <li class="author-tooltip-gs-link first">
                      <a href="/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Vicente%2BVerez-Bencomo%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on Google Scholar
                      </a>
                     </li>
                     <li class="author-tooltip-pubmed-link">
                      <a href="/lookup/external-ref?access_num=Verez-Bencomo%20V&link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on PubMed
                      </a>
                     </li>
                     <li class="author-site-search-link">
                      <a href="/search/author1%3AVicente%2BVerez-Bencomo%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">
                       Search for this author on this site
                      </a>
                     </li>
                     <li class="author-orcid-link">
                      <a href="http://orcid.org/0000-0001-5596-6847" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       ORCID record for Vicente Verez-Bencomo
                      </a>
                     </li>
                     <li class="author-corresp-email-link last">
                      <span>
                       For correspondence:
                       <a href="mailto:mariaeugenia@ipk.sld.cu" class="" data-icon-position="" data-hide-link-title="0">
                        mariaeugenia@ipk.sld.cu
                       </a>
                       <a href="mailto:vicente.verez@finlay.edu.cu" class="" data-icon-position="" data-hide-link-title="0">
                        vicente.verez@finlay.edu.cu
                       </a>
                      </span>
                     </li>
                    </ul>
                   </div>
                  </div>
                 </div>
                </div>
               </div>
               <div class="panel-separator">
               </div>
               <div class="panel-pane pane-highwire-panel-tabs pane-panels-ajax-tab-tabs">
                <div class="pane-content">
                 <div class="item-list">
                  <ul class="tabs inline panels-ajax-tab">
                   <li class="first">
                    <a href="/content/10.1101/2021.10.31.21265703v3" class="panels-ajax-tab-tab" data-panel-name="biorxiv_tab_art" data-target-id="highwire_article_tabs" data-entity-context="node:545164" data-trigger="" data-url-enabled="1">
                     Abstract
                    </a>
                    <a href="/panels_ajax_tab/biorxiv_tab_art/node:545164/1" rel="nofollow" style="display:none" class="js-crawler-link">
                    </a>
                   </li>
                   <li>
                    <a href="/content/10.1101/2021.10.31.21265703v3.full-text" class="panels-ajax-tab-tab" data-panel-name="article_tab_full_text" data-target-id="highwire_article_tabs" data-entity-context="node:545164" data-trigger="full-text" data-url-enabled="1">
                     Full Text
                    </a>
                    <a href="/panels_ajax_tab/article_tab_full_text/node:545164/1" rel="nofollow" style="display:none" class="js-crawler-link">
                    </a>
                   </li>
                   <li>
                    <a href="/content/10.1101/2021.10.31.21265703v3.article-info" class="panels-ajax-tab-tab" data-panel-name="biorxiv_tab_info" data-target-id="highwire_article_tabs" data-entity-context="node:545164" data-trigger="article-info" data-url-enabled="1">
                     Info/History
                    </a>
                    <a href="/panels_ajax_tab/biorxiv_tab_info/node:545164/1" rel="nofollow" style="display:none" class="js-crawler-link">
                    </a>
                   </li>
                   <li>
                    <a href="/content/10.1101/2021.10.31.21265703v3.article-metrics" class="panels-ajax-tab-tab" data-panel-name="article_tab_metrics" data-target-id="highwire_article_tabs" data-entity-context="node:545164" data-trigger="article-metrics" data-url-enabled="1">
                     Metrics
                    </a>
                    <a href="/panels_ajax_tab/article_tab_metrics/node:545164/1" rel="nofollow" style="display:none" class="js-crawler-link">
                    </a>
                   </li>
                   <li>
                    <a href="/content/10.1101/2021.10.31.21265703v3.external-links" class="panels-ajax-tab-tab" data-panel-name="article_tab_data_code" data-target-id="highwire_article_tabs" data-entity-context="node:545164" data-trigger="external-links" data-url-enabled="1">
                     Data/Code
                    </a>
                    <a href="/panels_ajax_tab/article_tab_data_code/node:545164/1" rel="nofollow" style="display:none" class="js-crawler-link">
                    </a>
                   </li>
                   <li class="last">
                    <a href="/content/10.1101/2021.10.31.21265703v3.full.pdf+html" class="panels-ajax-tab-tab" data-panel-name="biorxiv_tab_pdf" data-target-id="highwire_article_tabs" data-entity-context="node:545164" data-trigger="full.pdf+html" data-url-enabled="1">
                     <i class="icon-file-alt">
                     </i>
                     Preview PDF
                    </a>
                    <a href="/panels_ajax_tab/biorxiv_tab_pdf/node:545164/1" rel="nofollow" style="display:none" class="js-crawler-link">
                    </a>
                   </li>
                  </ul>
                 </div>
                </div>
               </div>
               <div class="panel-separator">
               </div>
               <div class="panel-pane pane-highwire-panel-tabs-container">
                <div class="pane-content">
                 <div data-panels-ajax-tab-preloaded="article_tab_full_text" id="panels-ajax-tab-container-highwire_article_tabs" class="panels-ajax-tab-container">
                  <div class="panels-ajax-tab-loading" style="display:none">
                   <img class="loading" src="https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif" alt="Loading" title="Loading"/>
                  </div>
                  <div class="panels-ajax-tab-wrap-article_tab_full_text">
                   <div class="panel-display panel-1col clearfix">
                    <div class="panel-panel panel-col">
                     <div>
                      <div class="panel-pane pane-highwire-markup">
                       <div class="pane-content">
                        <div class="highwire-markup">
                         <div xmlns="http://www.w3.org/1999/xhtml" data-highwire-cite-ref-tooltip-instance="highwire_reflinks_tooltip" class="content-block-markup" xmlns:xhtml="http://www.w3.org/1999/xhtml">
                          <div class="article fulltext-view">
                           <span class="highwire-journal-article-marker-start">
                           </span>
                           <div class="section abstract" id="abstract-1">
                            <h2 class="">
                             SUMMARY
                            </h2>
                            <div id="sec-1" class="subsection">
                             <p id="p-4">
                              <strong>
                               Background
                              </strong>
                              SOBERANA-02 is a COVID-19 conjugate vaccine (recombinant RBD conjugated to tetanus toxoid). Phases 1/2 clinical trials demonstrated high immunogenicity, promoting neutralizing IgG and specific T-cell response. A third heterologous dose of SOBERANA-Plus (RBD-dimer) further increased neutralizing antibodies.
                             </p>
                            </div>
                            <div id="sec-2" class="subsection">
                             <p id="p-5">
                              <strong>
                               Methods
                              </strong>
                              From March 8
                              <sup>
                               th
                              </sup>
                              to September 30
                              <sup>
                               th
                              </sup>
                              , 2021 we conducted in Havana, Cuba a multicentre randomized, double-blind, placebo-controlled, phase-3 trial evaluating two doses of SOBERANA-02 and a heterologous scheme with one dose SOBERANA-Plus added to it. Participants 19–80 years were randomly assigned to receiving 28 days apart either the two or three dose scheme or placebo. The main endpoint was vaccine efficacy in preventing the occurrence of RT-PCR confirmed symptomatic COVID-19 occurring at least 14 days after the second or third dose in the per-protocol population. We also assessed efficacy against severe disease and, in all participants receiving at least one vaccine/placebo dose, safety for 28 days after each dose.
                             </p>
                            </div>
                            <div id="sec-3" class="subsection">
                             <p id="p-6">
                              <strong>
                               Finding
                              </strong>
                              We included 44·031 participants in a context of Beta VOC predominance, with this variant being gradually replaced by Delta near the trial end. Vaccine efficacy in the heterologous combination was 92·0% (95%CI 80·4–96·7) against symptomatic and 100% against severe COVID-19. Two doses of SOBERANA-02 was 69·7% (95%CI 56·5-78·9) and 74·9% (95%CI 33·7-90·5) efficacious to protect against symptomatic and severe COVID-19, respectively. The occurrence of serious and severe AEs was very rare and equally distributed between placebo and vaccine groups. Solicited AEs were slightly more frequent in the vaccine group but predominantly local and mostly mild and transient.
                             </p>
                            </div>
                            <div id="sec-4" class="subsection">
                             <p id="p-7">
                              <strong>
                               Interpretation
                              </strong>
                              Our results indicate that the straightforward to manufacture SOBERANA vaccines are efficacious in a context of Beta and Delta VOC dominance and that they constitute an attractive, feasible option for low- and middle-income countries, where besides financial constraints ease of vaccine storage and distribution is of concern.
                             </p>
                            </div>
                            <div id="sec-5" class="subsection">
                             <p id="p-8">
                              <strong>
                               Funding
                              </strong>
                              This study received funds from Finlay Vaccine Institute and National Fund for Science and Technology (FONCI-CITMA-Cuba, contract 2020–20). of Ministry of Science, Technology and the Environment (Contract Project-2020-20) in Cuba.
                             </p>
                            </div>
                           </div>
                           <div class="section" id="sec-6">
                            <h2 class="">
                             Introduction
                            </h2>
                            <p id="p-23">
                             Immunization with an effective vaccine constitutes the main tool to fight the COVID-19 pandemic, and achieving high vaccination coverage is critical to control the emergence and spread of new SARS CoV-2 variants.
                             <sup>
                              <a id="xref-ref-1-1" class="xref-bibr" href="#ref-1">
                               1
                              </a>
                             </sup>
                             Clinical trials provided evidence on the efficacy of vaccines based on different technologies, which received WHO endorsed emergency use authorization.
                             <sup>
                              <a id="xref-ref-2-1" class="xref-bibr" href="#ref-2">
                               2
                              </a>
                             </sup>
                             Notwithstanding, even under optimistic manufacturing and delivery scenarios global equitable access to vaccines is likely to be limited when relying on the currently available products only.
                             <sup>
                              <a id="xref-ref-3-1" class="xref-bibr" href="#ref-3">
                               3
                              </a>
                             </sup>
                            </p>
                            <p id="p-24">
                             SOBERANA-02 is a subunit conjugated protein-based COVID-19 vaccine. The antigen is the recombinant receptor binding domain (RBD) protein conjugated chemically to tetanus toxoid (TT).
                             <sup>
                              <a id="xref-ref-4-1" class="xref-bibr" href="#ref-4">
                               4
                              </a>
                             </sup>
                             The well-known protein-polysaccharide conjugation technology provided novel, safe and highly immunogenic paediatric vaccines against Haemophilus influenzae type b from the 1980s onwards,
                             <sup>
                              <a id="xref-ref-5-1" class="xref-bibr" href="#ref-5">
                               5
                              </a>
                             </sup>
                             and some other for protecting against Neisseria meningitidis and Streptococcus pneumoniae.
                             <sup>
                              <a id="xref-ref-6-1" class="xref-bibr" href="#ref-6">
                               6
                              </a>
                              ,
                              <a id="xref-ref-7-1" class="xref-bibr" href="#ref-7">
                               7
                              </a>
                             </sup>
                            </p>
                            <p id="p-25">
                             In phase 1 and 2a clinical trials two doses of SOBERANA-02 induced neutralizing antibodies and T-cells with IFNγ secretion, indicative of a Th1 pattern.
                             <sup>
                              <a id="xref-ref-8-1" class="xref-bibr" href="#ref-8">
                               8
                              </a>
                             </sup>
                             A single dose of SOBERANA-Plus (RBD-dimer/Alum) demonstrated booster capacity in convalescent COVID-19 patients who had acquired natural immunity against the virus,
                             <sup>
                              <a id="xref-ref-9-1" class="xref-bibr" href="#ref-9">
                               9
                              </a>
                             </sup>
                             through hybrid immunity.
                             <sup>
                              <a id="xref-ref-10-1" class="xref-bibr" href="#ref-10">
                               10
                              </a>
                             </sup>
                             A third heterologous dose of SOBERANA-Plus after two doses of SOBERANA-02 significantly increased neutralizing anti-RBD IgG titres.
                             <sup>
                              <a id="xref-ref-8-2" class="xref-bibr" href="#ref-8">
                               8
                              </a>
                             </sup>
                             These results were confirmed in a phase 2b clinical trial.
                             <sup>
                              <a id="xref-ref-11-1" class="xref-bibr" href="#ref-11">
                               11
                              </a>
                             </sup>
                            </p>
                            <p id="p-26">
                             To determine whether the immunogenicity results would translate into differentiated clinical efficacy outcomes we set up a phase 3 trial (IFV/COR/09 number, RPCEC00000354) that evaluates the safety and the efficacy of two immunization regimes: two doses of SOBERANA-02, and the heterologous combination thereof with SOBERANA-Plus as a third dose.
                            </p>
                           </div>
                           <div class="section" id="sec-7">
                            <h2 class="">
                             Methods
                            </h2>
                            <div id="sec-8" class="subsection">
                             <h3>
                              Study design and context
                             </h3>
                             <p id="p-27">
                              A multicentre adaptive, randomized, placebo-controlled, double-blind phase 3 trial was set up to evaluate the efficacy and safety of vaccination against SARS-CoV-2 with 2 doses of SOBERANA-02 (FINLAY-FR-2) -subsequently referred to as So2- and with a three dose heterologous scheme adding SOBERANA-Plus (FINLAY-FR-1A) to it -hereafter So2P. Participants were recruited from March 8
                              <sup>
                               th
                              </sup>
                              to March 31
                              <sup>
                               th
                              </sup>
                              , 2021.
                             </p>
                             <p id="p-28">
                              The study was conducted in Havana, Cuba. Comprehensive primary health care services with a defined population of responsibility are a key element of the Cuban health care system. They consist of family doctor/nurse practices and policlinics. The former is the systems’ entry point, policlinics provide diagnostic and support services and specialized care. The routine identification of COVID-19 cases is based on first line services, which pinpoint suspects and refer to hospitals. Upon a positive RT-PCR test they are hospitalized until symptom resolution and negative PCR test. Contacts of COVID-19 cases are isolated for 5 days and PCR tested routinely.
                             </p>
                             <p id="p-29">
                              The epidemiological context at the start of the trial and during So2 efficacy evaluation coincided with the second epidemic wave in Havana (
                              <a id="xref-fig-4-1" class="xref-fig" href="#F4">
                               S4. Figure S1
                              </a>
                              ; source: Health Information System, Ministry of Public Health) and predominance of VOC Beta (epidemiological week 16 to 22: 83·7% to 72·5%). During So2P efficacy evaluation the Beta strain was partially replaced by Delta (epidemiological week 22 to 28: 72·5% to 29·2% Beta; 5·9% to 70·8% Delta). The latter was associated with a sharp rise of transmission and a significant increase in the incidence of clinical cases.
                             </p>
                            </div>
                            <div id="sec-9" class="subsection">
                             <h3>
                              Roles and responsibilities
                             </h3>
                             <p id="p-30">
                              The trial was sponsored by the Finlay Vaccine Institute. A central Research Ethics Committee was appointed ad hoc by the Cuban Ministry of Public Health. It approved the protocol (Clinical Trials IFV/COR/09 number, RPCEC00000354) and the informed consent forms. In the event of a medical problem requiring unmasking, approval by the principal investigator was planned for. All principles of the Helsinki Declaration and the International Council for Harmonization guidelines were adhered to.
                              <sup>
                               <a id="xref-ref-12-1" class="xref-bibr" href="#ref-12">
                                12
                               </a>
                              </sup>
                              Full details on procedures are provided in the protocol.
                             </p>
                             <p id="p-31">
                              The National Clinical Trials Coordinating Centre (CENCEC) monitored the trial for protocol adherence and observance of Good Clinical Practice, and oversaw data accuracy. An Independent Safety Data Monitoring Board (ISDMB) continuously supervised safety and conducted interim analysis. The ISDMB had access to the case files, confirmed severe cases of COVID-19 illness, and assessed whether any deaths were SARS CoV-2-related.
                             </p>
                            </div>
                            <div id="sec-10" class="subsection">
                             <h3>
                              Participants, randomization and blinding
                             </h3>
                             <p id="p-32">
                              In 8 municipalities of west Havana we set up, in existing health infrastructure, 48 vaccination and clinical sites. Practitioners of the family practices linked to each of these sites organized information campaigns in the community and summoned the population between 19 and 80 years old to participate in the study. The family doctors carried out a first eligibility screening before transferring potential participants to the nearest vaccination site, where formal inclusion took place.
                             </p>
                             <p id="p-33">
                              Persons between 19 and 80 years old with no known history of SARS-CoV-2 infection that consented to use reliable anticonception if female and in fertile age, and that provided written informed consent for participation were included. Exclusion criteria were, amongst others, previous receipt of a COVID-19 vaccine, acute febrile illness or infectious disease, pregnancy or breastfeeding, any uncontrolled non communicable diseases, history of severe allergic reactions to any component of the vaccines, and current or planned or history of receiving immunomodulatory drugs. A complete list of eligibility criteria is available in the protocol. At inclusion, a blood sample for asserting rapid serologic evidence of SARSCoV-2 prior asymptomatic infection (Realy Tech IgG/IgM, China) was collected in order to subsequently permit safety and efficacy analyses stratified by prior exposure.
                             </p>
                             <p id="p-34">
                              Block randomization into study arms and placebo was done at a 1:1:1 ratio stratified by site and by a priori defined risk strata: 19–64 years without risk of severe COVID-19, 19–64 years with risk of severe disease, and ≥65 years. Participants younger than 65 years of age were categorized as being at risk of severe COVID-19 if they had at least one of the following risk factors: obesity (body mass index ≥35), severe malnutrition (BMI < 18.5), hypertension (according to the Ministry of Public Health guidelines),
                              <sup>
                               <a id="xref-ref-13-1" class="xref-bibr" href="#ref-13">
                                13
                               </a>
                              </sup>
                              chronic kidney disease, ischemic heart disease, diabetes mellitus, chronic obstructive pulmonary disease, asthma (grade 2/3), cancer, HIV or primary/secondary immunodeficiency.
                             </p>
                             <p id="p-35">
                              The presentation of the vaccine candidates and placebo were undistinguishable. The participants, the involved health care workers and the investigators were masked to group allocation until the decision was taken to administer or complete the three-dose vaccine schedule.
                             </p>
                            </div>
                            <div id="sec-11" class="subsection">
                             <h3>
                              Products under evaluation
                             </h3>
                             <p id="p-36">
                              SOBERANA-02 is a subunit protein-based vaccine. The antigen is the recombinant SARS-CoV-2 RBD (25 μg), chemically conjugated to tetanus toxoid and adsorbed on 500 μg alumina.
                              <sup>
                               <a id="xref-ref-4-2" class="xref-bibr" href="#ref-4">
                                4
                               </a>
                               ,
                               <a id="xref-ref-8-3" class="xref-bibr" href="#ref-8">
                                8
                               </a>
                              </sup>
                              SOBERANA-Plus antigen is a dimeric RBD (50 μg) adsorbed on 1250 μg alumina.
                              <sup>
                               <a id="xref-ref-14-1" class="xref-bibr" href="#ref-14">
                                14
                               </a>
                               ,
                               <a id="xref-ref-15-1" class="xref-bibr" href="#ref-15">
                                15
                               </a>
                              </sup>
                              The placebo contained SOBERANA-02 ingredients except the active principle. All were stored at 2-8°C and distributed daily to the clinical sites.
                             </p>
                            </div>
                            <div id="sec-12" class="subsection">
                             <h3>
                              Efficacy assessment
                             </h3>
                             <p id="p-37">
                              The primary endpoint was Vaccine Efficacy (VE) for preventing occurrence of symptomatic COVID-19 confirmed by a positive SARS-CoV-2 RT-PCR nasopharyngeal swab (RT-PCR), with onset at least 14 days after the last injection in the per-protocol population (PPP). Secondary endpoints were the efficacy for the prevention of severe COVID-19 and death attributed to COVID-19. Agreement with case definition criteria for primary and secondary endpoints was judged blindly by COVID-19 hospital doctors and reviewed by specifically trained medical research team members. The study’s Principal Investigator resolved any discrepancy. COVID-19 symptomatic disease was considered if participants had at least one major symptom or sign (dyspnea, oxygen saturation ≤92%, persistent thoracic pain, neurological disorders, clinical or radiographic evidence of pneumonia) or two minor symptoms (fever, chills, myalgia, headache, sore throat, running nose, diarrhea/vomiting, myalgia, malaise, cough, dysgeusia/anosmia). RT-PCR (QIAGEN, Germany) confirmation was performed by the SARS CoV-2 national reference laboratory at the “Pedro Kourí” Tropical Medical Institute, Havana, Cuba.
                             </p>
                             <p id="p-38">
                              Severe COVID-19 was defined by the presence of any of the following: dyspnea; cyanosis, pulmonary infiltration/condensation, oxygen saturation ≤90% or assisted mechanical ventilation, acute respiratory distress syndrome, evidence of septic shock, or admission to intensive care. Death was attributed to COVID-19 if the cause could be attributed to a complication of COVID-19.
                             </p>
                            </div>
                            <div id="sec-13" class="subsection">
                             <h3>
                              Safety assessment
                             </h3>
                             <p id="p-39">
                              All adverse events (AE) were recorded in face to face medical consultations on the three consecutive days after receiving each dose of vaccine or placebo and by self-report using a diary of adverse events up to 28 days. AEs were classified as solicited (within 7 days after injection) and unsolicited (within 28 days after injection); local and systemic; grade 1, 2 or 3 (according to the Common Terminology Criteria for Adverse Events, version 5.0),
                              <sup>
                               <a id="xref-ref-16-1" class="xref-bibr" href="#ref-16">
                                16
                               </a>
                              </sup>
                              and causally vaccine related or not (during 28 days) following WHO recommendation.
                              <sup>
                               <a id="xref-ref-17-1" class="xref-bibr" href="#ref-17">
                                17
                               </a>
                              </sup>
                             </p>
                            </div>
                            <div id="sec-14" class="subsection">
                             <h3>
                              Statistical analysis (see also S3-Supplemental Statistical Methods)
                             </h3>
                             <p id="p-40">
                              The trial was designed to test the hypothesis that the risk of symptomatic COVID-19 is reduced >60% compared to placebo group. The lower limit of the 95% confidence interval was ≥30%, which points to the rejection of the null hypothesis (that the efficacy of either vaccination scheme is ≤30%).
                              <sup>
                               <a id="xref-ref-18-1" class="xref-bibr" href="#ref-18">
                                18
                               </a>
                              </sup>
                              The design required to achieve 90% power (and 2.5% 1-sided type I error) to detect a HR of 0.4 (VE >60% to reduce the risk of symptomatic disease compared to placebo), with a null hypothesis of HR 0.7. VE bounds were derived using a Lan-DeMets O’Brien-Fleming approximation spending function. Two interim analyses (IA) were planned at detection of 53 and 106 symptomatic cases meeting the primary outcome definition.
                             </p>
                             <p id="p-41">
                              Vaccine Efficacy was calculated in the per-protocol population (PPP) as percentage reduction in the hazard ratio (HR): VE=100 × (1 –HR) %, in the vaccine groups as compared to the placebo group, with HR estimated from a stratified Cox proportional hazards model, taking into account the defined risk strata. To take the evolution of the epidemiological situation over time into account, the VE for So2P was estimated considering the cases occurring in the same calendar period (14 days after dose 3 in So2P and 42 days after the 2nd dose in placebo).
                             </p>
                             <p id="p-42">
                              Safety was assessed in all participants in the safety population (those who received at least one injection). Descriptive summary statistics (numbers and percentages) for participants with any solicited AE, unsolicited AE, unsolicited severe AE, serious AE, and AE leading to discontinuation from the trial are provided by arm and after each dose.
                             </p>
                             <p id="p-43">
                              A criterion for stopping due to unacceptable toxicity (frequency of serious vaccine related adverse event >1%) was evaluated iteratively with a Bayesian algorithm (see study protocol).
                             </p>
                            </div>
                            <div id="sec-15" class="subsection">
                             <h3>
                              Decision to stop the trial
                             </h3>
                             <p id="p-44">
                              Considering the advantageous results demonstrated in the interim analyses and the explosive epidemiological situation, it was deemed unethical to withhold the benefits of the vaccine from individuals in the placebo group. The Central Research Ethics Committee of the Ministry of Public Health compelled the sponsor to start offering to participants randomised in that group the three-dose schedule. As a consequence, the observation period for efficacy estimation of So2P versus placebo was limited in time. Concurrently, So2 participants were invited to receive a third heterologous dose of SOBERANA-Plus.
                             </p>
                            </div>
                           </div>
                           <div class="section" id="sec-16">
                            <h2 class="">
                             Results
                            </h2>
                            <div id="sec-17" class="subsection">
                             <h3>
                              Trial Population
                             </h3>
                             <p id="p-45">
                              Between March 8–31
                              <sup>
                               th
                              </sup>
                              , 2021, 45.184 volunteer were screened and 44.031 were randomly assigned to So2 (14.679), So2P (14.677) or placebo (14.675) (
                              <a id="xref-fig-1-1" class="xref-fig" href="#F1">
                               Figure 1
                              </a>
                              ). Participants’ characteristics were balanced between the study arms (
                              <a id="xref-table-wrap-1-1" class="xref-table" href="#T1">
                               Table 1
                              </a>
                              ) and the gender and racial distribution were representative of the Cuban demographic structure (see also
                              <a id="xref-table-wrap-6-1" class="xref-table" href="#T6">
                               S4-Table S3
                              </a>
                              for characteristics by age and risk of severe COVID-19). At baseline, serologic evidence of a previous SARS-CoV-2 infection was detected in 0·3% of participants. All participants received the first dose of the treatment they were allocated to.
                             </p>
                             <div id="T1" class="table pos-float">
                              <div class="table-inline table-callout-links">
                               <div class="callout">
                                <span>
                                 View this table:
                                </span>
                                <ul class="callout-links">
                                 <li class="view-inline first">
                                  <a href="##" class="table-expand-inline" data-table-url="/highwire/markup/545796/expansion?postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed&table-expand-inline=1" data-icon-position="" data-hide-link-title="0">
                                   View inline
                                  </a>
                                 </li>
                                 <li class="view-popup">
                                  <a href="/highwire/markup/545796/expansion?width=1000&height=500&iframe=true&postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed" class="colorbox colorbox-load table-expand-popup" rel="gallery-fragment-tables" data-icon-position="" data-hide-link-title="0">
                                   View popup
                                  </a>
                                 </li>
                                 <li class="download-ppt last">
                                  <a href="/highwire/powerpoint/545796" class="highwire-figure-link highwire-figure-link-ppt" data-icon-position="" data-hide-link-title="0">
                                   Download powerpoint
                                  </a>
                                 </li>
                                </ul>
                               </div>
                              </div>
                              <div class="table-caption">
                               <span class="table-label">
                                Table 1.
                               </span>
                               <span class="caption-title">
                                Baseline Demographic and Clinical Characteristics of the randomized participants
                               </span>
                               <div class="sb-div caption-clear">
                               </div>
                              </div>
                             </div>
                             <div id="F1" class="fig pos-float type-figure odd">
                              <div class="highwire-figure">
                               <div class="fig-inline-img-wrapper">
                                <div class="fig-inline-img">
                                 <a href="https://www.medrxiv.org/content/medrxiv/early/2022/08/03/2021.10.31.21265703/F1.large.jpg?width=800&height=600&carousel=1" title="Flow chart. So2 Regimen: two doses of SOBERANA-02 every 28 days; So2P regimen: heterologous combination of two doses of SOBERANA-02 and a third dose with SOBERANA-Plus, every 28 days. " class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-1339357172" data-figure-caption='<div class="highwire-markup"><span xmlns="http://www.w3.org/1999/xhtml" class="caption-title">Flow chart. So2 Regimen: two doses of SOBERANA-02 every 28 days; So2P regimen: heterologous combination of two doses of SOBERANA-02 and a third dose with SOBERANA-Plus, every 28 days.</span> </div>' data-icon-position="" data-hide-link-title="0">
                                  <span class="hw-responsive-img">
                                   <img class="highwire-fragment fragment-image lazyload" alt="Figure 1:" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.medrxiv.org/content/medrxiv/early/2022/08/03/2021.10.31.21265703/F1.medium.gif" width="344" height="440"/>
                                   <noscript>
                                    <img class="highwire-fragment fragment-image" alt="Figure 1:" src="https://www.medrxiv.org/content/medrxiv/early/2022/08/03/2021.10.31.21265703/F1.medium.gif" width="344" height="440"/>
                                   </noscript>
                                  </span>
                                 </a>
                                </div>
                               </div>
                               <ul class="highwire-figure-links inline">
                                <li class="download-fig first">
                                 <a href="https://www.medrxiv.org/content/medrxiv/early/2022/08/03/2021.10.31.21265703/F1.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download Figure 1:" data-icon-position="" data-hide-link-title="0">
                                  Download figure
                                 </a>
                                </li>
                                <li class="new-tab last">
                                 <a href="https://www.medrxiv.org/content/medrxiv/early/2022/08/03/2021.10.31.21265703/F1.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">
                                  Open in new tab
                                 </a>
                                </li>
                               </ul>
                              </div>
                              <div class="fig-caption" xmlns:xhtml="http://www.w3.org/1999/xhtml">
                               <span class="fig-label">
                                Figure 1:
                               </span>
                               <span class="caption-title">
                                Flow chart. So2 Regimen: two doses of SOBERANA-02 every 28 days; So2P regimen: heterologous combination of two doses of SOBERANA-02 and a third dose with SOBERANA-Plus, every 28 days.
                               </span>
                               <div class="sb-div caption-clear">
                               </div>
                              </div>
                             </div>
                             <p id="p-46">
                              After receiving the first dose, overall 173 (0·39%) participants withdrew their consent and did not receive the second dose and after that dose, 7 (0·05%) from the So2P group withdrew their consent. 433 (0·98%) and 125 (0·85%) participants diagnosed with symptomatic PCR positive SARS-CoV-2 infection were excluded before receiving the second and the third dose, respectively. The PPP primary efficacy analysis included 42.511 subjects receiving the first injection: 14.355 in the So2, 13.871 in the So2P, and 14.285 in the placebo group. Follow-up after the second dose in the two doses analysis totalled 71.202 and 65.136 persons-weeks in the placebo and So2 arm, respectively, while in the three doses analysis it was 20.045 persons-weeks in the placebo and 47.088 persons-weeks in the So2P group.
                             </p>
                            </div>
                            <div id="sec-18" class="subsection">
                             <h3>
                              Safety
                             </h3>
                             <p id="p-47">
                              Local solicited Vaccine-Associated Adverse Events (VAAEs) occurred somewhat more frequently in the vaccine group than in the placebo group after the first dose (7·7%, vs. 2·6%, 95%CI for difference: 4·7-5·5) and the second dose (1·9%, vs. 0·4%, 95%CI for difference: 1·3-1·7) (
                              <a id="xref-fig-2-1" class="xref-fig" href="#F2">
                               Figure 2
                              </a>
                              ,
                              <a id="xref-table-wrap-7-1" class="xref-table" href="#T7">
                               S6-Table S4
                              </a>
                              ,
                              <a id="xref-table-wrap-8-1" class="xref-table" href="#T8">
                               S7-Table S5
                              </a>
                              ). After the third dose, the frequency of subjects with local AEs dropped to 0·3% (
                              <a id="xref-table-wrap-9-1" class="xref-table" href="#T9">
                               S7-Table S6
                              </a>
                              ). In the vaccine groups 97·5% of local adverse events were grade 1 and less than 0·2% grade 3. They lasted a median of 2 days after the first and second dose (25-75
                              <sup>
                               th
                              </sup>
                              percentile: 1-3 after the first and 1-2 after the 2
                              <sup>
                               nd
                              </sup>
                              dose), and 2 days after the third dose (25-75
                              <sup>
                               th
                              </sup>
                              percentile: 0-3). The most common local AE was pain at the injection site (2·6%, 7·5% and 8·7% in placebo and vaccine groups, respectively). Onset of injection-site reactions on or after day 8 were noted in 21 participants (0·05%) after the first dose (4 for placebo and 17 for vaccine groups), in 4 (0·01%) after the second dose (2 for placebo and 2 for vaccine groups) and in 1 participant (0·01%) after the third dose. Local reactions were characterized by erythema, induration, warmth, swelling and pain, and resolved after a median of 1 day (25-75
                              <sup>
                               th
                              </sup>
                              percentiles: 0·5-2).
                             </p>
                             <div id="F2" class="fig pos-float type-figure odd">
                              <div class="highwire-figure">
                               <div class="fig-inline-img-wrapper">
                                <div class="fig-inline-img">
                                 <a href="https://www.medrxiv.org/content/medrxiv/early/2022/08/03/2021.10.31.21265703/F2.large.jpg?width=800&height=600&carousel=1" title="Solicited Vaccine-Associated Adverse Events (VAAE) Within 7 Days After each dose by Grade Numbers in red above the bars indicate the % grade 3 AE" class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-1339357172" data-figure-caption='<div class="highwire-markup"><span xmlns="http://www.w3.org/1999/xhtml" class="caption-title">Solicited Vaccine-Associated Adverse Events (VAAE) Within 7 Days After each dose by Grade</span> Numbers in red above the bars indicate the % grade 3 AE</div>' data-icon-position="" data-hide-link-title="0">
                                  <span class="hw-responsive-img">
                                   <img class="highwire-fragment fragment-image lazyload" alt="Figure 2." src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.medrxiv.org/content/medrxiv/early/2022/08/03/2021.10.31.21265703/F2.medium.gif" width="298" height="440"/>
                                   <noscript>
                                    <img class="highwire-fragment fragment-image" alt="Figure 2." src="https://www.medrxiv.org/content/medrxiv/early/2022/08/03/2021.10.31.21265703/F2.medium.gif" width="298" height="440"/>
                                   </noscript>
                                  </span>
                                 </a>
                                </div>
                               </div>
                               <ul class="highwire-figure-links inline">
                                <li class="download-fig first">
                                 <a href="https://www.medrxiv.org/content/medrxiv/early/2022/08/03/2021.10.31.21265703/F2.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download Figure 2." data-icon-position="" data-hide-link-title="0">
                                  Download figure
                                 </a>
                                </li>
                                <li class="new-tab last">
                                 <a href="https://www.medrxiv.org/content/medrxiv/early/2022/08/03/2021.10.31.21265703/F2.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">
                                  Open in new tab
                                 </a>
                                </li>
                               </ul>
                              </div>
                              <div class="fig-caption">
                               <span class="fig-label">
                                Figure 2.
                               </span>
                               <span class="caption-title">
                                Solicited Vaccine-Associated Adverse Events (VAAE) Within 7 Days After each dose by Grade
                               </span>
                               <p id="p-48" class="first-child">
                                Numbers in red above the bars indicate the % grade 3 AE
                               </p>
                               <div class="sb-div caption-clear">
                               </div>
                              </div>
                             </div>
                             <p id="p-49">
                              Solicited systemic VAAEs occurred a little more often in the vaccine groups than in the placebo group after both the first dose (1·8% vs. 1·4%; 95%CI for difference: 0·1-0·6%) and the second dose (0·7% vs. 0·2%; 95%CI for difference: 0·4-0·6%) and dropped to 0·1% after the third dose (
                              <a id="xref-fig-2-2" class="xref-fig" href="#F2">
                               Figure 2
                              </a>
                              ,
                              <a id="xref-table-wrap-7-2" class="xref-table" href="#T7">
                               S6-Table S4
                              </a>
                              ,
                              <a id="xref-table-wrap-8-2" class="xref-table" href="#T8">
                               S7-Table S5
                              </a>
                              ,
                              <a id="xref-table-wrap-9-2" class="xref-table" href="#T9">
                               S8-Table S6
                              </a>
                              ). Their severity in the vaccine groups changed slightly from 6·5% after the first dose to 8·8% after the second dose for grade 2 events, and from 0·6% to 0·4% for grade 3 ones. Solicited systemic AEs in the vaccine groups lasted a median of 1 day after the first (25-75
                              <sup>
                               th
                              </sup>
                              percentile: 0-2) and second doses (25-75
                              <sup>
                               th
                              </sup>
                              percentile: 0-3), and 2 days after the third dose (25-75
                              <sup>
                               th
                              </sup>
                              percentile: 0·8-7·5). The frequency of solicited AE was very low in subject with serologic evidence of a past SARSCoV-2 infection at intake: 0·1% of local AE after any injection and <0.1% of systemic events.
                             </p>
                             <p id="p-50">
                              Unsolicited AE frequency reported during the 28 days following each injection was similar in all groups. The more frequent events (≥1%) were a high blood pressure measurement, mainly in subjects with known hypertension (1·8% for placebo, 2·1% for So2 and 2·2% for So2P) and headache (1·0% for placebo, 1·2% for So2 and 1·5% for So2P) (
                              <a id="xref-table-wrap-11-1" class="xref-table" href="#T11">
                               S9-Table S8
                              </a>
                              ). The occurrence of serious (<0·1%) and severe (0·1%) VAAE was equal between groups (
                              <a id="xref-table-wrap-10-1" class="xref-table" href="#T10">
                               S8-Table S7
                              </a>
                              ,
                              <a id="xref-table-wrap-12-1" class="xref-table" href="#T12">
                               S10-Table S9
                              </a>
                              ). 3·9% of all the AEs were grade 3 in the placebo group against 3·4% and 4·2% for groups So2 and So2P, respectively and 7·9%, 6·7% and 6·7% were serious in these groups, respectively. All-cause mortality was 24 (0·2%) amongst placebo recipients against 9 and 11 (0·1%) in groups So2 and So2P (P=0·014). No death was vaccine related.
                             </p>
                            </div>
                            <div id="sec-19" class="subsection">
                             <h3>
                              Efficacy
                             </h3>
                             <p id="p-51">
                              The final analysis of the two-doses schedule included 174 cases of symptomatic COVID-19: 136 in the placebo group (99·9 per 1000 person-years; 95%CI 83·8–118·2) and 38 in the So2 group (30·5 per 1000 person-years; 95%CI 21·6–41·9). This corresponds to 69·7% VE (95% CI 56·5-78·9%; P<0·001) for the prevention of symptomatic SARS-CoV-2 infection by the 2 dose So2 schedule (
                              <a id="xref-table-wrap-2-1" class="xref-table" href="#T2">
                               Table 2
                              </a>
                              ,
                              <a id="xref-fig-3-1" class="xref-fig" href="#F3">
                               Figure 3
                              </a>
                              ,
                              <a id="xref-fig-5-1" class="xref-fig" href="#F5">
                               S13-Figure S2
                              </a>
                              ). The vaccine efficacy to prevent COVID-19 was congruous across subgroups stratified by demographic and baseline characteristics (
                              <a id="xref-fig-6-1" class="xref-fig" href="#F6">
                               S14-Figure S3
                              </a>
                              ).
                             </p>
                             <div id="T2" class="table pos-float">
                              <div class="table-inline table-callout-links">
                               <div class="callout">
                                <span>
                                 View this table:
                                </span>
                                <ul class="callout-links">
                                 <li class="view-inline first">
                                  <a href="##" class="table-expand-inline" data-table-url="/highwire/markup/545809/expansion?postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed&table-expand-inline=1" data-icon-position="" data-hide-link-title="0">
                                   View inline
                                  </a>
                                 </li>
                                 <li class="view-popup">
                                  <a href="/highwire/markup/545809/expansion?width=1000&height=500&iframe=true&postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed" class="colorbox colorbox-load table-expand-popup" rel="gallery-fragment-tables" data-icon-position="" data-hide-link-title="0">
                                   View popup
                                  </a>
                                 </li>
                                 <li class="download-ppt last">
                                  <a href="/highwire/powerpoint/545809" class="highwire-figure-link highwire-figure-link-ppt" data-icon-position="" data-hide-link-title="0">
                                   Download powerpoint
                                  </a>
                                 </li>
                                </ul>
                               </div>
                              </div>
                              <div class="table-caption">
                               <span class="table-label">
                                Table 2.
                               </span>
                               <span class="caption-title">
                                Vaccine Efficacy to prevent symptomatic COVID-19 disease in the Per-Protocol Population (PPP)
                               </span>
                               <div class="sb-div caption-clear">
                               </div>
                              </div>
                             </div>
                             <div id="F3" class="fig pos-float type-figure odd">
                              <div class="highwire-figure">
                               <div class="fig-inline-img-wrapper">
                                <div class="fig-inline-img">
                                 <a href="https://www.medrxiv.org/content/medrxiv/early/2022/08/03/2021.10.31.21265703/F3.large.jpg?width=800&height=600&carousel=1" title="Cumulative incidence of Covid-19 disease Vertical dashed lines indicate the start of: dose 2 administration, of So2 efficacy evaluation, of dose 3 administration and of So2P efficacy evaluation, respectively" class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-1339357172" data-figure-caption='<div class="highwire-markup"><span xmlns="http://www.w3.org/1999/xhtml" class="caption-title">Cumulative incidence of Covid-19 disease</span> Vertical dashed lines indicate the start of: dose 2 administration, of So2 efficacy evaluation, of dose 3 administration and of So2P efficacy evaluation, respectively</div>' data-icon-position="" data-hide-link-title="0">
                                  <span class="hw-responsive-img">
                                   <img class="highwire-fragment fragment-image lazyload" alt="Figure 3." src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.medrxiv.org/content/medrxiv/early/2022/08/03/2021.10.31.21265703/F3.medium.gif" width="440" height="168"/>
                                   <noscript>
                                    <img class="highwire-fragment fragment-image" alt="Figure 3." src="https://www.medrxiv.org/content/medrxiv/early/2022/08/03/2021.10.31.21265703/F3.medium.gif" width="440" height="168"/>
                                   </noscript>
                                  </span>
                                 </a>
                                </div>
                               </div>
                               <ul class="highwire-figure-links inline">
                                <li class="download-fig first">
                                 <a href="https://www.medrxiv.org/content/medrxiv/early/2022/08/03/2021.10.31.21265703/F3.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download Figure 3." data-icon-position="" data-hide-link-title="0">
                                  Download figure
                                 </a>
                                </li>
                                <li class="new-tab last">
                                 <a href="https://www.medrxiv.org/content/medrxiv/early/2022/08/03/2021.10.31.21265703/F3.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">
                                  Open in new tab
                                 </a>
                                </li>
                               </ul>
                              </div>
                              <div class="fig-caption">
                               <span class="fig-label">
                                Figure 3.
                               </span>
                               <span class="caption-title">
                                Cumulative incidence of Covid-19 disease
                               </span>
                               <p id="p-52" class="first-child">
                                Vertical dashed lines indicate the start of: dose 2 administration, of So2 efficacy evaluation, of dose 3 administration and of So2P efficacy evaluation, respectively
                               </p>
                               <div class="sb-div caption-clear">
                               </div>
                              </div>
                             </div>
                             <p id="p-53">
                              The VE for prevention of severe COVID-19 (23 cases in placebo vs 5 in So2) was 74·9% (95%CI: 33·7-90·5). (
                              <a id="xref-table-wrap-13-1" class="xref-table" href="#T13">
                               S12-Table S10
                              </a>
                              ). There were 3 and 2 deaths from COVID-19 disease, respectively; the small number of events precludes a point estimate of VE.
                             </p>
                             <p id="p-54">
                              For the final analysis of the three-dose heterologous So2P schedule 41 cases of COVID-19 were included: 35 in the placebo group (91·4 per 1000 person-years; 95%CI 63·4-126·6) and 6 in the So2P group, (6·6 per 1000 person-years; 95%CI 2·4-14·5). This means 92·0% VE (95%CI 80·4–96·7%; P<0·001) for prevention of symptomatic SARS-CoV-2 infection by the 3-dose schedule (
                              <a id="xref-table-wrap-2-2" class="xref-table" href="#T2">
                               Table 2
                              </a>
                              ,
                              <a id="xref-fig-3-2" class="xref-fig" href="#F3">
                               Figure 3
                              </a>
                              ,
                              <a id="xref-fig-7-1" class="xref-fig" href="#F7">
                               S15-Figure S4
                              </a>
                              ). Subgroups analysis yields remarkably consistent VE estimates, but lacks precision for much of the strata (
                              <a id="xref-fig-8-1" class="xref-fig" href="#F8">
                               S16-Figure S5
                              </a>
                              ). Severe COVID-19 occurred in 6 and 0 participants in placebo and So2P, respectively, implying 100% VE (
                              <a id="xref-table-wrap-13-2" class="xref-table" href="#T13">
                               S12-Table S10
                              </a>
                              ). There were no deaths from COVID-19 disease. Including in the analysis subjects that were PCR negative but had a IgG/IgM positive test at inclusion, indicating past SARSCoV-2 infection, did not affect any of the VE estimates reported in all the above PPP analysis.
                             </p>
                            </div>
                           </div>
                           <div class="section" id="sec-20">
                            <h2 class="">
                             Discussion
                            </h2>
                            <p id="p-55">
                             The SOBERANA vaccines demonstrated to be efficacious in preventing PCR-confirmed symptomatic SARS-CoV-2 infections among adults aged 19–80 years. Efficacy after two doses SOBERANA-02 administration, 69·7%, was well over the WHO-set 50% threshold.
                             <sup>
                              <a id="xref-ref-19-1" class="xref-bibr" href="#ref-19">
                               19
                              </a>
                             </sup>
                             After completion of the heterologous schedule with SOBERANA-Plus, VE attained an excellent 92·0%. Efficacy to prevent severe COVID-19 was 74·9% and 100·0% for the two dose and heterologous regimen, respectively. The occurrence of serious and severe AEs was very rare and equally distributed between the placebo and vaccine groups. Solicited AEs were slightly more frequent in the vaccine group but predominantly local and mostly mild and transient.
                            </p>
                            <p id="p-56">
                             Subunit protein vaccines present clear advantages in terms of manufacturing, storage and distribution.
                             <sup>
                              <a id="xref-ref-19-2" class="xref-bibr" href="#ref-19">
                               19
                              </a>
                             </sup>
                             Still, administration of a third heterologous dose in the So2P regimen, which significantly further increases SOBERANA’s VE, could be construed as a disadvantage compared to COVID-19 vaccines using two dose regimens. However, the need for and benefits of administering a booster dose to the primary schedules of registered vaccines is increasingly recognized.
                             <sup>
                              <a id="xref-ref-20-1" class="xref-bibr" href="#ref-20">
                               20
                              </a>
                              ,
                              <a id="xref-ref-21-1" class="xref-bibr" href="#ref-21">
                               21
                              </a>
                             </sup>
                             Furthermore, due to the T-epitopes from the tetanus toxoid carrier protein, SOBERANA-02 -the first conjugate SARS CoV-2 RBD protein based vaccine-induces T-helper response and long lasting immunity.
                             <sup>
                              <a id="xref-ref-8-4" class="xref-bibr" href="#ref-8">
                               8
                              </a>
                              ,
                              <a id="xref-ref-11-2" class="xref-bibr" href="#ref-11">
                               11
                              </a>
                             </sup>
                             Heterologous combination for priming and booster using protein vaccines are reported by others with excellent results.
                             <sup>
                              <a id="xref-ref-22-1" class="xref-bibr" href="#ref-22">
                               22
                              </a>
                              ,
                              <a id="xref-ref-23-1" class="xref-bibr" href="#ref-23">
                               23
                              </a>
                             </sup>
                            </p>
                            <p id="p-57">
                             Preclinical results highlighted the stimulation of specific B- and T-memory cells, affinity maturation and a significant and boostable IgG immune response in mice.
                             <sup>
                              <a id="xref-ref-4-3" class="xref-bibr" href="#ref-4">
                               4
                              </a>
                             </sup>
                             The immunogenicity pattern observed in a phase 1 and 2a trials suggested as the best option two doses of 25-μg SOBERANA-02 followed by a third dose of SOBERANA-Plus.
                             <sup>
                              <a id="xref-ref-8-5" class="xref-bibr" href="#ref-8">
                               8
                              </a>
                             </sup>
                             In phase 2b the 4-fold anti-RBD IgG seroconversion rate in 758 volunteers was 76·3 % after two doses and 96·8% after the third heterologous dose, against 7.3% in the placebo group.
                             <sup>
                              <a id="xref-ref-11-3" class="xref-bibr" href="#ref-11">
                               11
                              </a>
                             </sup>
                             Neutralizing IgG antibodies were detected against D614G and VOCs Alpha, Beta, Delta and Omicron, and neutralizing antibodies were still present 7-8 months after the third dose.
                             <sup>
                              <a id="xref-ref-11-4" class="xref-bibr" href="#ref-11">
                               11
                              </a>
                             </sup>
                             The results of the present trial permit to conclude that this leads to improved clinical efficacy of the 3-dose scheme.
                            </p>
                            <p id="p-58">
                             A living systematic review reports pooled vaccine efficacy against symptomatic COVID 19 for different platform as: mRNA vaccines 95% (95%CI: 92%-97%); protein subunit vaccines 77% (95%CI 5%-95%); viral vector vaccines 68% (95%CI: 61%-74%) inactivated vaccines 61% (95%CI 52%-68%]. It found that viral vector vaccines decreased overall mortality (risk ratio=0·25; 95%CI 0·09-0·67), but analogous estimates for other platform vaccines are imprecise.
                             <sup>
                              <a id="xref-ref-24-1" class="xref-bibr" href="#ref-24">
                               24
                              </a>
                             </sup>
                             SOBERANA’s performance in the present study compares favourably with the above findings.
                            </p>
                            <p id="p-59">
                             Furthermore, the trial was conducted in a challenging epidemiological context: VOC Beta was by far predominant during So2 efficacy evaluation and gradually replaced by VOC Delta after starting So2P evaluation. Beta has demonstrated significant immune evasion ability. It carries the E484K mutation that substantially reduces neutralization by antibodies in sera of convalescent and vaccinated persons.
                             <sup>
                              <a id="xref-ref-25-1" class="xref-bibr" href="#ref-25">
                               25
                              </a>
                             </sup>
                             The few available VE trials on Beta, most of them conducted in South Africa, show efficacy decline with respect to the original SARS-CoV-2 strain. Except for BNT162b2 (Pfizer/BioNTech), with reported efficacy of 100% (95%CI 53·5-100·0),
                             <sup>
                              <a id="xref-ref-26-1" class="xref-bibr" href="#ref-26">
                               26
                              </a>
                             </sup>
                             ChAdOx1-nCoV-19 (AstraZeneca) was not efficacious against mild-to-moderate Beta variant disease,
                             <sup>
                              <a id="xref-ref-27-1" class="xref-bibr" href="#ref-27">
                               27
                              </a>
                             </sup>
                             a single dose Ad26.COV2.S (Janssen) shows 52·0% (95% CI 30·3 to 67·4) against moderate disease,
                             <sup>
                              <a id="xref-ref-28-1" class="xref-bibr" href="#ref-28">
                               28
                              </a>
                             </sup>
                             NVX-CoV2373 (Novavax) was 60·1% (95%CI 19·9-80·1) against symptomatic disease.
                             <sup>
                              <a id="xref-ref-29-1" class="xref-bibr" href="#ref-29">
                               29
                              </a>
                             </sup>
                            </p>
                            <p id="p-60">
                             Two doses of SOBERANA-02 hence achieved 69·7% (95% CI 56·5-78·9%), quite remarkable efficacy against VOC Beta in our racially diverse Latin-American trial population. One could surmise that, being a conjugated protein-based vaccine that triggers a broad immune response, the efficacy might remain relatively well at par against other immune evading variants. The heterologous combination performed still considerably better. It is, however, not possible to fully unravel this further improved efficacy with a third SOBERANA-Plus dose from the partial replacement of Beta by Delta VOC.
                            </p>
                            <p id="p-61">
                             Notwithstanding, both variants have evasion ability and observational studies have been providing evidence of reduced effectiveness of WHO authorised emergency use listing vaccines against both of them.
                             <sup>
                              <a id="xref-ref-2-2" class="xref-bibr" href="#ref-2">
                               2
                              </a>
                             </sup>
                             The encouraging safety profile observed during the phase 2 SOBERANA clinical trial was confirmed in this phase 3 study.
                             <sup>
                              <a id="xref-ref-8-6" class="xref-bibr" href="#ref-8">
                               8
                              </a>
                              ,
                              <a id="xref-ref-11-5" class="xref-bibr" href="#ref-11">
                               11
                              </a>
                             </sup>
                             Pain at the injection site was not uncommon, akin to what has been observed for other subunit protein and mRNA COVID 19 vaccines,
                             <sup>
                              <a id="xref-ref-23-2" class="xref-bibr" href="#ref-23">
                               23
                              </a>
                             </sup>
                             but mostly mild, while rates of other local reactions were low. Fever and general discomfort were rather uncommon and generally mild, as were other systemic reactions. Serious and severe AEs occurred very rarely and similarly in the vaccine and placebo groups and no death was vaccine related, but sample sizes far beyond those of a typical clinical trial may be needed to adequately appraise these frequencies.
                            </p>
                            <p id="p-62">
                             The decision to stop the trial early, remove masking and offer full 3 dose vaccination to all participants constitutes a limitation of our study. It shortened the follow up period for assessing the efficacy of the three dose So2P schedule. However, we still obtained a precise and unbiased VE estimate with narrow CI. Furthermore, to observe waning of protection approximately 6 months follow up would be needed, which can generally only be achieved in observational studies under real life conditions.
                            </p>
                            <p id="p-63">
                             Recruitment of participants through family medicine practices, which guaranteed accelerated inclusion reflecting the composition of the population in terms of gender, race and pre-existing conditions, constitutes a strength of this study. Coordination with the health system’s established and well adhered to routine SARS-CoV-2/COVID-19 activities for case ascertainment, hospitalization standardized case management contribute to the strengths.
                            </p>
                            <p id="p-64">
                             Overall, our results indicate that the straightforward to manufacture SOBERANA vaccines are efficacious in a context of Beta and Delta VOC dominance and that they constitute an attractive, feasible option for low- and middle-income countries, where besides financial constraints also ease of vaccine storage and distribution is of concern.
                            </p>
                           </div>
                           <div class="section data-availability" id="sec-21">
                            <h2 class="">
                             Data Availability
                            </h2>
                            <p id="p-65">
                             All data produced in the present study are available upon reasonable request to the authors
                            </p>
                            <p id="p-66">
                             <a href="https://rpcec.sld.cu/en/trials/RPCEC00000354-En">
                              https://rpcec.sld.cu/en/trials/RPCEC00000354-En
                             </a>
                            </p>
                           </div>
                           <div class="section" id="sec-22">
                            <h2 class="">
                             Declaration of Interests
                            </h2>
                            <p id="p-67">
                             The Finlay Vaccine Institute manufacture the vaccine and have filed patent applications related to the vaccine’s SOBERANA-02 and SOBERANA-Plus. VVB, YVB, DGR, YCR, SFC are authors of these patent applications. The other authors declare no competing interests. No authors received an honorarium for this paper
                            </p>
                           </div>
                           <div class="section" id="sec-23">
                            <h2 class="">
                             Data sharing
                            </h2>
                            <p id="p-68">
                             Protocol (English version) is available at submission. Data about adverse events and VE are shared in the Supplementary Material. Information is also available at the Cuban Public Registry of Clinical Trials, included in WHO International Clinical Trials Registry Platform (
                             <a href="https://rpcec.sld.cu/en/trials/RPCEC00000354-En">
                              https://rpcec.sld.cu/en/trials/RPCEC00000354-En
                             </a>
                             ). Other supporting clinical documents, including statistical analysis plan and the informed consent form will be available after publication of this article. Proposals should be sent to:
                             <span class="em-link">
                              <span class="em-addr">
                               mariaeugenia{at}ipk.sld.cu
                              </span>
                             </span>
                             and
                             <span class="em-link">
                              <span class="em-addr">
                               vicente.verez{at}finlay.edu.cu
                              </span>
                             </span>
                             . These proposals must be reviewed and approved by the sponsor and the investigator. Finally, a data access agreement must be signed.
                            </p>
                           </div>
                           <div class="section" id="sec-24">
                            <h2 class="">
                             SUPLEMENTARY INFORMATION
                            </h2>
                            <div id="T3" class="table pos-float">
                             <div class="table-inline table-callout-links">
                              <div class="callout">
                               <span>
                                View this table:
                               </span>
                               <ul class="callout-links">
                                <li class="view-inline first">
                                 <a href="##" class="table-expand-inline" data-table-url="/highwire/markup/545804/expansion?postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed&table-expand-inline=1" data-icon-position="" data-hide-link-title="0">
                                  View inline
                                 </a>
                                </li>
                                <li class="view-popup">
                                 <a href="/highwire/markup/545804/expansion?width=1000&height=500&iframe=true&postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed" class="colorbox colorbox-load table-expand-popup" rel="gallery-fragment-tables" data-icon-position="" data-hide-link-title="0">
                                  View popup
                                 </a>
                                </li>
                                <li class="download-ppt last">
                                 <a href="/highwire/powerpoint/545804" class="highwire-figure-link highwire-figure-link-ppt" data-icon-position="" data-hide-link-title="0">
                                  Download powerpoint
                                 </a>
                                </li>
                               </ul>
                              </div>
                             </div>
                             <div class="table-caption">
                              <span class="table-label">
                               S1. Table S1.
                              </span>
                              <span class="caption-title">
                               SOBERANA-2 Phase 3 Team
                              </span>
                              <div class="sb-div caption-clear">
                              </div>
                             </div>
                            </div>
                            <div id="T4" class="table pos-float">
                             <div class="table-inline table-callout-links">
                              <div class="callout">
                               <span>
                                View this table:
                               </span>
                               <ul class="callout-links">
                                <li class="view-inline first">
                                 <a href="##" class="table-expand-inline" data-table-url="/highwire/markup/545805/expansion?postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed&table-expand-inline=1" data-icon-position="" data-hide-link-title="0">
                                  View inline
                                 </a>
                                </li>
                                <li class="view-popup last">
                                 <a href="/highwire/markup/545805/expansion?width=1000&height=500&iframe=true&postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed" class="colorbox colorbox-load table-expand-popup" rel="gallery-fragment-tables" data-icon-position="" data-hide-link-title="0">
                                  View popup
                                 </a>
                                </li>
                               </ul>
                              </div>
                             </div>
                             <div class="table-caption">
                              <span class="table-label">
                               S2. Table S2.
                              </span>
                              <span class="caption-title">
                               List of SOBERANA-2 Phase 3 Medical Investigators
                              </span>
                              <div class="sb-div caption-clear">
                              </div>
                             </div>
                            </div>
                            <div class="section" id="sec-25">
                             <h3>
                              S3. Supplemental Statistical Methods
                             </h3>
                             <div class="section" id="sec-26">
                              <h4>
                               Statistical aspects of the vaccine efficacy analysis
                              </h4>
                              <p id="p-72">
                               Stratified Cox proportional regression model according to randomization strata was used to evaluate vaccine efficacy (VE), under the assumption of proportional hazard measured as 1 – HR (in each schedule vs. placebo) to test the hypothesis H0: HR ≥ 0.7 (equivalent to VE ≤ 0.3).
                              </p>
                              <p id="p-73">
                               Subjects with no confirmed symptomatic illness were censored (assuming that the confirmed illness event did not occur when the subject was under observation). The following intercurrent events were considered:
                              </p>
                              <div id="T5" class="table pos-float">
                               <div class="table-inline table-callout-links">
                                <div class="callout">
                                 <span>
                                  View this table:
                                 </span>
                                 <ul class="callout-links">
                                  <li class="view-inline first">
                                   <a href="##" class="table-expand-inline" data-table-url="/highwire/markup/545794/expansion?postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed&table-expand-inline=1" data-icon-position="" data-hide-link-title="0">
                                    View inline
                                   </a>
                                  </li>
                                  <li class="view-popup">
                                   <a href="/highwire/markup/545794/expansion?width=1000&height=500&iframe=true&postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed" class="colorbox colorbox-load table-expand-popup" rel="gallery-fragment-tables" data-icon-position="" data-hide-link-title="0">
                                    View popup
                                   </a>
                                  </li>
                                  <li class="download-ppt last">
                                   <a href="/highwire/powerpoint/545794" class="highwire-figure-link highwire-figure-link-ppt" data-icon-position="" data-hide-link-title="0">
                                    Download powerpoint
                                   </a>
                                  </li>
                                 </ul>
                                </div>
                               </div>
                              </div>
                              <div id="F4" class="fig pos-float type-figure odd">
                               <div class="highwire-figure">
                                <div class="fig-inline-img-wrapper">
                                 <div class="fig-inline-img">
                                  <a href="https://www.medrxiv.org/content/medrxiv/early/2022/08/03/2021.10.31.21265703/F4.large.jpg?width=800&height=600&carousel=1" title="Relative frequency of circulating SARS-CoV-2 variants of concern and incidence rate of symptomatic infection in West Havana around the study period ─ dose 1; -- start So2 efficacy evaluation; ─.─ start So2P efficacy evaluation * Incidence of symptomatic infection per 105 in 19-80 years old in the population of the study area (8 municipalities of west Havana)" class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-1339357172" data-figure-caption='<div class="highwire-markup"><div xmlns="http://www.w3.org/1999/xhtml"><span class="caption-title">Relative frequency of circulating SARS-CoV-2 variants of concern and incidence rate of symptomatic infection in West Havana around the study period</span> ─ dose 1; -- start So2 efficacy evaluation; ─.─ start So2P efficacy evaluation * Incidence of symptomatic infection per 10<sup>5</sup> in 19-80 years old in the population of the study area (8 municipalities of west Havana)</div></div>' data-icon-position="" data-hide-link-title="0">
                                   <span class="hw-responsive-img">
                                    <img class="highwire-fragment fragment-image lazyload" alt="S4. Figure S1." src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.medrxiv.org/content/medrxiv/early/2022/08/03/2021.10.31.21265703/F4.medium.gif" width="440" height="263"/>
                                    <noscript>
                                     <img class="highwire-fragment fragment-image" alt="S4. Figure S1." src="https://www.medrxiv.org/content/medrxiv/early/2022/08/03/2021.10.31.21265703/F4.medium.gif" width="440" height="263"/>
                                    </noscript>
                                   </span>
                                  </a>
                                 </div>
                                </div>
                                <ul class="highwire-figure-links inline">
                                 <li class="download-fig first">
                                  <a href="https://www.medrxiv.org/content/medrxiv/early/2022/08/03/2021.10.31.21265703/F4.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download S4. Figure S1." data-icon-position="" data-hide-link-title="0">
                                   Download figure
                                  </a>
                                 </li>
                                 <li class="new-tab last">
                                  <a href="https://www.medrxiv.org/content/medrxiv/early/2022/08/03/2021.10.31.21265703/F4.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">
                                   Open in new tab
                                  </a>
                                 </li>
                                </ul>
                               </div>
                               <div class="fig-caption">
                                <span class="fig-label">
                                 S4. Figure S1.
                                </span>
                                <span class="caption-title">
                                 Relative frequency of circulating SARS-CoV-2 variants of concern and incidence rate of symptomatic infection in West Havana around the study period
                                </span>
                                <p id="p-74" class="first-child">
                                 ─ dose 1; -- start So2 efficacy evaluation; ─.─ start So2P efficacy evaluation
                                </p>
                                <p id="p-75">
                                 * Incidence of symptomatic infection per 10
                                 <sup>
                                  5
                                 </sup>
                                 in 19-80 years old in the population of the study area (8 municipalities of west Havana)
                                </p>
                                <div class="sb-div caption-clear">
                                </div>
                               </div>
                              </div>
                              <div id="T6" class="table pos-float">
                               <div class="table-inline table-callout-links">
                                <div class="callout">
                                 <span>
                                  View this table:
                                 </span>
                                 <ul class="callout-links">
                                  <li class="view-inline first">
                                   <a href="##" class="table-expand-inline" data-table-url="/highwire/markup/545811/expansion?postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed&table-expand-inline=1" data-icon-position="" data-hide-link-title="0">
                                    View inline
                                   </a>
                                  </li>
                                  <li class="view-popup">
                                   <a href="/highwire/markup/545811/expansion?width=1000&height=500&iframe=true&postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed" class="colorbox colorbox-load table-expand-popup" rel="gallery-fragment-tables" data-icon-position="" data-hide-link-title="0">
                                    View popup
                                   </a>
                                  </li>
                                  <li class="download-ppt last">
                                   <a href="/highwire/powerpoint/545811" class="highwire-figure-link highwire-figure-link-ppt" data-icon-position="" data-hide-link-title="0">
                                    Download powerpoint
                                   </a>
                                  </li>
                                 </ul>
                                </div>
                               </div>
                               <div class="table-caption">
                                <span class="table-label">
                                 S5. Table S3.
                                </span>
                                <span class="caption-title">
                                 Baseline Demographics and Characteristics by Age and risk of severe COVID-19.
                                </span>
                                <div class="sb-div caption-clear">
                                </div>
                               </div>
                              </div>
                              <div id="T7" class="table pos-float">
                               <div class="table-inline table-callout-links">
                                <div class="callout">
                                 <span>
                                  View this table:
                                 </span>
                                 <ul class="callout-links">
                                  <li class="view-inline first">
                                   <a href="##" class="table-expand-inline" data-table-url="/highwire/markup/545797/expansion?postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed&table-expand-inline=1" data-icon-position="" data-hide-link-title="0">
                                    View inline
                                   </a>
                                  </li>
                                  <li class="view-popup">
                                   <a href="/highwire/markup/545797/expansion?width=1000&height=500&iframe=true&postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed" class="colorbox colorbox-load table-expand-popup" rel="gallery-fragment-tables" data-icon-position="" data-hide-link-title="0">
                                    View popup
                                   </a>
                                  </li>
                                  <li class="download-ppt last">
                                   <a href="/highwire/powerpoint/545797" class="highwire-figure-link highwire-figure-link-ppt" data-icon-position="" data-hide-link-title="0">
                                    Download powerpoint
                                   </a>
                                  </li>
                                 </ul>
                                </div>
                               </div>
                               <div class="table-caption">
                                <span class="table-label">
                                 S6. Table S4.
                                </span>
                                <span class="caption-title">
                                 Solicited vaccine-associated Adverse Events (VAAEs) Within 7 Days After First Injection by Grade
                                </span>
                                <div class="sb-div caption-clear">
                                </div>
                               </div>
                              </div>
                              <div id="T8" class="table pos-float">
                               <div class="table-inline table-callout-links">
                                <div class="callout">
                                 <span>
                                  View this table:
                                 </span>
                                 <ul class="callout-links">
                                  <li class="view-inline first">
                                   <a href="##" class="table-expand-inline" data-table-url="/highwire/markup/545810/expansion?postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed&table-expand-inline=1" data-icon-position="" data-hide-link-title="0">
                                    View inline
                                   </a>
                                  </li>
                                  <li class="view-popup">
                                   <a href="/highwire/markup/545810/expansion?width=1000&height=500&iframe=true&postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed" class="colorbox colorbox-load table-expand-popup" rel="gallery-fragment-tables" data-icon-position="" data-hide-link-title="0">
                                    View popup
                                   </a>
                                  </li>
                                  <li class="download-ppt last">
                                   <a href="/highwire/powerpoint/545810" class="highwire-figure-link highwire-figure-link-ppt" data-icon-position="" data-hide-link-title="0">
                                    Download powerpoint
                                   </a>
                                  </li>
                                 </ul>
                                </div>
                               </div>
                               <div class="table-caption">
                                <span class="table-label">
                                 S7. Table S5.
                                </span>
                                <span class="caption-title">
                                 Solicited vaccine-associated Adverse Events (VAAEs) Within 7 Days After Second Injection by Grade
                                </span>
                                <div class="sb-div caption-clear">
                                </div>
                               </div>
                              </div>
                              <div id="T9" class="table pos-float">
                               <div class="table-inline table-callout-links">
                                <div class="callout">
                                 <span>
                                  View this table:
                                 </span>
                                 <ul class="callout-links">
                                  <li class="view-inline first">
                                   <a href="##" class="table-expand-inline" data-table-url="/highwire/markup/545808/expansion?postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed&table-expand-inline=1" data-icon-position="" data-hide-link-title="0">
                                    View inline
                                   </a>
                                  </li>
                                  <li class="view-popup">
                                   <a href="/highwire/markup/545808/expansion?width=1000&height=500&iframe=true&postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed" class="colorbox colorbox-load table-expand-popup" rel="gallery-fragment-tables" data-icon-position="" data-hide-link-title="0">
                                    View popup
                                   </a>
                                  </li>
                                  <li class="download-ppt last">
                                   <a href="/highwire/powerpoint/545808" class="highwire-figure-link highwire-figure-link-ppt" data-icon-position="" data-hide-link-title="0">
                                    Download powerpoint
                                   </a>
                                  </li>
                                 </ul>
                                </div>
                               </div>
                               <div class="table-caption">
                                <span class="table-label">
                                 S8. Table S6.
                                </span>
                                <span class="caption-title">
                                 Solicited vaccine-associated Adverse Events (VAAEs) Within 7 Days After Third Injection by Grade
                                </span>
                                <div class="sb-div caption-clear">
                                </div>
                               </div>
                              </div>
                              <div id="T10" class="table pos-float">
                               <div class="table-inline table-callout-links">
                                <div class="callout">
                                 <span>
                                  View this table:
                                 </span>
                                 <ul class="callout-links">
                                  <li class="view-inline first">
                                   <a href="##" class="table-expand-inline" data-table-url="/highwire/markup/545798/expansion?postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed&table-expand-inline=1" data-icon-position="" data-hide-link-title="0">
                                    View inline
                                   </a>
                                  </li>
                                  <li class="view-popup">
                                   <a href="/highwire/markup/545798/expansion?width=1000&height=500&iframe=true&postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed" class="colorbox colorbox-load table-expand-popup" rel="gallery-fragment-tables" data-icon-position="" data-hide-link-title="0">
                                    View popup
                                   </a>
                                  </li>
                                  <li class="download-ppt last">
                                   <a href="/highwire/powerpoint/545798" class="highwire-figure-link highwire-figure-link-ppt" data-icon-position="" data-hide-link-title="0">
                                    Download powerpoint
                                   </a>
                                  </li>
                                 </ul>
                                </div>
                               </div>
                               <div class="table-caption">
                                <span class="table-label">
                                 S9. Table S7.
                                </span>
                                <span class="caption-title">
                                 Unsolicited AEs Within 28 Days After Any Injection, Overall Safety Set
                                </span>
                                <div class="sb-div caption-clear">
                                </div>
                               </div>
                              </div>
                              <div id="T11" class="table pos-float">
                               <div class="table-inline table-callout-links">
                                <div class="callout">
                                 <span>
                                  View this table:
                                 </span>
                                 <ul class="callout-links">
                                  <li class="view-inline first">
                                   <a href="##" class="table-expand-inline" data-table-url="/highwire/markup/545793/expansion?postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed&table-expand-inline=1" data-icon-position="" data-hide-link-title="0">
                                    View inline
                                   </a>
                                  </li>
                                  <li class="view-popup">
                                   <a href="/highwire/markup/545793/expansion?width=1000&height=500&iframe=true&postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed" class="colorbox colorbox-load table-expand-popup" rel="gallery-fragment-tables" data-icon-position="" data-hide-link-title="0">
                                    View popup
                                   </a>
                                  </li>
                                  <li class="download-ppt last">
                                   <a href="/highwire/powerpoint/545793" class="highwire-figure-link highwire-figure-link-ppt" data-icon-position="" data-hide-link-title="0">
                                    Download powerpoint
                                   </a>
                                  </li>
                                 </ul>
                                </div>
                               </div>
                               <div class="table-caption">
                                <span class="table-label">
                                 S10. Table S8.
                                </span>
                                <span class="caption-title">
                                 Summary of Unsolicited Adverse Events (AEs) ≥0.1%, within 28 Days After Any Injection Overall Safety Set
                                </span>
                                <div class="sb-div caption-clear">
                                </div>
                               </div>
                              </div>
                              <div id="T12" class="table pos-float">
                               <div class="table-inline table-callout-links">
                                <div class="callout">
                                 <span>
                                  View this table:
                                 </span>
                                 <ul class="callout-links">
                                  <li class="view-inline first">
                                   <a href="##" class="table-expand-inline" data-table-url="/highwire/markup/545800/expansion?postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed&table-expand-inline=1" data-icon-position="" data-hide-link-title="0">
                                    View inline
                                   </a>
                                  </li>
                                  <li class="view-popup">
                                   <a href="/highwire/markup/545800/expansion?width=1000&height=500&iframe=true&postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed" class="colorbox colorbox-load table-expand-popup" rel="gallery-fragment-tables" data-icon-position="" data-hide-link-title="0">
                                    View popup
                                   </a>
                                  </li>
                                  <li class="download-ppt last">
                                   <a href="/highwire/powerpoint/545800" class="highwire-figure-link highwire-figure-link-ppt" data-icon-position="" data-hide-link-title="0">
                                    Download powerpoint
                                   </a>
                                  </li>
                                 </ul>
                                </div>
                               </div>
                               <div class="table-caption">
                                <span class="table-label">
                                 S11. Table S9.
                                </span>
                                <span class="caption-title">
                                 Summary of Unsolicited Serious Adverse Events (AEs), 28 Days After Any Injection Overall Safety Set
                                </span>
                                <div class="sb-div caption-clear">
                                </div>
                               </div>
                              </div>
                              <div id="T13" class="table pos-float">
                               <div class="table-inline table-callout-links">
                                <div class="callout">
                                 <span>
                                  View this table:
                                 </span>
                                 <ul class="callout-links">
                                  <li class="view-inline first">
                                   <a href="##" class="table-expand-inline" data-table-url="/highwire/markup/545801/expansion?postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed&table-expand-inline=1" data-icon-position="" data-hide-link-title="0">
                                    View inline
                                   </a>
                                  </li>
                                  <li class="view-popup">
                                   <a href="/highwire/markup/545801/expansion?width=1000&height=500&iframe=true&postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed" class="colorbox colorbox-load table-expand-popup" rel="gallery-fragment-tables" data-icon-position="" data-hide-link-title="0">
                                    View popup
                                   </a>
                                  </li>
                                  <li class="download-ppt last">
                                   <a href="/highwire/powerpoint/545801" class="highwire-figure-link highwire-figure-link-ppt" data-icon-position="" data-hide-link-title="0">
                                    Download powerpoint
                                   </a>
                                  </li>
                                 </ul>
                                </div>
                               </div>
                               <div class="table-caption">
                                <span class="table-label">
                                 S12. Table S10.
                                </span>
                                <span class="caption-title">
                                 Vaccine Efficacy for Prevention of severe COVID-19 disease in Per-Protocol Population (PPP).
                                </span>
                                <div class="sb-div caption-clear">
                                </div>
                               </div>
                              </div>
                              <div id="F5" class="fig pos-float type-figure odd">
                               <div class="highwire-figure">
                                <div class="fig-inline-img-wrapper">
                                 <div class="fig-inline-img">
                                  <a href="https://www.medrxiv.org/content/medrxiv/early/2022/08/03/2021.10.31.21265703/F5.large.jpg?width=800&height=600&carousel=1" title="Cumulative incidence of Covid-19 for two doses of Soberana-02 and Placebo. Per-Protocol Analysis. " class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-1339357172" data-figure-caption='<div class="highwire-markup"><span xmlns="http://www.w3.org/1999/xhtml" class="caption-title">Cumulative incidence of Covid-19 for two doses of Soberana-02 and Placebo. Per-Protocol Analysis.</span> </div>' data-icon-position="" data-hide-link-title="0">
                                   <span class="hw-responsive-img">
                                    <img class="highwire-fragment fragment-image lazyload" alt="S13. Figure S2." src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.medrxiv.org/content/medrxiv/early/2022/08/03/2021.10.31.21265703/F5.medium.gif" width="440" height="168"/>
                                    <noscript>
                                     <img class="highwire-fragment fragment-image" alt="S13. Figure S2." src="https://www.medrxiv.org/content/medrxiv/early/2022/08/03/2021.10.31.21265703/F5.medium.gif" width="440" height="168"/>
                                    </noscript>
                                   </span>
                                  </a>
                                 </div>
                                </div>
                                <ul class="highwire-figure-links inline">
                                 <li class="download-fig first">
                                  <a href="https://www.medrxiv.org/content/medrxiv/early/2022/08/03/2021.10.31.21265703/F5.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download S13. Figure S2." data-icon-position="" data-hide-link-title="0">
                                   Download figure
                                  </a>
                                 </li>
                                 <li class="new-tab last">
                                  <a href="https://www.medrxiv.org/content/medrxiv/early/2022/08/03/2021.10.31.21265703/F5.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">
                                   Open in new tab
                                  </a>
                                 </li>
                                </ul>
                               </div>
                               <div class="fig-caption">
                                <span class="fig-label">
                                 S13. Figure S2.
                                </span>
                                <span class="caption-title">
                                 Cumulative incidence of Covid-19 for two doses of Soberana-02 and Placebo. Per-Protocol Analysis.
                                </span>
                                <div class="sb-div caption-clear">
                                </div>
                               </div>
                              </div>
                              <div id="F6" class="fig pos-float type-figure odd">
                               <div class="highwire-figure">
                                <div class="fig-inline-img-wrapper">
                                 <div class="fig-inline-img">
                                  <a href="https://www.medrxiv.org/content/medrxiv/early/2022/08/03/2021.10.31.21265703/F6.large.jpg?width=800&height=600&carousel=1" title="Vaccine Efficacy of two dose of Soberana-02 to Prevent Covid-19 disease in Subgroups, 14 days after 2nd dose. The efficacy in preventing COVID-19 in various subgroups in the per-protocol population was based on adjudicated assessments starting 14 days after the second injection. Vaccine efficacy, defined as 1 minus the hazard ratio (So2 vs. placebo), and 95% confidence intervals were estimated with the use of a stratified Cox proportional hazards model." class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-1339357172" data-figure-caption='<div class="highwire-markup"><div xmlns="http://www.w3.org/1999/xhtml"><span class="caption-title">Vaccine Efficacy of two dose of Soberana-02 to Prevent Covid-19 disease in Subgroups, 14 days after 2<sup>nd</sup> dose.</span> The efficacy in preventing COVID-19 in various subgroups in the per-protocol population was based on adjudicated assessments starting 14 days after the second injection. Vaccine efficacy, defined as 1 minus the hazard ratio (So2 vs. placebo), and 95% confidence intervals were estimated with the use of a stratified Cox proportional hazards model.</div></div>' data-icon-position="" data-hide-link-title="0">
                                   <span class="hw-responsive-img">
                                    <img class="highwire-fragment fragment-image lazyload" alt="S14. Figure S3." src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.medrxiv.org/content/medrxiv/early/2022/08/03/2021.10.31.21265703/F6.medium.gif" width="440" height="172"/>
                                    <noscript>
                                     <img class="highwire-fragment fragment-image" alt="S14. Figure S3." src="https://www.medrxiv.org/content/medrxiv/early/2022/08/03/2021.10.31.21265703/F6.medium.gif" width="440" height="172"/>
                                    </noscript>
                                   </span>
                                  </a>
                                 </div>
                                </div>
                                <ul class="highwire-figure-links inline">
                                 <li class="download-fig first">
                                  <a href="https://www.medrxiv.org/content/medrxiv/early/2022/08/03/2021.10.31.21265703/F6.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download S14. Figure S3." data-icon-position="" data-hide-link-title="0">
                                   Download figure
                                  </a>
                                 </li>
                                 <li class="new-tab last">
                                  <a href="https://www.medrxiv.org/content/medrxiv/early/2022/08/03/2021.10.31.21265703/F6.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">
                                   Open in new tab
                                  </a>
                                 </li>
                                </ul>
                               </div>
                               <div class="fig-caption">
                                <span class="fig-label">
                                 S14. Figure S3.
                                </span>
                                <span class="caption-title">
                                 Vaccine Efficacy of two dose of Soberana-02 to Prevent Covid-19 disease in Subgroups, 14 days after 2
                                 <sup>
                                  nd
                                 </sup>
                                 dose.
                                </span>
                                <p id="p-76" class="first-child">
                                 The efficacy in preventing COVID-19 in various subgroups in the per-protocol population was based on adjudicated assessments starting 14 days after the second injection. Vaccine efficacy, defined as 1 minus the hazard ratio (So2 vs. placebo), and 95% confidence intervals were estimated with the use of a stratified Cox proportional hazards model.
                                </p>
                                <div class="sb-div caption-clear">
                                </div>
                               </div>
                              </div>
                              <div id="F7" class="fig pos-float type-figure odd">
                               <div class="highwire-figure">
                                <div class="fig-inline-img-wrapper">
                                 <div class="fig-inline-img">
                                  <a href="https://www.medrxiv.org/content/medrxiv/early/2022/08/03/2021.10.31.21265703/F7.large.jpg?width=800&height=600&carousel=1" title="Cumulative incidence of Covid-19 for Soberana-02+Plus and Placebo. Per-Protocol Analysis. " class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-1339357172" data-figure-caption='<div class="highwire-markup"><span xmlns="http://www.w3.org/1999/xhtml" class="caption-title">Cumulative incidence of Covid-19 for Soberana-02+Plus and Placebo. Per-Protocol Analysis.</span> </div>' data-icon-position="" data-hide-link-title="0">
                                   <span class="hw-responsive-img">
                                    <img class="highwire-fragment fragment-image lazyload" alt="S15. Figure S4." src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.medrxiv.org/content/medrxiv/early/2022/08/03/2021.10.31.21265703/F7.medium.gif" width="440" height="164"/>
                                    <noscript>
                                     <img class="highwire-fragment fragment-image" alt="S15. Figure S4." src="https://www.medrxiv.org/content/medrxiv/early/2022/08/03/2021.10.31.21265703/F7.medium.gif" width="440" height="164"/>
                                    </noscript>
                                   </span>
                                  </a>
                                 </div>
                                </div>
                                <ul class="highwire-figure-links inline">
                                 <li class="download-fig first">
                                  <a href="https://www.medrxiv.org/content/medrxiv/early/2022/08/03/2021.10.31.21265703/F7.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download S15. Figure S4." data-icon-position="" data-hide-link-title="0">
                                   Download figure
                                  </a>
                                 </li>
                                 <li class="new-tab last">
                                  <a href="https://www.medrxiv.org/content/medrxiv/early/2022/08/03/2021.10.31.21265703/F7.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">
                                   Open in new tab
                                  </a>
                                 </li>
                                </ul>
                               </div>
                               <div class="fig-caption">
                                <span class="fig-label">
                                 S15. Figure S4.
                                </span>
                                <span class="caption-title">
                                 Cumulative incidence of Covid-19 for Soberana-02+Plus and Placebo. Per-Protocol Analysis.
                                </span>
                                <div class="sb-div caption-clear">
                                </div>
                               </div>
                              </div>
                              <div id="F8" class="fig pos-float type-figure odd">
                               <div class="highwire-figure">
                                <div class="fig-inline-img-wrapper">
                                 <div class="fig-inline-img">
                                  <a href="https://www.medrxiv.org/content/medrxiv/early/2022/08/03/2021.10.31.21265703/F8.large.jpg?width=800&height=600&carousel=1" title="Vaccine Efficacy of heterologous schedule to Prevent Covid-19 disease in Subgroups 14 days after 3rd dose. The efficacy in preventing COVID-19 in various subgroups in the per-protocol population was based on adjudicated assessments starting 14 days after the third injection (42 days after second injection for Placebo group). Vaccine efficacy, defined as 1 minus the hazard ratio (So2p vs. placebo), and 95% confidence intervals were estimated with the use of a stratified Cox proportional hazards model." class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-1339357172" data-figure-caption='<div class="highwire-markup"><div xmlns="http://www.w3.org/1999/xhtml"><span class="caption-title">Vaccine Efficacy of heterologous schedule to Prevent Covid-19 disease in Subgroups 14 days after 3<sup>rd</sup> dose.</span> The efficacy in preventing COVID-19 in various subgroups in the per-protocol population was based on adjudicated assessments starting 14 days after the third injection (42 days after second injection for Placebo group). Vaccine efficacy, defined as 1 minus the hazard ratio (So2p vs. placebo), and 95% confidence intervals were estimated with the use of a stratified Cox proportional hazards model.</div></div>' data-icon-position="" data-hide-link-title="0">
                                   <span class="hw-responsive-img">
                                    <img class="highwire-fragment fragment-image lazyload" alt="S16. Figure S5." src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.medrxiv.org/content/medrxiv/early/2022/08/03/2021.10.31.21265703/F8.medium.gif" width="440" height="172"/>
                                    <noscript>
                                     <img class="highwire-fragment fragment-image" alt="S16. Figure S5." src="https://www.medrxiv.org/content/medrxiv/early/2022/08/03/2021.10.31.21265703/F8.medium.gif" width="440" height="172"/>
                                    </noscript>
                                   </span>
                                  </a>
                                 </div>
                                </div>
                                <ul class="highwire-figure-links inline">
                                 <li class="download-fig first">
                                  <a href="https://www.medrxiv.org/content/medrxiv/early/2022/08/03/2021.10.31.21265703/F8.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download S16. Figure S5." data-icon-position="" data-hide-link-title="0">
                                   Download figure
                                  </a>
                                 </li>
                                 <li class="new-tab last">
                                  <a href="https://www.medrxiv.org/content/medrxiv/early/2022/08/03/2021.10.31.21265703/F8.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">
                                   Open in new tab
                                  </a>
                                 </li>
                                </ul>
                               </div>
                               <div class="fig-caption">
                                <span class="fig-label">
                                 S16. Figure S5.
                                </span>
                                <span class="caption-title">
                                 Vaccine Efficacy of heterologous schedule to Prevent Covid-19 disease in Subgroups 14 days after 3
                                 <sup>
                                  rd
                                 </sup>
                                 dose.
                                </span>
                                <p id="p-77" class="first-child">
                                 The efficacy in preventing COVID-19 in various subgroups in the per-protocol population was based on adjudicated assessments starting 14 days after the third injection (42 days after second injection for Placebo group). Vaccine efficacy, defined as 1 minus the hazard ratio (So2p vs. placebo), and 95% confidence intervals were estimated with the use of a stratified Cox proportional hazards model.
                                </p>
                                <div class="sb-div caption-clear">
                                </div>
                               </div>
                              </div>
                             </div>
                            </div>
                           </div>
                           <div class="section ack" id="ack-1">
                            <h2 class="">
                             Acknowledgments
                            </h2>
                            <p id="p-69">
                             We especially thank all the volunteers who participated in the trial and the members of the SOBERANA-Phase 3 clinical trial team (listed in the Supplementary Information) for their dedication and contributions to the trial.
                            </p>
                            <p id="p-70">
                             We further thank the IDSMB members: N. A. Jimenez Perez (Chair and Clinical Expert) and C. M. Fonseca Gómez (Clinical Expert) from the Pedro Kourí Tropical Medicine Institute, G. María Suárez Formigo (Immunological Expert) and P. Lorenzo-Luaces Alvarez (Statistical Expert) from the Center for Molecular Immunology, M. Martínez Cabrera (Clinical Expert) from the Ministry of Public Health.
                            </p>
                            <p id="p-71">
                             We also thank Rolando Pérez, Ileana Morales and Eduardo Martínez (BioCubaFarma), and Lila Castellanos for their advice and support.
                            </p>
                           </div>
                           <div class="section fn-group" id="fn-group-1">
                            <h2>
                             Footnotes
                            </h2>
                            <ul>
                             <li class="fn-others" id="fn-2">
                              <p id="p-2">
                               <a class="rev-xref" href="#xref-fn-2-1">
                                ↵
                               </a>
                               <span class="fn-label">
                                **
                               </span>
                               The members of the SOBERANA Phase 3 team are listed in the Supplementary information (S1 and S2)
                              </p>
                             </li>
                             <li class="fn-update fn-group-summary-of-updates" id="fn-3">
                              <p id="p-22">
                               This new version includes the final analysis for the main outcomes, following the recommendations of reviewers during the peer-review process for the publication. The final value of vaccine efficacy for preventing symptomatic COVID-19 disease after two doses of SOBERANA 02 changed from 71% (first version) to 69.7% (second version); and from 92.4 (first version) to 92.0% (second version) after the third dose with SOBERANA Plus. These are minimal changes consequences of some precisions in the follow-up period.
Also, the vaccine efficacy versus severe diseases in the first version included only a preliminary analysis of the patients attended in the Unit of Intensive Care, and this new version included the classification of severe disease following the symptoms declared in the protocol, as final analysis.
This new version will be now re-submitted to a peer-review process for publication. The authors have decided to update the version available in MedRxiv.
                              </p>
                             </li>
                            </ul>
                           </div>
                           <div class="section ref-list" id="ref-list-1">
                            <h2 class="">
                             References
                            </h2>
                            <ol class="cit-list">
                             <li>
                              <a class="rev-xref-ref" href="#xref-ref-1-1" title="View reference 1 in text" id="ref-1">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-journal" id="cit-2021.10.31.21265703v3.1" data-doi="10.1056/NEJMsr2105280">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Krause
                                  </span>
                                  <span class="cit-name-given-names">
                                   PR
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Fleming
                                  </span>
                                  <span class="cit-name-given-names">
                                   TR
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Longini
                                  </span>
                                  <span class="cit-name-given-names">
                                   IM
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-etal">
                                  et al.
                                 </span>
                                 <span class="cit-article-title">
                                  SARS-CoV-2 Variants and Vaccines
                                 </span>
                                 .
                                 <abbr class="cit-jnl-abbrev">
                                  N Engl J Med
                                 </abbr>
                                 <span class="cit-pub-date">
                                  2021
                                 </span>
                                 ;
                                 <span class="cit-vol">
                                  385
                                 </span>
                                 :
                                 <span class="cit-fpage">
                                  179
                                 </span>
                                 –
                                 <span class="cit-lpage">
                                  186
                                 </span>
                                 <span class="cit-pub-id-sep cit-pub-id-doi-sep">
                                 </span>
                                 <span class="cit-pub-id-scheme">
                                  DOI:
                                 </span>
                                 <span class="cit-pub-id cit-pub-id-doi">
                                  10.1056/NEJMsr2105280
                                 </span>
                                </cite>
                               </div>
                               <div class="cit-extra">
                                <a href="{openurl}?query=rft.jtitle%253DN%2BEngl%2BJ%2BMed%26rft_id%253Dinfo%253Adoi%252F10.1056%252FNEJMsr2105280%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
                                 <span>
                                  OpenUrl
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=10.1056/NEJMsr2105280&link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
                                 <span>
                                  CrossRef
                                 </span>
                                </a>
                               </div>
                              </div>
                             </li>
                             <li>
                              <a class="rev-xref-ref" href="#xref-ref-2-1" title="View reference 2 in text" id="ref-2">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-journal" id="cit-2021.10.31.21265703v3.2">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Rotshild
                                  </span>
                                  <span class="cit-name-given-names">
                                   V
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Hirsh-Raccah
                                  </span>
                                  <span class="cit-name-given-names">
                                   B
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Miskin
                                  </span>
                                  <span class="cit-name-given-names">
                                   I
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-etal">
                                  et al.
                                 </span>
                                 <span class="cit-article-title">
                                  Comparing the clinical efficacy of COVID-19 vaccines: a systematic review and network meta-analysis
                                 </span>
                                 .
                                 <abbr class="cit-jnl-abbrev">
                                  Scientific Reports
                                 </abbr>
                                 <span class="cit-pub-date">
                                  2021
                                 </span>
                                 ;
                                 <span class="cit-vol">
                                  11
                                 </span>
                                 :
                                 <span class="cit-fpage">
                                  22777
                                 </span>
                                 <a href="https://doi.org/10.1038/s41598-021-02321-z">
                                  https://doi.org/10.1038/s41598-021-02321-z
                                 </a>
                                </cite>
                               </div>
                               <div class="cit-extra">
                                <a href="{openurl}?query=rft.jtitle%253DScientific%2BReports%26rft.volume%253D11%26rft.spage%253D22777%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
                                 <span>
                                  OpenUrl
                                 </span>
                                </a>
                               </div>
                              </div>
                             </li>
                             <li>
                              <a class="rev-xref-ref" href="#xref-ref-3-1" title="View reference 3 in text" id="ref-3">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-web" id="cit-2021.10.31.21265703v3.3">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth cit-collab">
                                  WHO
                                 </span>
                                 .
                                 <span class="cit-source">
                                  Vaccine Equity
                                 </span>
                                 .
                                 <a href="https://www.who.int/campaigns/vaccine-equity">
                                  https://www.who.int/campaigns/vaccine-equity
                                 </a>
                                 (Accessed
                                 <span class="cit-date-in-citation">
                                  22 February 2021
                                 </span>
                                 )
                                </cite>
                               </div>
                               <div class="cit-extra">
                               </div>
                              </div>
                             </li>
                             <li>
                              <a class="rev-xref-ref" href="#xref-ref-4-1" title="View reference 4 in text" id="ref-4">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-journal" id="cit-2021.10.31.21265703v3.4" data-doi="10.1021/acschembio.1c00272">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Valdes-Balbin
                                  </span>
                                  <span class="cit-name-given-names">
                                   Y
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Santana-Medero
                                  </span>
                                  <span class="cit-name-given-names">
                                   D
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Quintero
                                  </span>
                                  <span class="cit-name-given-names">
                                   L
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-etal">
                                  et al.
                                 </span>
                                 <span class="cit-article-title">
                                  SARS-CoV-2 RBD-Tetanus Toxoid Conjugate Vaccine Induces a Strong Neutralizing Immunity in Preclinical Studies
                                 </span>
                                 .
                                 <abbr class="cit-jnl-abbrev">
                                  ACS Chem. Biol
                                 </abbr>
                                 <span class="cit-pub-date">
                                  2021
                                 </span>
                                 ;
                                 <span class="cit-vol">
                                  16
                                 </span>
                                 :
                                 <span class="cit-fpage">
                                  1223
                                 </span>
                                 –
                                 <span class="cit-lpage">
                                  1233
                                 </span>
                                 <a href="https://doi.org/10.1101/2021.02.08.430146">
                                  https://doi.org/10.1101/2021.02.08.430146
                                 </a>
                                 .
                                </cite>
                               </div>
                               <div class="cit-extra">
                                <a href="{openurl}?query=rft.jtitle%253DACS%2BChem.%2BBiol%26rft.volume%253D16%26rft.spage%253D1223%26rft_id%253Dinfo%253Adoi%252F10.1021%252Facschembio.1c00272%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
                                 <span>
                                  OpenUrl
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=10.1021/acschembio.1c00272&link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
                                 <span>
                                  CrossRef
                                 </span>
                                </a>
                               </div>
                              </div>
                             </li>
                             <li>
                              <a class="rev-xref-ref" href="#xref-ref-5-1" title="View reference 5 in text" id="ref-5">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-journal" id="cit-2021.10.31.21265703v3.5">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Schneerson
                                  </span>
                                  <span class="cit-name-given-names">
                                   R
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Robbins
                                  </span>
                                  <span class="cit-name-given-names">
                                   JB
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Barrera
                                  </span>
                                  <span class="cit-name-given-names">
                                   O
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-etal">
                                  et al.
                                 </span>
                                 <span class="cit-article-title">
                                  Haemophilus influenzae type B polysaccharide-protein conjugates: Model for a new generation of capsular polysaccharide vaccines
                                 </span>
                                 .
                                 <abbr class="cit-jnl-abbrev">
                                  Prog Clin Biol Res
                                 </abbr>
                                 <span class="cit-pub-date">
                                  1980
                                 </span>
                                 ;
                                 <span class="cit-vol">
                                  47
                                 </span>
                                 :
                                 <span class="cit-fpage">
                                  77
                                 </span>
                                 –
                                 <span class="cit-lpage">
                                  94
                                 </span>
                                </cite>
                               </div>
                               <div class="cit-extra">
                                <a href="{openurl}?query=rft.jtitle%253DProgress%2Bin%2Bclinical%2Band%2Bbiological%2Bresearch%26rft.stitle%253DProg%2BClin%2BBiol%2BRes%26rft.aulast%253DSchneerson%26rft.auinit1%253DR.%26rft.volume%253D47%26rft.spage%253D77%26rft.epage%253D94%26rft.atitle%253DHaemophilus%2Binfluenzae%2Btype%2BB%2Bpolysaccharide-protein%2Bconjugates%253A%2Bmodel%2Bfor%2Ba%2Bnew%2Bgeneration%2Bof%2Bcapsular%2Bpolysaccharide%2Bvaccines.%26rft_id%253Dinfo%253Apmid%252F6970933%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
                                 <span>
                                  OpenUrl
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=6970933&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F08%2F03%2F2021.10.31.21265703.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline">
                                 <span>
                                  PubMed
                                 </span>
                                </a>
                               </div>
                              </div>
                             </li>
                             <li>
                              <a class="rev-xref-ref" href="#xref-ref-6-1" title="View reference 6 in text" id="ref-6">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-journal" id="cit-2021.10.31.21265703v3.6">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Goldblatt
                                  </span>
                                  <span class="cit-name-given-names">
                                   D.
                                  </span>
                                 </span>
                                 <span class="cit-article-title">
                                  The indirect effect of pneumococcal conjugate vaccine
                                 </span>
                                 .
                                 <abbr class="cit-jnl-abbrev">
                                  Lancet Glob Health
                                 </abbr>
                                 <span class="cit-pub-date">
                                  2017
                                 </span>
                                 ;
                                 <span class="cit-vol">
                                  5
                                 </span>
                                 :
                                 <span class="cit-fpage">
                                  e6
                                 </span>
                                 –
                                 <span class="cit-lpage">
                                  7
                                 </span>
                                 <a href="https://doi.org/10.1016/S2214-109X(16)30338-2">
                                  https://doi.org/10.1016/S2214-109X(16)30338-2
                                 </a>
                                </cite>
                               </div>
                               <div class="cit-extra">
                                <a href="{openurl}?query=rft.jtitle%253DLancet%2BGlob%2BHealth%26rft.volume%253D5%26rft.spage%253D6e%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
                                 <span>
                                  OpenUrl
                                 </span>
                                </a>
                               </div>
                              </div>
                             </li>
                             <li>
                              <a class="rev-xref-ref" href="#xref-ref-7-1" title="View reference 7 in text" id="ref-7">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-journal" id="cit-2021.10.31.21265703v3.7" data-doi="10.4161/hv.7.2.13717">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Gasparini
                                  </span>
                                  <span class="cit-name-given-names">
                                   R
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Panatto
                                  </span>
                                  <span class="cit-name-given-names">
                                   D.
                                  </span>
                                 </span>
                                 <span class="cit-article-title">
                                  Meningococcal glycoconjugate vaccines
                                 </span>
                                 .
                                 <abbr class="cit-jnl-abbrev">
                                  Hum Vaccin
                                 </abbr>
                                 <span class="cit-pub-date">
                                  2011
                                 </span>
                                 ;
                                 <span class="cit-vol">
                                  7
                                 </span>
                                 :
                                 <span class="cit-fpage">
                                  170
                                 </span>
                                 –
                                 <span class="cit-lpage">
                                  82
                                 </span>
                                 <span class="cit-pub-id-sep cit-pub-id-doi-sep">
                                 </span>
                                 <span class="cit-pub-id-scheme">
                                  doi:
                                 </span>
                                 <span class="cit-pub-id cit-pub-id-doi">
                                  10.4161/hv.7.2.13717
                                 </span>
                                </cite>
                               </div>
                               <div class="cit-extra">
                                <a href="{openurl}?query=rft.stitle%253DHum%2BVaccin%26rft.aulast%253DGasparini%26rft.auinit1%253DR.%26rft.volume%253D7%26rft.issue%253D2%26rft.spage%253D170%26rft.epage%253D182%26rft.atitle%253DMeningococcal%2Bglycoconjugate%2Bvaccines.%26rft_id%253Dinfo%253Adoi%252F10.4161%252Fhv.7.2.13717%26rft_id%253Dinfo%253Apmid%252F21178398%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
                                 <span>
                                  OpenUrl
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=10.4161/hv.7.2.13717&link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
                                 <span>
                                  CrossRef
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=21178398&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F08%2F03%2F2021.10.31.21265703.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline">
                                 <span>
                                  PubMed
                                 </span>
                                </a>
                               </div>
                              </div>
                             </li>
                             <li>
                              <a class="rev-xref-ref" href="#xref-ref-8-1" title="View reference 8 in text" id="ref-8">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-journal" id="cit-2021.10.31.21265703v3.8">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Toledo-Romani
                                  </span>
                                  <span class="cit-name-given-names">
                                   ME
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Verdecia-Sánchez
                                  </span>
                                  <span class="cit-name-given-names">
                                   L
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Rodríguez-González
                                  </span>
                                  <span class="cit-name-given-names">
                                   M
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-etal">
                                  et al.
                                 </span>
                                 <span class="cit-article-title">
                                  Safety and immunogenicity of anti-SARS CoV-2 vaccine SOBERANA 02 in homologous or heterologous scheme: Open label phase I and phase IIa clinical trials
                                 </span>
                                 ,
                                 <abbr class="cit-jnl-abbrev">
                                  Vaccine
                                 </abbr>
                                 <span class="cit-pub-date">
                                  2022
                                 </span>
                                 ;
                                 <span class="cit-vol">
                                  40
                                 </span>
                                 :
                                 <span class="cit-fpage">
                                  4220
                                 </span>
                                 –
                                 <span class="cit-lpage">
                                  4230
                                 </span>
                                 <a href="https://doi.org/10.1016/j.vaccine.2022.05.082">
                                  https://doi.org/10.1016/j.vaccine.2022.05.082
                                 </a>
                                </cite>
                               </div>
                               <div class="cit-extra">
                                <a href="{openurl}?query=rft.jtitle%253DVaccine%26rft.volume%253D40%26rft.spage%253D4220%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
                                 <span>
                                  OpenUrl
                                 </span>
                                </a>
                               </div>
                              </div>
                             </li>
                             <li>
                              <a class="rev-xref-ref" href="#xref-ref-9-1" title="View reference 9 in text" id="ref-9">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-journal" id="cit-2021.10.31.21265703v3.9">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Chang-Monteagudo
                                  </span>
                                  <span class="cit-name-given-names">
                                   A
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Ochoa-Azze
                                  </span>
                                  <span class="cit-name-given-names">
                                   R
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Climent-Ruiz
                                  </span>
                                  <span class="cit-name-given-names">
                                   Y
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-etal">
                                  et al.
                                 </span>
                                 <span class="cit-article-title">
                                  A single dose of SARS-CoV-2 FINLAY-FR-1A vaccine enhances neutralization response in COVID-19 convalescents, with a very good safety profile: An open-label phase 1 clinical trial
                                 </span>
                                 ,
                                 <abbr class="cit-jnl-abbrev">
                                  Lancet Reg Health Am
                                 </abbr>
                                 <span class="cit-pub-date">
                                  2021
                                 </span>
                                 ;
                                 <span class="cit-vol">
                                  4
                                 </span>
                                 :
                                 <span class="cit-fpage">
                                  100079
                                 </span>
                                 <a href="https://doi.org/10.1016/j.lana.2021.100079">
                                  https://doi.org/10.1016/j.lana.2021.100079
                                 </a>
                                </cite>
                               </div>
                               <div class="cit-extra">
                                <a href="{openurl}?query=rft.jtitle%253DLancet%2BReg%2BHealth%2BAm%26rft.volume%253D4%26rft.spage%253D100079%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
                                 <span>
                                  OpenUrl
                                 </span>
                                </a>
                               </div>
                              </div>
                             </li>
                             <li>
                              <a class="rev-xref-ref" href="#xref-ref-10-1" title="View reference 10 in text" id="ref-10">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-journal" id="cit-2021.10.31.21265703v3.10" data-doi="10.1126/sciimmunol.abn801">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Bates
                                  </span>
                                  <span class="cit-name-given-names">
                                   TA
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Mcbride
                                  </span>
                                  <span class="cit-name-given-names">
                                   SK
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Leier
                                  </span>
                                  <span class="cit-name-given-names">
                                   HC
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-etal">
                                  et al.
                                 </span>
                                 <span class="cit-article-title">
                                  Vaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variants
                                 </span>
                                 .
                                 <abbr class="cit-jnl-abbrev">
                                  Sci. Immunol
                                 </abbr>
                                 <span class="cit-pub-date">
                                  2022
                                 </span>
                                 ;
                                 <span class="cit-vol">
                                  7
                                 </span>
                                 :
                                 <span class="cit-fpage">
                                  eabn8014
                                 </span>
                                 <span class="cit-pub-id-sep cit-pub-id-doi-sep">
                                 </span>
                                 <span class="cit-pub-id-scheme">
                                  DOI:
                                 </span>
                                 <span class="cit-pub-id cit-pub-id-doi">
                                  10.1126/sciimmunol.abn801
                                 </span>
                                </cite>
                               </div>
                               <div class="cit-extra">
                                <a href="{openurl}?query=rft.jtitle%253DSci.%2BImmunol%26rft.volume%253D7%26rft.spage%253Deabn8014%26rft_id%253Dinfo%253Adoi%252F10.1126%252Fsciimmunol.abn801%26rft_id%253Dinfo%253Apmid%252Fhttp%253A%252F%252Fwww.n%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
                                 <span>
                                  OpenUrl
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=10.1126/sciimmunol.abn801&link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
                                 <span>
                                  CrossRef
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F08%2F03%2F2021.10.31.21265703.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline">
                                 <span>
                                  PubMed
                                 </span>
                                </a>
                               </div>
                              </div>
                             </li>
                             <li>
                              <a class="rev-xref-ref" href="#xref-ref-11-1" title="View reference 11 in text" id="ref-11">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-web" id="cit-2021.10.31.21265703v3.11">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Toledo-Romani
                                  </span>
                                  <span class="cit-name-given-names">
                                   ME
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   García-Carmenate
                                  </span>
                                  <span class="cit-name-given-names">
                                   M
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Verdecia-Sánchez
                                  </span>
                                  <span class="cit-name-given-names">
                                   L
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-etal">
                                  et al.
                                 </span>
                                 <span class="cit-article-title">
                                  Safety and immunogenicity of anti-SARS-CoV-2 heterologous scheme with SOBERANA 02 and SOBERANA Plus vaccines: Phase IIb clinical trial in adults
                                 </span>
                                 .
                                 <span class="cit-source">
                                  Med
                                 </span>
                                 <span class="cit-pub-date">
                                  2022
                                 </span>
                                 . (accepted). Preprint:
                                 <a href="https://doi.org/10.1101/2022.01.01.21268271">
                                  https://doi.org/10.1101/2022.01.01.21268271
                                 </a>
                                 .
                                </cite>
                               </div>
                               <div class="cit-extra">
                               </div>
                              </div>
                             </li>
                             <li>
                              <a class="rev-xref-ref" href="#xref-ref-12-1" title="View reference 12 in text" id="ref-12">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-book" id="cit-2021.10.31.21265703v3.12">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth cit-collab">
                                  Food and Drug Administration
                                 </span>
                                 .
                                 <span class="cit-source">
                                  E6(R2) Good Clinical Practice: Integrated Addendum to ICH E6(R1)
                                 </span>
                                 .
                                 <span class="cit-publ-name">
                                  Guidance for Industry
                                 </span>
                                 .
                                 <span class="cit-pub-date">
                                  2018
                                 </span>
                                 ;
                                 <a href="https://www.fda.gov/regulatory-information/search-fda-guidance-documents/e6r2-good-clinical-practice-integrated-addendum-ich-e6r1">
                                  https://www.fda.gov/regulatory-information/search-fda-guidance-documents/e6r2-good-clinical-practice-integrated-addendum-ich-e6r1
                                 </a>
                                 (Accessed
                                 <span class="cit-date-in-citation">
                                  February 2021
                                 </span>
                                 )
                                </cite>
                               </div>
                               <div class="cit-extra">
                               </div>
                              </div>
                             </li>
                             <li>
                              <a class="rev-xref-ref" href="#xref-ref-13-1" title="View reference 13 in text" id="ref-13">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-book" id="cit-2021.10.31.21265703v3.13">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Pérez-Caballero
                                  </span>
                                  <span class="cit-name-given-names">
                                   MD
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   León-Álvarez
                                  </span>
                                  <span class="cit-name-given-names">
                                   JL
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Dueñas-Herrera
                                  </span>
                                  <span class="cit-name-given-names">
                                   A
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-etal">
                                  et al.
                                 </span>
                                 <span class="cit-chapter-title">
                                  Cuban guide for hypertension diagnosis, evaluation and treatment
                                 </span>
                                 .
                                 <span class="cit-source">
                                  Rev Cub. Med
                                 </span>
                                 <span class="cit-pub-date">
                                  2017
                                 </span>
                                 ,
                                 <span class="cit-vol">
                                  56
                                 </span>
                                 :
                                 <span class="cit-fpage">
                                  242
                                 </span>
                                 –
                                 <span class="cit-lpage">
                                  321
                                 </span>
                                 . Available:
                                 <a href="http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75232017000400001&lng=es">
                                  http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75232017000400001&lng=es
                                 </a>
                                </cite>
                               </div>
                               <div class="cit-extra">
                                <a href="{openurl}?query=rft.jtitle%253DRev%2BCub.%2BMed%26rft.volume%253D56%26rft.spage%253D242%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
                                 <span>
                                  OpenUrl
                                 </span>
                                </a>
                               </div>
                              </div>
                             </li>
                             <li>
                              <a class="rev-xref-ref" href="#xref-ref-14-1" title="View reference 14 in text" id="ref-14">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-web" id="cit-2021.10.31.21265703v3.14">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Ochoa-Azze
                                  </span>
                                  <span class="cit-name-given-names">
                                   R
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Chang-Monteagudo
                                  </span>
                                  <span class="cit-name-given-names">
                                   A
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Climent-Ruiz
                                  </span>
                                  <span class="cit-name-given-names">
                                   Y
                                  </span>
                                 </span>
                                 <span class="cit-etal">
                                  et al.
                                 </span>
                                 <span class="cit-article-title">
                                  Safety and immunogenicity of the FINLAY-FR-1A vaccine in COVID-19 convalescent participants: an open-label phase 2a and double-blind, randomised, placebo-controlled, phase 2b, seamless, clinical trial
                                 </span>
                                 .
                                 <span class="cit-source">
                                  Lancet Respir Med
                                 </span>
                                 <span class="cit-pub-date">
                                  2022
                                 </span>
                                 ;
                                 <a href="https://doi.org/10.1016/S2213-2600(22)00100-X">
                                  https://doi.org/10.1016/S2213-2600(22)00100-X
                                 </a>
                                </cite>
                               </div>
                               <div class="cit-extra">
                               </div>
                              </div>
                             </li>
                             <li>
                              <a class="rev-xref-ref" href="#xref-ref-15-1" title="View reference 15 in text" id="ref-15">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-journal" id="cit-2021.10.31.21265703v3.15" data-doi="10.1016/j.vaccine.2022.02.029">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Pérez-Rodríguez
                                  </span>
                                  <span class="cit-name-given-names">
                                   S
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Rodríguez-González
                                  </span>
                                  <span class="cit-name-given-names">
                                   MC
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Ochoa-Azze
                                  </span>
                                  <span class="cit-name-given-names">
                                   R
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-etal">
                                  et al.
                                 </span>
                                 <span class="cit-article-title">
                                  A randomized, double-blind phase I clinical trial of two recombinant dimeric RBD COVID-19 vaccine candidates: Safety, reactogenicity and immunogenicity
                                 </span>
                                 .
                                 <abbr class="cit-jnl-abbrev">
                                  Vaccine
                                 </abbr>
                                 <span class="cit-pub-date">
                                  2022
                                 </span>
                                 :
                                 <span class="cit-vol">
                                  40
                                 </span>
                                 :
                                 <span class="cit-fpage">
                                  2068
                                 </span>
                                 –
                                 <span class="cit-lpage">
                                  2075
                                 </span>
                                 <span class="cit-pub-id-sep cit-pub-id-doi-sep">
                                 </span>
                                 <span class="cit-pub-id-scheme">
                                  doi:
                                 </span>
                                 <span class="cit-pub-id cit-pub-id-doi">
                                  10.1016/j.vaccine.2022.02.029
                                 </span>
                                </cite>
                               </div>
                               <div class="cit-extra">
                                <a href="{openurl}?query=rft.jtitle%253DVaccine%26rft.volume%253D40%26rft.spage%253D2068%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.vaccine.2022.02.029%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
                                 <span>
                                  OpenUrl
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=10.1016/j.vaccine.2022.02.029&link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
                                 <span>
                                  CrossRef
                                 </span>
                                </a>
                               </div>
                              </div>
                             </li>
                             <li>
                              <a class="rev-xref-ref" href="#xref-ref-16-1" title="View reference 16 in text" id="ref-16">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-book" id="cit-2021.10.31.21265703v3.16">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth cit-collab">
                                  US Department of Health and Human Services
                                 </span>
                                 .
                                 <span class="cit-chapter-title">
                                  Common Terminology Criteria for Adverse Events (CTCAE)
                                 </span>
                                 .
                                 <span class="cit-source">
                                  Version 5.0
                                 </span>
                                 .
                                 <span class="cit-publ-loc">
                                  Washington
                                 </span>
                                 :
                                 <span class="cit-publ-name">
                                  HHS
                                 </span>
                                 ;
                                 <span class="cit-pub-date">
                                  2017
                                 </span>
                                 ;
                                 <a href="https://ctep.cancer.gov/protocoldevelopment/electronic_applications/ctc.htm#ctc_50">
                                  https://ctep.cancer.gov/protocoldevelopment/electronic_applications/ctc.htm#ctc_50
                                 </a>
                                 (accessed
                                 <span class="cit-date-in-citation">
                                  February, 2021
                                 </span>
                                 ).
                                </cite>
                               </div>
                               <div class="cit-extra">
                               </div>
                              </div>
                             </li>
                             <li>
                              <a class="rev-xref-ref" href="#xref-ref-17-1" title="View reference 17 in text" id="ref-17">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-book" id="cit-2021.10.31.21265703v3.17">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth cit-collab">
                                  World Health Organization
                                 </span>
                                 .
                                 <span class="cit-source">
                                  Causality Assessment of an Adverse Event Following Immunization (AEFI)
                                 </span>
                                 .
                                 <span class="cit-edition">
                                  2nd
                                 </span>
                                 ed.
                                 <span class="cit-publ-loc">
                                  Geneva
                                 </span>
                                 :
                                 <span class="cit-publ-name">
                                  WHO
                                 </span>
                                 ;
                                 <span class="cit-pub-date">
                                  2018
                                 </span>
                                 .
                                 <a href="https://apps.who.int/iris/bitstream/handle/10665/259959/9789241513654-eng.pdf">
                                  https://apps.who.int/iris/bitstream/handle/10665/259959/9789241513654-eng.pdf
                                 </a>
                                 (accessed
                                 <span class="cit-date-in-citation">
                                  Dec 10, 2020
                                 </span>
                                 ).
                                </cite>
                               </div>
                               <div class="cit-extra">
                               </div>
                              </div>
                             </li>
                             <li>
                              <a class="rev-xref-ref" href="#xref-ref-18-1" title="View reference 18 in text" id="ref-18">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-web" id="cit-2021.10.31.21265703v3.18">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth cit-collab">
                                  WHO consideration for an evaluation of COVID19 Vaccines
                                 </span>
                                 .
                                 <span class="cit-source">
                                  Point to consider for manufacturers of COVID-19 vaccines
                                 </span>
                                 ,
                                 <span class="cit-month">
                                  Sept
                                 </span>
                                 <span class="cit-pub-date">
                                  2020
                                 </span>
                                 ;
                                 <a href="https://www.who.int/default-source/COVID19">
                                  https://www.who.int/default-source/COVID19
                                 </a>
                                 . Accessed
                                 <span class="cit-date-in-citation">
                                  February 2021
                                 </span>
                                </cite>
                               </div>
                               <div class="cit-extra">
                               </div>
                              </div>
                             </li>
                             <li>
                              <a class="rev-xref-ref" href="#xref-ref-19-1" title="View reference 19 in text" id="ref-19">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-journal" id="cit-2021.10.31.21265703v3.19" data-doi="10.1016/j.addr.2021.01.001">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Pollet
                                  </span>
                                  <span class="cit-name-given-names">
                                   J
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Chen
                                  </span>
                                  <span class="cit-name-given-names">
                                   WH
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Strych
                                  </span>
                                  <span class="cit-name-given-names">
                                   U.
                                  </span>
                                 </span>
                                 <span class="cit-article-title">
                                  Recombinant protein vaccines, a proven approach against coronavirus pandemics
                                 </span>
                                 .
                                 <abbr class="cit-jnl-abbrev">
                                  Advanced Drug Delivery Reviews
                                 </abbr>
                                 <span class="cit-pub-date">
                                  2021
                                 </span>
                                 ;
                                 <span class="cit-vol">
                                  170
                                 </span>
                                 :
                                 <span class="cit-fpage">
                                  71
                                 </span>
                                 –
                                 <span class="cit-lpage">
                                  82
                                 </span>
                                 <span class="cit-pub-id-sep cit-pub-id-doi-sep">
                                 </span>
                                 <span class="cit-pub-id-scheme">
                                  doi:
                                 </span>
                                 <span class="cit-pub-id cit-pub-id-doi">
                                  10.1016/j.addr.2021.01.001
                                 </span>
                                 .
                                </cite>
                               </div>
                               <div class="cit-extra">
                                <a href="{openurl}?query=rft.jtitle%253DAdvanced%2BDrug%2BDelivery%2BReviews%26rft.volume%253D170%26rft.spage%253D71%26rft_id%253Dinfo%253Adoi%252F10.1016%252Fj.addr.2021.01.001%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
                                 <span>
                                  OpenUrl
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=10.1016/j.addr.2021.01.001&link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
                                 <span>
                                  CrossRef
                                 </span>
                                </a>
                               </div>
                              </div>
                             </li>
                             <li>
                              <a class="rev-xref-ref" href="#xref-ref-20-1" title="View reference 20 in text" id="ref-20">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-journal" id="cit-2021.10.31.21265703v3.20" data-doi="10.1136/bmj-2022-069989">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Ying
                                  </span>
                                  <span class="cit-name-given-names">
                                   W
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Pak-Hang
                                  </span>
                                  <span class="cit-name-given-names">
                                   P.
                                  </span>
                                 </span>
                                 <span class="cit-article-title">
                                  Effectiveness of heterologous and homologous covid-19 vaccine regimens: living systematic review with network meta-analysis
                                 </span>
                                 .
                                 <abbr class="cit-jnl-abbrev">
                                  BMJ
                                 </abbr>
                                 <span class="cit-pub-date">
                                  2022
                                 </span>
                                 ;
                                 <span class="cit-vol">
                                  377
                                 </span>
                                 :
                                 <span class="cit-fpage">
                                  e069989
                                 </span>
                                 .
                                 <span class="cit-pub-id-scheme">
                                  doi:
                                 </span>
                                 <span class="cit-pub-id cit-pub-id-doi">
                                  10.1136/bmj-2022-069989
                                 </span>
                                </cite>
                               </div>
                               <div class="cit-extra">
                                <a href="{openurl}?query=rft.jtitle%253DBMJ%26rft_id%253Dinfo%253Adoi%252F10.1136%252Fbmj-2022-069989%26rft_id%253Dinfo%253Apmid%252F35640925%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
                                 <span>
                                  OpenUrl
                                 </span>
                                </a>
                                <a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoiYm1qIjtzOjU6InJlc2lkIjtzOjIwOiIzNzcvbWF5MzFfMTIvZTA2OTk4OSI7czo0OiJhdG9tIjtzOjUwOiIvbWVkcnhpdi9lYXJseS8yMDIyLzA4LzAzLzIwMjEuMTAuMzEuMjEyNjU3MDMuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink">
                                 <span>
                                  <span class="cit-reflinks-abstract">
                                   Abstract
                                  </span>
                                  <span class="cit-sep cit-reflinks-variant-name-sep">
                                   /
                                  </span>
                                  <span class="cit-reflinks-full-text">
                                   <span class="free-full-text">
                                    FREE
                                   </span>
                                   Full Text
                                  </span>
                                 </span>
                                </a>
                               </div>
                              </div>
                             </li>
                             <li>
                              <a class="rev-xref-ref" href="#xref-ref-21-1" title="View reference 21 in text" id="ref-21">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-journal" id="cit-2021.10.31.21265703v3.21" data-doi="10.1016/S0140-6736(21)01115-6">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Shaw
                                  </span>
                                  <span class="cit-name-given-names">
                                   R
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Stuart
                                  </span>
                                  <span class="cit-name-given-names">
                                   A
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Greenland
                                  </span>
                                  <span class="cit-name-given-names">
                                   M
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Liu
                                  </span>
                                  <span class="cit-name-given-names">
                                   X
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Nguyen
                                  </span>
                                  <span class="cit-name-given-names">
                                   JVT
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Snape
                                  </span>
                                  <span class="cit-name-given-names">
                                   M
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth cit-collab">
                                  Com-COV Study Group
                                 </span>
                                 .
                                 <span class="cit-article-title">
                                  Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data
                                 </span>
                                 .
                                 <abbr class="cit-jnl-abbrev">
                                  Lancet
                                 </abbr>
                                 <span class="cit-pub-date">
                                  2021
                                 </span>
                                 ;
                                 <span class="cit-vol">
                                  397
                                 </span>
                                 :
                                 <span class="cit-fpage">
                                  2043
                                 </span>
                                 –
                                 <span class="cit-lpage">
                                  2046
                                 </span>
                                 <span class="cit-pub-id-sep cit-pub-id-doi-sep">
                                 </span>
                                 <span class="cit-pub-id-scheme">
                                  doi:
                                 </span>
                                 <span class="cit-pub-id cit-pub-id-doi">
                                  10.1016/S0140-6736(21)01115-6
                                 </span>
                                 .
                                </cite>
                               </div>
                               <div class="cit-extra">
                                <a href="{openurl}?query=rft.jtitle%253DLancet%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS0140-6736%252821%252901115-6%26rft_id%253Dinfo%253Apmid%252F33991480%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
                                 <span>
                                  OpenUrl
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=10.1016/S0140-6736(21)01115-6&link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
                                 <span>
                                  CrossRef
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=33991480&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F08%2F03%2F2021.10.31.21265703.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline">
                                 <span>
                                  PubMed
                                 </span>
                                </a>
                               </div>
                              </div>
                             </li>
                             <li>
                              <a class="rev-xref-ref" href="#xref-ref-22-1" title="View reference 22 in text" id="ref-22">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-journal" id="cit-2021.10.31.21265703v3.22" data-doi="10.1016/S0140-6736(21)02718-5">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Stuart
                                  </span>
                                  <span class="cit-name-given-names">
                                   A
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Shaw
                                  </span>
                                  <span class="cit-name-given-names">
                                   R
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Liu
                                  </span>
                                  <span class="cit-name-given-names">
                                   X
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-etal">
                                  et al.
                                 </span>
                                 <span class="cit-article-title">
                                  Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial
                                 </span>
                                 .
                                 <abbr class="cit-jnl-abbrev">
                                  Lancet
                                 </abbr>
                                 <span class="cit-pub-date">
                                  2022
                                 </span>
                                 ;
                                 <span class="cit-vol">
                                  399
                                 </span>
                                 :
                                 <span class="cit-fpage">
                                  36
                                 </span>
                                 –
                                 <span class="cit-lpage">
                                  49
                                 </span>
                                 .
                                 <span class="cit-pub-id-sep cit-pub-id-doi-sep">
                                 </span>
                                 <span class="cit-pub-id-scheme">
                                  doi:
                                 </span>
                                 <span class="cit-pub-id cit-pub-id-doi">
                                  10.1016/S0140-6736(21)02718-5
                                 </span>
                                 .
                                </cite>
                               </div>
                               <div class="cit-extra">
                                <a href="{openurl}?query=rft.jtitle%253DLancet%26rft.volume%253D399%26rft.spage%253D36%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS0140-6736%252821%252902718-5%26rft_id%253Dinfo%253Apmid%252F34883053%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
                                 <span>
                                  OpenUrl
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=10.1016/S0140-6736(21)02718-5&link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
                                 <span>
                                  CrossRef
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=34883053&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F08%2F03%2F2021.10.31.21265703.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline">
                                 <span>
                                  PubMed
                                 </span>
                                </a>
                               </div>
                              </div>
                             </li>
                             <li>
                              <a class="rev-xref-ref" href="#xref-ref-23-1" title="View reference 23 in text" id="ref-23">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-journal" id="cit-2021.10.31.21265703v3.23" data-doi="10.1371/journal.pmed.1003953">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Jin
                                  </span>
                                  <span class="cit-name-given-names">
                                   P
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Guo
                                  </span>
                                  <span class="cit-name-given-names">
                                   X
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Chen
                                  </span>
                                  <span class="cit-name-given-names">
                                   W
                                  </span>
                                 </span>
                                 <span class="cit-etal">
                                  et al.
                                 </span>
                                 <span class="cit-article-title">
                                  Safety and immunogenicity of heterologous boost immunization with an adenovirus type-5-vectored and protein-subunit-based COVID-19 vaccine (Convidecia/ZF2001): A randomized, observer-blinded, placebo-controlled trial
                                 </span>
                                 .
                                 <abbr class="cit-jnl-abbrev">
                                  PLoS Med
                                 </abbr>
                                 <span class="cit-pub-date">
                                  2022
                                 </span>
                                 ;
                                 <span class="cit-vol">
                                  19
                                 </span>
                                 :
                                 <span class="cit-fpage">
                                  e1003953.
                                 </span>
                                 <span class="cit-pub-id-sep cit-pub-id-doi-sep">
                                 </span>
                                 <span class="cit-pub-id-scheme">
                                  doi:
                                 </span>
                                 <span class="cit-pub-id cit-pub-id-doi">
                                  10.1371/journal.pmed.1003953
                                 </span>
                                 .
                                </cite>
                               </div>
                               <div class="cit-extra">
                                <a href="{openurl}?query=rft.jtitle%253DPLoS%2BMed%26rft.volume%253D19%26rft.spage%253De1003953%26rft_id%253Dinfo%253Adoi%252F10.1371%252Fjournal.pmed.1003953%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
                                 <span>
                                  OpenUrl
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=10.1371/journal.pmed.1003953&link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
                                 <span>
                                  CrossRef
                                 </span>
                                </a>
                               </div>
                              </div>
                             </li>
                             <li>
                              <a class="rev-xref-ref" href="#xref-ref-24-1" title="View reference 24 in text" id="ref-24">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-journal" id="cit-2021.10.31.21265703v3.24" data-doi="10.1371/journal.pone.0262491">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Korang
                                  </span>
                                  <span class="cit-name-given-names">
                                   SK
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   von Rohden
                                  </span>
                                  <span class="cit-name-given-names">
                                   E
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Veroniki
                                  </span>
                                  <span class="cit-name-given-names">
                                   AA
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-etal">
                                  et al.
                                 </span>
                                 <span class="cit-article-title">
                                  Vaccines to prevent COVID-19: A living systematic review with Trial Sequential Analysis and network meta-analysis of randomized clinical trials
                                 </span>
                                 .
                                 <abbr class="cit-jnl-abbrev">
                                  PLoS ONE
                                 </abbr>
                                 <span class="cit-pub-date">
                                  2022
                                 </span>
                                 ;
                                 <span class="cit-vol">
                                  17
                                 </span>
                                 (
                                 <span class="cit-issue">
                                  1
                                 </span>
                                 ):
                                 <span class="cit-fpage">
                                  1
                                 </span>
                                 –
                                 <span class="cit-lpage">
                                  23
                                 </span>
                                 e0260733
                                 <a href="https://doi.org/10.1371/journal.pone.0260733">
                                  https://doi.org/10.1371/journal.pone.0260733
                                 </a>
                                </cite>
                               </div>
                               <div class="cit-extra">
                                <a href="{openurl}?query=rft.jtitle%253DPLoS%2BONE%26rft.volume%253D17%26rft.spage%253D1%26rft_id%253Dinfo%253Adoi%252F10.1371%252Fjournal.pone.0262491%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
                                 <span>
                                  OpenUrl
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=10.1371/journal.pone.0262491&link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
                                 <span>
                                  CrossRef
                                 </span>
                                </a>
                               </div>
                              </div>
                             </li>
                             <li>
                              <a class="rev-xref-ref" href="#xref-ref-25-1" title="View reference 25 in text" id="ref-25">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-journal" id="cit-2021.10.31.21265703v3.25">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Jangra
                                  </span>
                                  <span class="cit-name-given-names">
                                   S.
                                  </span>
                                 </span>
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Ye
                                  </span>
                                  <span class="cit-name-given-names">
                                   C
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Rathnasinghe
                                  </span>
                                  <span class="cit-name-given-names">
                                   R
                                  </span>
                                 </span>
                                 <span class="cit-etal">
                                  et al.
                                 </span>
                                 <span class="cit-article-title">
                                  SARS-CoV-2 spike E484K mutation reduces antibody neutralization
                                 </span>
                                 .
                                 <abbr class="cit-jnl-abbrev">
                                  The Lancet Microbe
                                 </abbr>
                                 202;
                                 <span class="cit-vol">
                                  2
                                 </span>
                                 :
                                 <span class="cit-fpage">
                                  283
                                 </span>
                                 –
                                 <span class="cit-lpage">
                                  284
                                 </span>
                                 ,
                                 <a href="https://doi.org/10.1016/S2666-5247(21)00068-9">
                                  https://doi.org/10.1016/S2666-5247(21)00068-9
                                 </a>
                                </cite>
                               </div>
                               <div class="cit-extra">
                               </div>
                              </div>
                             </li>
                             <li>
                              <a class="rev-xref-ref" href="#xref-ref-26-1" title="View reference 26 in text" id="ref-26">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-journal" id="cit-2021.10.31.21265703v3.26" data-doi="10.1056/NEJMoa2110345">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Thomas
                                  </span>
                                  <span class="cit-name-given-names">
                                   SJ
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Moreira
                                  </span>
                                  <span class="cit-name-given-names">
                                   ED
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Kitchin
                                  </span>
                                  <span class="cit-name-given-names">
                                   N
                                  </span>
                                 </span>
                                 <span class="cit-etal">
                                  et al.
                                 </span>
                                 <span class="cit-article-title">
                                  Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine through 6 Months
                                 </span>
                                 .
                                 <abbr class="cit-jnl-abbrev">
                                  N Engl J Med
                                 </abbr>
                                 <span class="cit-pub-date">
                                  2021
                                 </span>
                                 ;
                                 <span class="cit-vol">
                                  385
                                 </span>
                                 :
                                 <span class="cit-fpage">
                                  1761
                                 </span>
                                 –
                                 <span class="cit-lpage">
                                  1773
                                 </span>
                                 <span class="cit-pub-id-sep cit-pub-id-doi-sep">
                                 </span>
                                 <span class="cit-pub-id-scheme">
                                  doi:
                                 </span>
                                 <span class="cit-pub-id cit-pub-id-doi">
                                  10.1056/NEJMoa2110345
                                 </span>
                                </cite>
                               </div>
                               <div class="cit-extra">
                                <a href="{openurl}?query=rft.jtitle%253DN%2BEngl%2BJ%2BMed%26rft_id%253Dinfo%253Adoi%252F10.1056%252FNEJMoa2110345%26rft_id%253Dinfo%253Apmid%252F34525277%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
                                 <span>
                                  OpenUrl
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=10.1056/NEJMoa2110345&link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
                                 <span>
                                  CrossRef
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=34525277&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F08%2F03%2F2021.10.31.21265703.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline">
                                 <span>
                                  PubMed
                                 </span>
                                </a>
                               </div>
                              </div>
                             </li>
                             <li>
                              <a class="rev-xref-ref" href="#xref-ref-27-1" title="View reference 27 in text" id="ref-27">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-journal" id="cit-2021.10.31.21265703v3.27" data-doi="10.1056/NEJMoa2102214">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Madhi
                                  </span>
                                  <span class="cit-name-given-names">
                                   SA
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Baillie
                                  </span>
                                  <span class="cit-name-given-names">
                                   V
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Cutland
                                  </span>
                                  <span class="cit-name-given-names">
                                   CL
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-etal">
                                  et al.
                                 </span>
                                 <span class="cit-article-title">
                                  Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant
                                 </span>
                                 .
                                 <abbr class="cit-jnl-abbrev">
                                  N Engl J Med
                                 </abbr>
                                 <span class="cit-pub-date">
                                  2021
                                 </span>
                                 ;
                                 <span class="cit-vol">
                                  384
                                 </span>
                                 :
                                 <span class="cit-fpage">
                                  1885
                                 </span>
                                 –
                                 <span class="cit-lpage">
                                  98
                                 </span>
                                 .
                                 <span class="cit-pub-id-sep cit-pub-id-doi-sep">
                                 </span>
                                 <span class="cit-pub-id-scheme">
                                  doi:
                                 </span>
                                 <span class="cit-pub-id cit-pub-id-doi">
                                  10.1056/NEJMoa2102214
                                 </span>
                                </cite>
                               </div>
                               <div class="cit-extra">
                                <a href="{openurl}?query=rft.jtitle%253DN%2BEngl%2BJ%2BMed%26rft_id%253Dinfo%253Adoi%252F10.1056%252FNEJMoa2102214%26rft_id%253Dinfo%253Apmid%252F33725432%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
                                 <span>
                                  OpenUrl
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=10.1056/NEJMoa2102214&link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
                                 <span>
                                  CrossRef
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=33725432&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F08%2F03%2F2021.10.31.21265703.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline">
                                 <span>
                                  PubMed
                                 </span>
                                </a>
                               </div>
                              </div>
                             </li>
                             <li>
                              <a class="rev-xref-ref" href="#xref-ref-28-1" title="View reference 28 in text" id="ref-28">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-journal" id="cit-2021.10.31.21265703v3.28" data-doi="10.1056/NEJMoa2101544">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Sadoff
                                  </span>
                                  <span class="cit-name-given-names">
                                   J
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Gray
                                  </span>
                                  <span class="cit-name-given-names">
                                   G
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Vandebosch
                                  </span>
                                  <span class="cit-name-given-names">
                                   A.
                                  </span>
                                 </span>
                                 <span class="cit-article-title">
                                  Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19. Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
                                 </span>
                                 .
                                 <abbr class="cit-jnl-abbrev">
                                  N Engl J Med
                                 </abbr>
                                 <span class="cit-pub-date">
                                  2021
                                 </span>
                                 ;
                                 <span class="cit-vol">
                                  384
                                 </span>
                                 :
                                 <span class="cit-fpage">
                                  2187
                                 </span>
                                 –
                                 <span class="cit-lpage">
                                  2201
                                 </span>
                                 <span class="cit-pub-id-sep cit-pub-id-doi-sep">
                                 </span>
                                 <span class="cit-pub-id-scheme">
                                  doi:
                                 </span>
                                 <span class="cit-pub-id cit-pub-id-doi">
                                  10.1056/NEJMoa2101544
                                 </span>
                                 .
                                </cite>
                               </div>
                               <div class="cit-extra">
                                <a href="{openurl}?query=rft.jtitle%253DN%2BEngl%2BJ%2BMed%26rft_id%253Dinfo%253Adoi%252F10.1056%252FNEJMoa2101544%26rft_id%253Dinfo%253Apmid%252F33882225%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
                                 <span>
                                  OpenUrl
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=10.1056/NEJMoa2101544&link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
                                 <span>
                                  CrossRef
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=33882225&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F08%2F03%2F2021.10.31.21265703.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline">
                                 <span>
                                  PubMed
                                 </span>
                                </a>
                               </div>
                              </div>
                             </li>
                             <li>
                              <a class="rev-xref-ref" href="#xref-ref-29-1" title="View reference 29 in text" id="ref-29">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-journal" id="cit-2021.10.31.21265703v3.29" data-doi="10.1056/nejmoa2103055">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Shinde
                                  </span>
                                  <span class="cit-name-given-names">
                                   V
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Bhikha
                                  </span>
                                  <span class="cit-name-given-names">
                                   S.
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Hoosain
                                  </span>
                                  <span class="cit-name-given-names">
                                   Z
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-etal">
                                  et al.
                                 </span>
                                 <span class="cit-article-title">
                                  Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant
                                 </span>
                                 .
                                 <abbr class="cit-jnl-abbrev">
                                  N Engl J Med
                                 </abbr>
                                 <span class="cit-pub-date">
                                  2021
                                 </span>
                                 ,
                                 <span class="cit-vol">
                                  384
                                 </span>
                                 :
                                 <span class="cit-fpage">
                                  1899
                                 </span>
                                 –
                                 <span class="cit-lpage">
                                  1909
                                 </span>
                                 <span class="cit-pub-id-sep cit-pub-id-doi-sep">
                                 </span>
                                 <span class="cit-pub-id-scheme">
                                  doi:
                                 </span>
                                 <span class="cit-pub-id cit-pub-id-doi">
                                  10.1056/NEJMoa210305
                                 </span>
                                </cite>
                               </div>
                               <div class="cit-extra">
                                <a href="{openurl}?query=rft.jtitle%253DN%2BEngl%2BJ%2BMed%26rft.volume%253D384%26rft.spage%253D1899%26rft_id%253Dinfo%253Adoi%252F10.1056%252Fnejmoa2103055%26rft_id%253Dinfo%253Apmid%252Fhttp%253A%252F%252Fwww.n%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
                                 <span>
                                  OpenUrl
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=10.1056/nejmoa2103055&link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
                                 <span>
                                  CrossRef
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F08%2F03%2F2021.10.31.21265703.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline">
                                 <span>
                                  PubMed
                                 </span>
                                </a>
                               </div>
                              </div>
                             </li>
                            </ol>
                           </div>
                           <span class="highwire-journal-article-marker-end">
                           </span>
                          </div>
                          <span class="related-urls">
                          </span>
                         </div>
                        </div>
                       </div>
                      </div>
                     </div>
                    </div>
                   </div>
                  </div>
                 </div>
                </div>
               </div>
               <div class="panel-separator">
               </div>
               <div class="panel-pane pane-disqus-comment">
                <div class="pane-content">
                 <div id="disqus_thread">
                  <noscript>
                   <p>
                    <a href="http://medRxiv.disqus.com/?url=https%3A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.1101%2F2021.10.31.21265703v3" class="" data-icon-position="" data-hide-link-title="0">
                     View the discussion thread.
                    </a>
                   </p>
                  </noscript>
                 </div>
                </div>
               </div>
               <div class="panel-separator">
               </div>
               <div class="panel-pane pane-highwire-back-to-top">
                <div class="pane-content">
                 <a href="#page" class="back-to-top" data-icon-position="" data-hide-link-title="0">
                  <span class="icon-chevron-up">
                  </span>
                  Back to top
                 </a>
                </div>
               </div>
              </div>
             </div>
            </div>
            <div class="sidebar-right-wrapper grid-10 omega">
             <div class="panel-panel panel-region-sidebar-right">
              <div class="inside">
               <div class="panel-pane pane-highwire-node-pager">
                <div class="pane-content">
                 <div class="pager highwire-pager pager-mini clearfix highwire-node-pager highwire-article-pager">
                  <span class="pager-prev">
                   <a href="/content/10.1101/2022.08.01.22278287v1" title="Brief report: Determinants of potential sexual activity reduction in the face of the Monkeypox epidemic" rel="prev" class="pager-link-prev link-icon">
                    <span class="icon-circle-arrow-left">
                    </span>
                    <span class="title">
                     Previous
                    </span>
                   </a>
                  </span>
                  <span class="pager-next">
                   <a href="/content/10.1101/2022.07.28.22277637v1" title="A randomized controlled trial on the effects of decision aids for choosing discharge destinations of older stroke patients" rel="next" class="pager-link-next link-icon-right link-icon">
                    <span class="title">
                     Next
                    </span>
                    <span class="icon-circle-arrow-right">
                    </span>
                   </a>
                  </span>
                 </div>
                </div>
               </div>
               <div class="panel-separator">
               </div>
               <div class="panel-pane pane-custom pane-1">
                <div class="pane-content">
                 Posted August 03, 2022.
                </div>
               </div>
               <div class="panel-separator">
               </div>
               <div class="panel-pane pane-panels-mini pane-biorxiv-art-tools">
                <div class="pane-content">
                 <div id="mini-panel-biorxiv_art_tools" class="highwire-2col-stacked panel-display">
                  <div class="panel-row-wrapper clearfix">
                   <div class="content-left-wrapper content-column">
                    <div class="panel-panel panel-region-content-left">
                     <div class="inside">
                      <div class="panel-pane pane-highwire-variant-link">
                       <div class="pane-content">
                        <a href="/content/10.1101/2021.10.31.21265703v3.full.pdf" target="_self" class="article-dl-pdf-link link-icon">
                         <span class="icon-external-link-sign">
                         </span>
                         <span class="title">
                          Download PDF
                         </span>
                        </a>
                       </div>
                      </div>
                      <div class="panel-separator">
                      </div>
                      <div class="panel-pane pane-highwire-variant-link">
                       <div class="pane-content">
                        <a href="/content/early/2022/08/03/2021.10.31.21265703.external-links" target="_self" class="link-icon">
                         <span class="icon-file">
                         </span>
                         <span class="title">
                          Data/Code
                         </span>
                        </a>
                       </div>
                      </div>
                     </div>
                    </div>
                   </div>
                   <div class="content-right-wrapper content-column">
                    <div class="panel-panel panel-region-content-right">
                     <div class="inside">
                      <div class="panel-pane pane-minipanel-dialog-link pane-biorxiv-art-email">
                       <div class="pane-content">
                        <div class="minipanel-dialog-wrapper">
                         <div class="minipanel-dialog-link-link">
                          <a href="/" oncontextmenu="javascript: return false;" class="minipanel-dialog-link-trigger" title="Email this Article" data-icon-position="" data-hide-link-title="0">
                           <i class="icon-envelope">
                           </i>
                           Email
                          </a>
                         </div>
                         <div class="minipanel-dialog-link-mini" style="display:none">
                          <div class="panel-display panel-1col clearfix" id="mini-panel-biorxiv_art_email">
                           <div class="panel-panel panel-col">
                            <div>
                             <div class="panel-pane pane-block pane-forward-form pane-forward">
                              <div class="pane-content">
                               <form action="/content/10.1101/2021.10.31.21265703v3.full" method="post" id="forward-form" accept-charset="UTF-8">
                                <div>
                                 <div id="edit-instructions" class="form-item form-item-label-before form-type-item">
                                  <p>
                                   Thank you for your interest in spreading the word about medRxiv.
                                  </p>
                                  <p>
                                   NOTE: Your email address is requested solely to identify you as the sender of this article.
                                  </p>
                                 </div>
                                 <div class="form-item form-item-label-before form-type-textfield form-item-email">
                                  <label for="edit-email">
                                   Your Email
                                   <span class="form-required" title="This field is required.">
                                    *
                                   </span>
                                  </label>
                                  <input type="text" id="edit-email" name="email" value="" size="58" maxlength="256" class="form-text required"/>
                                 </div>
                                 <div class="form-item form-item-label-before form-type-textfield form-item-name">
                                  <label for="edit-name">
                                   Your Name
                                   <span class="form-required" title="This field is required.">
                                    *
                                   </span>
                                  </label>
                                  <input type="text" id="edit-name" name="name" value="" size="58" maxlength="256" class="form-text required"/>
                                 </div>
                                 <div class="form-item form-item-label-before form-type-textarea form-item-recipients">
                                  <label for="edit-recipients">
                                   Send To
                                   <span class="form-required" title="This field is required.">
                                    *
                                   </span>
                                  </label>
                                  <div class="form-textarea-wrapper resizable">
                                   <textarea id="edit-recipients" name="recipients" cols="50" rows="5" class="form-textarea required"></textarea>
                                  </div>
                                  <div class="description">
                                   Enter multiple addresses on separate lines or separate them with commas.
                                  </div>
                                 </div>
                                 <div id="edit-page" class="form-item form-item-label-before form-type-item">
                                  <label for="edit-page">
                                   You are going to email the following
                                  </label>
                                  <a href="/content/10.1101/2021.10.31.21265703v3" class="active" data-icon-position="" data-hide-link-title="0">
                                   Safety and efficacy of the two doses conjugated protein-based SOBERANA-02 COVID-19 vaccine and of a heterologous three-dose combination with SOBERANA-PLUS: double-blind, randomised, placebo-controlled phase 3 clinical trial
                                  </a>
                                 </div>
                                 <div id="edit-subject" class="form-item form-item-label-before form-type-item">
                                  <label for="edit-subject">
                                   Message Subject
                                  </label>
                                  (Your Name) has forwarded a page to you from medRxiv
                                 </div>
                                 <div id="edit-body" class="form-item form-item-label-before form-type-item">
                                  <label for="edit-body">
                                   Message Body
                                  </label>
                                  (Your Name) thought you would like to see this page from the medRxiv website.
                                 </div>
                                 <div class="form-item form-item-label-before form-type-textarea form-item-message">
                                  <label for="edit-message--2">
                                   Your Personal Message
                                  </label>
                                  <div class="form-textarea-wrapper resizable">
                                   <textarea id="edit-message--2" name="message" cols="50" rows="10" class="form-textarea"></textarea>
                                  </div>
                                 </div>
                                 <input type="hidden" name="path" value="node/545164"/>
                                 <input type="hidden" name="path_cid" value=""/>
                                 <input type="hidden" name="forward_footer" value=" "/>
                                 <input type="hidden" name="form_build_id" value="form-twxpLAh2Xc8BEHO9B8NlCBVURP6oy3KsPfrhI0TPbnc"/>
                                 <input type="hidden" name="form_id" value="forward_form"/>
                                 <fieldset class="captcha form-wrapper">
                                  <legend>
                                   <span class="fieldset-legend">
                                    CAPTCHA
                                   </span>
                                  </legend>
                                  <div class="fieldset-wrapper">
                                   <div class="fieldset-description">
                                    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
                                   </div>
                                   <input type="hidden" name="captcha_sid" value="277160989"/>
                                   <input type="hidden" name="captcha_token" value="da4d7db45beee526c2c452ea39c26fb4"/>
                                   <input type="hidden" name="captcha_response" value="Google no captcha"/>
                                   <div class="g-recaptcha" data-sitekey="6LfnJVIUAAAAAE-bUOMg0MJGki4lqSvDmhJp19fN" data-theme="light" data-type="image">
                                   </div>
                                  </div>
                                 </fieldset>
                                 <div class="form-actions form-wrapper" id="edit-actions">
                                  <input type="submit" id="edit-submit" name="op" value="Send Message" class="form-submit"/>
                                 </div>
                                </div>
                               </form>
                              </div>
                             </div>
                            </div>
                           </div>
                          </div>
                         </div>
                        </div>
                       </div>
                      </div>
                      <div class="panel-separator">
                      </div>
                      <div class="panel-pane pane-highwire-share-link highwire_clipboard_link_ajax" id="shareit">
                       <div class="pane-content">
                        <a href="/" class="link-icon">
                         <span class="icon-share-alt">
                         </span>
                         <span class="title">
                          Share
                         </span>
                        </a>
                       </div>
                      </div>
                      <div class="panel-separator">
                      </div>
                      <div class="panel-pane pane-panels-mini pane-biorxiv-share highwire_clipboard_form_ajax_shareit">
                       <div class="pane-content">
                        <div class="panel-display omega-12-onecol" id="mini-panel-biorxiv_share">
                         <div class="panel-panel grid-12 panel-region-preface">
                          <div class="inside">
                           <div class="panel-pane pane-highwire-article-citation">
                            <div class="pane-content">
                             <div class="highwire-article-citation highwire-citation-type-highwire-article node545164--3" data-node-nid="545164" id="node-545164--4255727381" data-pisa="medrxiv;2021.10.31.21265703v3" data-pisa-master="medrxiv;2021.10.31.21265703" data-seqnum="545164" data-apath="/medrxiv/early/2022/08/03/2021.10.31.21265703.atom">
                              <div class="highwire-cite highwire-cite-highwire-article highwire-citation-biorxiv-article-pap-list clearfix">
                               <div class="highwire-cite-title">
                                <div class="highwire-cite-title">
                                 Safety and efficacy of the two doses conjugated protein-based SOBERANA-02 COVID-19 vaccine and of a heterologous three-dose combination with SOBERANA-PLUS: double-blind, randomised, placebo-controlled phase 3 clinical trial
                                </div>
                               </div>
                               <div class="highwire-cite-authors">
                                <span class="highwire-citation-authors">
                                 <span class="highwire-citation-author first" data-delta="0">
                                  <span class="nlm-given-names">
                                   María
                                  </span>
                                  <span class="nlm-surname">
                                   Eugenia Toledo-Romaní
                                  </span>
                                 </span>
                                 ,
                                 <span class="highwire-citation-author" data-delta="1">
                                  <span class="nlm-given-names">
                                   Mayra
                                  </span>
                                  <span class="nlm-surname">
                                   García-Carmenate
                                  </span>
                                 </span>
                                 ,
                                 <span class="highwire-citation-author" data-delta="2">
                                  <span class="nlm-given-names">
                                   Carmen
                                  </span>
                                  <span class="nlm-surname">
                                   Valenzuela-Silva
                                  </span>
                                 </span>
                                 ,
                                 <span class="highwire-citation-author" data-delta="3">
                                  <span class="nlm-given-names">
                                   Waldemar
                                  </span>
                                  <span class="nlm-surname">
                                   Baldoquín-Rodríguez
                                  </span>
                                 </span>
                                 ,
                                 <span class="highwire-citation-author" data-delta="4">
                                  <span class="nlm-given-names">
                                   Marisel
                                  </span>
                                  <span class="nlm-surname">
                                   Martínez-Pérez
                                  </span>
                                 </span>
                                 ,
                                 <span class="highwire-citation-author" data-delta="5">
                                  <span class="nlm-given-names">
                                   Meiby
                                  </span>
                                  <span class="nlm-surname">
                                   Rodríguez-González
                                  </span>
                                 </span>
                                 ,
                                 <span class="highwire-citation-author" data-delta="6">
                                  <span class="nlm-given-names">
                                   Beatriz
                                  </span>
                                  <span class="nlm-surname">
                                   Paredes-Moreno
                                  </span>
                                 </span>
                                 ,
                                 <span class="highwire-citation-author" data-delta="7">
                                  <span class="nlm-given-names">
                                   Ivis
                                  </span>
                                  <span class="nlm-surname">
                                   Mendoza-Hernández
                                  </span>
                                 </span>
                                 ,
                                 <span class="highwire-citation-author" data-delta="8">
                                  <span class="nlm-given-names">
                                   Raúl
                                  </span>
                                  <span class="nlm-surname">
                                   González-Mujica
                                  </span>
                                 </span>
                                 ,
                                 <span class="highwire-citation-author" data-delta="9">
                                  <span class="nlm-given-names">
                                   Oscar
                                  </span>
                                  <span class="nlm-surname">
                                   Samón-Tabio
                                  </span>
                                 </span>
                                 ,
                                 <span class="highwire-citation-author" data-delta="10">
                                  <span class="nlm-given-names">
                                   Pablo
                                  </span>
                                  <span class="nlm-surname">
                                   Velazco-Villares
                                  </span>
                                 </span>
                                 ,
                                 <span class="highwire-citation-author" data-delta="11">
                                  <span class="nlm-given-names">
                                   Juan Pablo
                                  </span>
                                  <span class="nlm-surname">
                                   Bacallao-Castillo
                                  </span>
                                 </span>
                                 ,
                                 <span class="highwire-citation-author" data-delta="12">
                                  <span class="nlm-given-names">
                                   Ernesto
                                  </span>
                                  <span class="nlm-surname">
                                   Licea-Martín
                                  </span>
                                 </span>
                                 ,
                                 <span class="highwire-citation-author" data-delta="13">
                                  <span class="nlm-given-names">
                                   Misladys
                                  </span>
                                  <span class="nlm-surname">
                                   Rodríguez-Ortega
                                  </span>
                                 </span>
                                 ,
                                 <span class="highwire-citation-author" data-delta="14">
                                  <span class="nlm-given-names">
                                   Nuris
                                  </span>
                                  <span class="nlm-surname">
                                   Herrera-Marrero
                                  </span>
                                 </span>
                                 ,
                                 <span class="highwire-citation-author" data-delta="15">
                                  <span class="nlm-given-names">
                                   Esperanza
                                  </span>
                                  <span class="nlm-surname">
                                   Caballero-González
                                  </span>
                                 </span>
                                 ,
                                 <span class="highwire-citation-author" data-delta="16">
                                  <span class="nlm-given-names">
                                   Liudmila
                                  </span>
                                  <span class="nlm-surname">
                                   Egües-Torres
                                  </span>
                                 </span>
                                 ,
                                 <span class="highwire-citation-author" data-delta="17">
                                  <span class="nlm-given-names">
                                   Reinaldo
                                  </span>
                                  <span class="nlm-surname">
                                   Duartes-González
                                  </span>
                                 </span>
                                 ,
                                 <span class="highwire-citation-author" data-delta="18">
                                  <span class="nlm-given-names">
                                   Serguey
                                  </span>
                                  <span class="nlm-surname">
                                   García-Blanco
                                  </span>
                                 </span>
                                 ,
                                 <span class="highwire-citation-author" data-delta="19">
                                  <span class="nlm-given-names">
                                   Suzette
                                  </span>
                                  <span class="nlm-surname">
                                   Pérez-Cabrera
                                  </span>
                                 </span>
                                 ,
                                 <span class="highwire-citation-author" data-delta="20">
                                  <span class="nlm-given-names">
                                   Santos
                                  </span>
                                  <span class="nlm-surname">
                                   Huete-Ferreira
                                  </span>
                                 </span>
                                 ,
                                 <span class="highwire-citation-author" data-delta="21">
                                  <span class="nlm-given-names">
                                   Kirenia
                                  </span>
                                  <span class="nlm-surname">
                                   Idalmis-Cisnero
                                  </span>
                                 </span>
                                 ,
                                 <span class="highwire-citation-author" data-delta="22">
                                  <span class="nlm-given-names">
                                   Omayda
                                  </span>
                                  <span class="nlm-surname">
                                   Fonte-Galindo
                                  </span>
                                 </span>
                                 ,
                                 <span class="highwire-citation-author" data-delta="23">
                                  <span class="nlm-given-names">
                                   Dania
                                  </span>
                                  <span class="nlm-surname">
                                   Meliá-Pérez
                                  </span>
                                 </span>
                                 ,
                                 <span class="highwire-citation-author" data-delta="24">
                                  <span class="nlm-given-names">
                                   Ivonne
                                  </span>
                                  <span class="nlm-surname">
                                   Rojas-Remedios
                                  </span>
                                 </span>
                                 ,
                                 <span class="highwire-citation-author" data-delta="25">
                                  <span class="nlm-given-names">
                                   Delaram
                                  </span>
                                  <span class="nlm-surname">
                                   Doroud
                                  </span>
                                 </span>
                                 ,
                                 <span class="highwire-citation-author" data-delta="26">
                                  <span class="nlm-given-names">
                                   Mohammad Mehdi
                                  </span>
                                  <span class="nlm-surname">
                                   Gouya
                                  </span>
                                 </span>
                                 ,
                                 <span class="highwire-citation-author" data-delta="27">
                                  <span class="nlm-given-names">
                                   Alireza
                                  </span>
                                  <span class="nlm-surname">
                                   Biglari
                                  </span>
                                 </span>
                                 ,
                                 <span class="highwire-citation-author" data-delta="28">
                                  <span class="nlm-given-names">
                                   Patrick
                                  </span>
                                  <span class="nlm-surname">
                                   Van der Stuyft
                                  </span>
                                 </span>
                                 ,
                                 <span class="highwire-citation-author" data-delta="29">
                                  <span class="nlm-given-names">
                                   Sonsire
                                  </span>
                                  <span class="nlm-surname">
                                   Fernández-Castillo
                                  </span>
                                 </span>
                                 ,
                                 <span class="highwire-citation-author" data-delta="30">
                                  <span class="nlm-given-names">
                                   Yanet
                                  </span>
                                  <span class="nlm-surname">
                                   Climent-Ruiz
                                  </span>
                                 </span>
                                 ,
                                 <span class="highwire-citation-author" data-delta="31">
                                  <span class="nlm-given-names">
                                   Yury
                                  </span>
                                  <span class="nlm-surname">
                                   Valdes-Balbín
                                  </span>
                                 </span>
                                 ,
                                 <span class="highwire-citation-author" data-delta="32">
                                  <span class="nlm-given-names">
                                   Dagmar
                                  </span>
                                  <span class="nlm-surname">
                                   García-Rivera
                                  </span>
                                 </span>
                                 ,
                                 <span class="highwire-citation-author" data-delta="33">
                                  <span class="nlm-given-names">
                                   Vicente
                                  </span>
                                  <span class="nlm-surname">
                                   Verez-Bencomo
                                  </span>
                                 </span>
                                 ,
                                 <span class="highwire-citation-author" data-delta="34">
                                  <span class="nlm-collab" data-hwp-id="collab-1">
                                   the SOBERANA Phase 3 team
                                  </span>
                                 </span>
                                </span>
                               </div>
                               <div class="highwire-cite-metadata">
                                <span class="highwire-cite-metadata-journal highwire-cite-metadata">
                                 medRxiv
                                </span>
                                <span class="highwire-cite-metadata-pages highwire-cite-metadata">
                                 2021.10.31.21265703;
                                </span>
                                <span class="highwire-cite-metadata-doi highwire-cite-metadata">
                                 <span class="doi_label">
                                  doi:
                                 </span>
                                 https://doi.org/10.1101/2021.10.31.21265703
                                </span>
                               </div>
                              </div>
                             </div>
                            </div>
                           </div>
                          </div>
                         </div>
                         <div class="panel-panel grid-12 panel-region-content">
                          <div class="inside">
                           <div class="panel-pane pane-highwire-article-clipboard-copy">
                            <div class="pane-content">
                             <div class="clipboard-copy">
                              <span class="label-url">
                               <label for="dynamic">
                                Share This Article:
                               </label>
                              </span>
                              <span class="input-text-url">
                               <input type="text" id="dynamic" value="https://www.medrxiv.org/content/10.1101/2021.10.31.21265703v3" size="50"/>
                              </span>
                              <span class="copy-button button">
                               <button id="copy-dynamic" class="clipboardjs-button" data-clipboard-target="#dynamic" data-clipboard-alert-style="tooltip" data-clipboard-alert-text="Copied!">
                                Copy
                               </button>
                              </span>
                             </div>
                            </div>
                           </div>
                          </div>
                         </div>
                         <div class="panel-panel grid-12 panel-region-postscript">
                          <div class="inside">
                           <div class="panel-pane pane-service-links">
                            <div class="pane-content">
                             <div class="service-links">
                              <a href="http://digg.com/submit?phase=2&url=https%3A//www.medrxiv.org/content/10.1101/2021.10.31.21265703v3&title=Safety%20and%20efficacy%20of%20the%20two%20doses%20conjugated%20protein-based%20SOBERANA-02%20COVID-19%20vaccine%20and%20of%20a%20heterologous%20three-dose%20combination%20with%20SOBERANA-PLUS%3A%20double-blind%2C%20randomised%2C%20placebo-controlled%20phase%203%20clinical%20trial" id="digg" title="Digg this post on digg.com" class="service-links-digg" rel="nofollow" data-icon-position="" data-hide-link-title="0">
                               <img src="https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/digg.png" alt="Digg logo"/>
                              </a>
                              <a href="http://reddit.com/submit?url=https%3A//www.medrxiv.org/content/10.1101/2021.10.31.21265703v3&title=Safety%20and%20efficacy%20of%20the%20two%20doses%20conjugated%20protein-based%20SOBERANA-02%20COVID-19%20vaccine%20and%20of%20a%20heterologous%20three-dose%20combination%20with%20SOBERANA-PLUS%3A%20double-blind%2C%20randomised%2C%20placebo-controlled%20phase%203%20clinical%20trial" id="reddit" title="Submit this post on reddit.com" class="service-links-reddit" rel="nofollow" data-icon-position="" data-hide-link-title="0">
                               <img src="https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/reddit.png" alt="Reddit logo"/>
                              </a>
                              <a href="http://twitter.com/share?url=https%3A//www.medrxiv.org/content/10.1101/2021.10.31.21265703v3&text=Safety%20and%20efficacy%20of%20the%20two%20doses%20conjugated%20protein-based%20SOBERANA-02%20COVID-19%20vaccine%20and%20of%20a%20heterologous%20three-dose%20combination%20with%20SOBERANA-PLUS%3A%20double-blind%2C%20randomised%2C%20placebo-controlled%20phase%203%20clinical%20trial" id="twitter" title="Share this on Twitter" class="service-links-twitter" rel="nofollow" data-icon-position="" data-hide-link-title="0">
                               <img src="https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png" alt="Twitter logo"/>
                              </a>
                              <a href="http://www.facebook.com/sharer.php?u=https%3A//www.medrxiv.org/content/10.1101/2021.10.31.21265703v3&t=Safety%20and%20efficacy%20of%20the%20two%20doses%20conjugated%20protein-based%20SOBERANA-02%20COVID-19%20vaccine%20and%20of%20a%20heterologous%20three-dose%20combination%20with%20SOBERANA-PLUS%3A%20double-blind%2C%20randomised%2C%20placebo-controlled%20phase%203%20clinical%20trial" id="facebook" title="Share on Facebook" class="service-links-facebook" rel="nofollow" data-icon-position="" data-hide-link-title="0">
                               <img src="https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png" alt="Facebook logo"/>
                              </a>
                              <a href="http://www.google.com/bookmarks/mark?op=add&bkmk=https%3A//www.medrxiv.org/content/10.1101/2021.10.31.21265703v3&title=Safety%20and%20efficacy%20of%20the%20two%20doses%20conjugated%20protein-based%20SOBERANA-02%20COVID-19%20vaccine%20and%20of%20a%20heterologous%20three-dose%20combination%20with%20SOBERANA-PLUS%3A%20double-blind%2C%20randomised%2C%20placebo-controlled%20phase%203%20clinical%20trial" id="google" title="Bookmark this post on Google" class="service-links-google" rel="nofollow" data-icon-position="" data-hide-link-title="0">
                               <img src="https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/google-32.png" alt="Google logo"/>
                              </a>
                              <a href="http://www.linkedin.com/shareArticle?mini=true&url=https%3A//www.medrxiv.org/content/10.1101/2021.10.31.21265703v3&title=Safety%20and%20efficacy%20of%20the%20two%20doses%20conjugated%20protein-based%20SOBERANA-02%20COVID-19%20vaccine%20and%20of%20a%20heterologous%20three-dose%20combination%20with%20SOBERANA-PLUS%3A%20double-blind%2C%20randomised%2C%20placebo-controlled%20phase%203%20clinical%20trial&summary=&source=medRxiv" id="linkedin" title="Publish this post to LinkedIn" class="service-links-linkedin" rel="nofollow" data-icon-position="" data-hide-link-title="0">
                               <img src="https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png" alt="LinkedIn logo"/>
                              </a>
                              <a href="http://www.mendeley.com/import/?url=https%3A//www.medrxiv.org/content/10.1101/2021.10.31.21265703v3&title=Safety%20and%20efficacy%20of%20the%20two%20doses%20conjugated%20protein-based%20SOBERANA-02%20COVID-19%20vaccine%20and%20of%20a%20heterologous%20three-dose%20combination%20with%20SOBERANA-PLUS%3A%20double-blind%2C%20randomised%2C%20placebo-controlled%20phase%203%20clinical%20trial" id="mendeley" title="Share on Mendeley" class="service-links-mendeley" rel="nofollow" data-icon-position="" data-hide-link-title="0">
                               <img src="https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png" alt="Mendeley logo"/>
                              </a>
                             </div>
                            </div>
                           </div>
                          </div>
                         </div>
                        </div>
                       </div>
                      </div>
                      <div class="panel-separator">
                      </div>
                      <div class="panel-pane pane-minipanel-dialog-link pane-biorxiv-cite-tool">
                       <div class="pane-content">
                        <div class="minipanel-dialog-wrapper">
                         <div class="minipanel-dialog-link-link">
                          <a href="/" oncontextmenu="javascript: return false;" class="minipanel-dialog-link-trigger link-icon" title="Citation Tools">
                           <span class="icon-globe">
                           </span>
                           <span class="title">
                            Citation Tools
                           </span>
                          </a>
                         </div>
                         <div class="minipanel-dialog-link-mini" style="display:none">
                          <div class="panel-display panel-1col clearfix" id="mini-panel-biorxiv_cite_tool">
                           <div class="panel-panel panel-col">
                            <div>
                             <div class="panel-pane pane-highwire-citation-export">
                              <div class="pane-content">
                               <div class="highwire-citation-export">
                                <div class="highwire-citation-info">
                                 <div class="highwire-article-citation highwire-citation-type-highwire-article cite-tool-node545164--3" data-node-nid="545164" id="citation-node-545164--41721467922" data-pisa="medrxiv;2021.10.31.21265703v3" data-pisa-master="medrxiv;2021.10.31.21265703" data-seqnum="545164" data-apath="/medrxiv/early/2022/08/03/2021.10.31.21265703.atom">
                                  <div class="highwire-cite highwire-cite-highwire-article highwire-citation-biorxiv-article-pap-list clearfix">
                                   <div class="highwire-cite-title">
                                    <div class="highwire-cite-title">
                                     Safety and efficacy of the two doses conjugated protein-based SOBERANA-02 COVID-19 vaccine and of a heterologous three-dose combination with SOBERANA-PLUS: double-blind, randomised, placebo-controlled phase 3 clinical trial
                                    </div>
                                   </div>
                                   <div class="highwire-cite-authors">
                                    <span class="highwire-citation-authors">
                                     <span class="highwire-citation-author first" data-delta="0">
                                      <span class="nlm-given-names">
                                       María
                                      </span>
                                      <span class="nlm-surname">
                                       Eugenia Toledo-Romaní
                                      </span>
                                     </span>
                                     ,
                                     <span class="highwire-citation-author" data-delta="1">
                                      <span class="nlm-given-names">
                                       Mayra
                                      </span>
                                      <span class="nlm-surname">
                                       García-Carmenate
                                      </span>
                                     </span>
                                     ,
                                     <span class="highwire-citation-author" data-delta="2">
                                      <span class="nlm-given-names">
                                       Carmen
                                      </span>
                                      <span class="nlm-surname">
                                       Valenzuela-Silva
                                      </span>
                                     </span>
                                     ,
                                     <span class="highwire-citation-author" data-delta="3">
                                      <span class="nlm-given-names">
                                       Waldemar
                                      </span>
                                      <span class="nlm-surname">
                                       Baldoquín-Rodríguez
                                      </span>
                                     </span>
                                     ,
                                     <span class="highwire-citation-author" data-delta="4">
                                      <span class="nlm-given-names">
                                       Marisel
                                      </span>
                                      <span class="nlm-surname">
                                       Martínez-Pérez
                                      </span>
                                     </span>
                                     ,
                                     <span class="highwire-citation-author" data-delta="5">
                                      <span class="nlm-given-names">
                                       Meiby
                                      </span>
                                      <span class="nlm-surname">
                                       Rodríguez-González
                                      </span>
                                     </span>
                                     ,
                                     <span class="highwire-citation-author" data-delta="6">
                                      <span class="nlm-given-names">
                                       Beatriz
                                      </span>
                                      <span class="nlm-surname">
                                       Paredes-Moreno
                                      </span>
                                     </span>
                                     ,
                                     <span class="highwire-citation-author" data-delta="7">
                                      <span class="nlm-given-names">
                                       Ivis
                                      </span>
                                      <span class="nlm-surname">
                                       Mendoza-Hernández
                                      </span>
                                     </span>
                                     ,
                                     <span class="highwire-citation-author" data-delta="8">
                                      <span class="nlm-given-names">
                                       Raúl
                                      </span>
                                      <span class="nlm-surname">
                                       González-Mujica
                                      </span>
                                     </span>
                                     ,
                                     <span class="highwire-citation-author" data-delta="9">
                                      <span class="nlm-given-names">
                                       Oscar
                                      </span>
                                      <span class="nlm-surname">
                                       Samón-Tabio
                                      </span>
                                     </span>
                                     ,
                                     <span class="highwire-citation-author" data-delta="10">
                                      <span class="nlm-given-names">
                                       Pablo
                                      </span>
                                      <span class="nlm-surname">
                                       Velazco-Villares
                                      </span>
                                     </span>
                                     ,
                                     <span class="highwire-citation-author" data-delta="11">
                                      <span class="nlm-given-names">
                                       Juan Pablo
                                      </span>
                                      <span class="nlm-surname">
                                       Bacallao-Castillo
                                      </span>
                                     </span>
                                     ,
                                     <span class="highwire-citation-author" data-delta="12">
                                      <span class="nlm-given-names">
                                       Ernesto
                                      </span>
                                      <span class="nlm-surname">
                                       Licea-Martín
                                      </span>
                                     </span>
                                     ,
                                     <span class="highwire-citation-author" data-delta="13">
                                      <span class="nlm-given-names">
                                       Misladys
                                      </span>
                                      <span class="nlm-surname">
                                       Rodríguez-Ortega
                                      </span>
                                     </span>
                                     ,
                                     <span class="highwire-citation-author" data-delta="14">
                                      <span class="nlm-given-names">
                                       Nuris
                                      </span>
                                      <span class="nlm-surname">
                                       Herrera-Marrero
                                      </span>
                                     </span>
                                     ,
                                     <span class="highwire-citation-author" data-delta="15">
                                      <span class="nlm-given-names">
                                       Esperanza
                                      </span>
                                      <span class="nlm-surname">
                                       Caballero-González
                                      </span>
                                     </span>
                                     ,
                                     <span class="highwire-citation-author" data-delta="16">
                                      <span class="nlm-given-names">
                                       Liudmila
                                      </span>
                                      <span class="nlm-surname">
                                       Egües-Torres
                                      </span>
                                     </span>
                                     ,
                                     <span class="highwire-citation-author" data-delta="17">
                                      <span class="nlm-given-names">
                                       Reinaldo
                                      </span>
                                      <span class="nlm-surname">
                                       Duartes-González
                                      </span>
                                     </span>
                                     ,
                                     <span class="highwire-citation-author" data-delta="18">
                                      <span class="nlm-given-names">
                                       Serguey
                                      </span>
                                      <span class="nlm-surname">
                                       García-Blanco
                                      </span>
                                     </span>
                                     ,
                                     <span class="highwire-citation-author" data-delta="19">
                                      <span class="nlm-given-names">
                                       Suzette
                                      </span>
                                      <span class="nlm-surname">
                                       Pérez-Cabrera
                                      </span>
                                     </span>
                                     ,
                                     <span class="highwire-citation-author" data-delta="20">
                                      <span class="nlm-given-names">
                                       Santos
                                      </span>
                                      <span class="nlm-surname">
                                       Huete-Ferreira
                                      </span>
                                     </span>
                                     ,
                                     <span class="highwire-citation-author" data-delta="21">
                                      <span class="nlm-given-names">
                                       Kirenia
                                      </span>
                                      <span class="nlm-surname">
                                       Idalmis-Cisnero
                                      </span>
                                     </span>
                                     ,
                                     <span class="highwire-citation-author" data-delta="22">
                                      <span class="nlm-given-names">
                                       Omayda
                                      </span>
                                      <span class="nlm-surname">
                                       Fonte-Galindo
                                      </span>
                                     </span>
                                     ,
                                     <span class="highwire-citation-author" data-delta="23">
                                      <span class="nlm-given-names">
                                       Dania
                                      </span>
                                      <span class="nlm-surname">
                                       Meliá-Pérez
                                      </span>
                                     </span>
                                     ,
                                     <span class="highwire-citation-author" data-delta="24">
                                      <span class="nlm-given-names">
                                       Ivonne
                                      </span>
                                      <span class="nlm-surname">
                                       Rojas-Remedios
                                      </span>
                                     </span>
                                     ,
                                     <span class="highwire-citation-author" data-delta="25">
                                      <span class="nlm-given-names">
                                       Delaram
                                      </span>
                                      <span class="nlm-surname">
                                       Doroud
                                      </span>
                                     </span>
                                     ,
                                     <span class="highwire-citation-author" data-delta="26">
                                      <span class="nlm-given-names">
                                       Mohammad Mehdi
                                      </span>
                                      <span class="nlm-surname">
                                       Gouya
                                      </span>
                                     </span>
                                     ,
                                     <span class="highwire-citation-author" data-delta="27">
                                      <span class="nlm-given-names">
                                       Alireza
                                      </span>
                                      <span class="nlm-surname">
                                       Biglari
                                      </span>
                                     </span>
                                     ,
                                     <span class="highwire-citation-author" data-delta="28">
                                      <span class="nlm-given-names">
                                       Patrick
                                      </span>
                                      <span class="nlm-surname">
                                       Van der Stuyft
                                      </span>
                                     </span>
                                     ,
                                     <span class="highwire-citation-author" data-delta="29">
                                      <span class="nlm-given-names">
                                       Sonsire
                                      </span>
                                      <span class="nlm-surname">
                                       Fernández-Castillo
                                      </span>
                                     </span>
                                     ,
                                     <span class="highwire-citation-author" data-delta="30">
                                      <span class="nlm-given-names">
                                       Yanet
                                      </span>
                                      <span class="nlm-surname">
                                       Climent-Ruiz
                                      </span>
                                     </span>
                                     ,
                                     <span class="highwire-citation-author" data-delta="31">
                                      <span class="nlm-given-names">
                                       Yury
                                      </span>
                                      <span class="nlm-surname">
                                       Valdes-Balbín
                                      </span>
                                     </span>
                                     ,
                                     <span class="highwire-citation-author" data-delta="32">
                                      <span class="nlm-given-names">
                                       Dagmar
                                      </span>
                                      <span class="nlm-surname">
                                       García-Rivera
                                      </span>
                                     </span>
                                     ,
                                     <span class="highwire-citation-author" data-delta="33">
                                      <span class="nlm-given-names">
                                       Vicente
                                      </span>
                                      <span class="nlm-surname">
                                       Verez-Bencomo
                                      </span>
                                     </span>
                                     ,
                                     <span class="highwire-citation-author" data-delta="34">
                                      <span class="nlm-collab" data-hwp-id="collab-1">
                                       the SOBERANA Phase 3 team
                                      </span>
                                     </span>
                                    </span>
                                   </div>
                                   <div class="highwire-cite-metadata">
                                    <span class="highwire-cite-metadata-journal highwire-cite-metadata">
                                     medRxiv
                                    </span>
                                    <span class="highwire-cite-metadata-pages highwire-cite-metadata">
                                     2021.10.31.21265703;
                                    </span>
                                    <span class="highwire-cite-metadata-doi highwire-cite-metadata">
                                     <span class="doi_label">
                                      doi:
                                     </span>
                                     https://doi.org/10.1101/2021.10.31.21265703
                                    </span>
                                   </div>
                                  </div>
                                 </div>
                                </div>
                                <div class="highwire-citation-formats">
                                 <h2>
                                  Citation Manager Formats
                                 </h2>
                                 <div class="highwire-citation-formats-links">
                                  <span class="Z3988" title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.spage&rft.epage&rft.atitle=Safety%20and%20efficacy%20of%20the%20two%20doses%20conjugated%20protein-based%20SOBERANA-02%20COVID-19%20vaccine%20and%20of%20a%20heterologous%20three-dose%20combination%20with%20SOBERANA-PLUS%3A%20double-blind%2C%20randomised%2C%20placebo-controlled%20phase%203%20clinical%20trial&rft.volume&rft.issue&rft.date=2022-01-01%2000%3A00%3A00&rft.stitle&rft.jtitle=medRxiv&rft.au=Eugenia+Toledo-Roman%C3%AD%2C+Mar%C3%ADa&rft.au=Garc%C3%ADa-Carmenate%2C+Mayra&rft.au=Valenzuela-Silva%2C+Carmen&rft.au=Baldoqu%C3%ADn-Rodr%C3%ADguez%2C+Waldemar&rft.au=Mart%C3%ADnez-P%C3%A9rez%2C+Marisel&rft.au=Rodr%C3%ADguez-Gonz%C3%A1lez%2C+Meiby&rft.au=Paredes-Moreno%2C+Beatriz&rft.au=Mendoza-Hern%C3%A1ndez%2C+Ivis&rft.au=Gonz%C3%A1lez-Mujica%2C+Ra%C3%BAl&rft.au=Sam%C3%B3n-Tabio%2C+Oscar&rft.au=Velazco-Villares%2C+Pablo&rft.au=Bacallao-Castillo%2C+Juan+Pablo&rft.au=Licea-Mart%C3%ADn%2C+Ernesto&rft.au=Rodr%C3%ADguez-Ortega%2C+Misladys&rft.au=Herrera-Marrero%2C+Nuris&rft.au=Caballero-Gonz%C3%A1lez%2C+Esperanza&rft.au=Eg%C3%BCes-Torres%2C+Liudmila&rft.au=Duartes-Gonz%C3%A1lez%2C+Reinaldo&rft.au=Garc%C3%ADa-Blanco%2C+Serguey&rft.au=P%C3%A9rez-Cabrera%2C+Suzette&rft.au=Huete-Ferreira%2C+Santos&rft.au=Idalmis-Cisnero%2C+Kirenia&rft.au=Fonte-Galindo%2C+Omayda&rft.au=Meli%C3%A1-P%C3%A9rez%2C+Dania&rft.au=Rojas-Remedios%2C+Ivonne&rft.au=Doroud%2C+Delaram&rft.au=Gouya%2C+Mohammad+Mehdi&rft.au=Biglari%2C+Alireza&rft.au=Van+der+Stuyft%2C+Patrick&rft.au=Fern%C3%A1ndez-Castillo%2C+Sonsire&rft.au=Climent-Ruiz%2C+Yanet&rft.au=Valdes-Balb%C3%ADn%2C+Yury&rft.au=Garc%C3%ADa-Rivera%2C+Dagmar&rft.au=Verez-Bencomo%2C+Vicente&rft.au=%2C+">
                                  </span>
                                  <ul class="hw-citation-links inline button button-alt button-grid clearfix">
                                   <li class="bibtext first">
                                    <a href="/highwire/citation/545164/bibtext" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">
                                     BibTeX
                                    </a>
                                   </li>
                                   <li class="bookends">
                                    <a href="/highwire/citation/545164/bookends" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">
                                     Bookends
                                    </a>
                                   </li>
                                   <li class="easybib">
                                    <a href="/highwire/citation/545164/easybib" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">
                                     EasyBib
                                    </a>
                                   </li>
                                   <li class="endnote-tagged">
                                    <a href="/highwire/citation/545164/endnote-tagged" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">
                                     EndNote (tagged)
                                    </a>
                                   </li>
                                   <li class="endnote-8-xml">
                                    <a href="/highwire/citation/545164/endnote-8-xml" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">
                                     EndNote 8 (xml)
                                    </a>
                                   </li>
                                   <li class="medlars">
                                    <a href="/highwire/citation/545164/medlars" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">
                                     Medlars
                                    </a>
                                   </li>
                                   <li class="mendeley">
                                    <a href="/highwire/citation/545164/mendeley" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">
                                     Mendeley
                                    </a>
                                   </li>
                                   <li class="papers">
                                    <a href="/highwire/citation/545164/papers" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">
                                     Papers
                                    </a>
                                   </li>
                                   <li class="refworks-tagged">
                                    <a href="/highwire/citation/545164/refworks-tagged" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">
                                     RefWorks Tagged
                                    </a>
                                   </li>
                                   <li class="reference-manager">
                                    <a href="/highwire/citation/545164/reference-manager" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">
                                     Ref Manager
                                    </a>
                                   </li>
                                   <li class="ris">
                                    <a href="/highwire/citation/545164/ris" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">
                                     RIS
                                    </a>
                                   </li>
                                   <li class="zotero last">
                                    <a href="/highwire/citation/545164/zotero" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">
                                     Zotero
                                    </a>
                                   </li>
                                  </ul>
                                 </div>
                                </div>
                               </div>
                              </div>
                             </div>
                            </div>
                           </div>
                          </div>
                         </div>
                        </div>
                       </div>
                      </div>
                     </div>
                    </div>
                   </div>
                  </div>
                 </div>
                </div>
               </div>
               <div class="panel-separator">
               </div>
               <div class="panel-pane pane-service-links">
                <div class="pane-content">
                 <div class="service-links">
                  <div class="item-list">
                   <ul>
                    <li class="first">
                     <a href="http://twitter.com/share?url=https%3A//www.medrxiv.org/content/10.1101/2021.10.31.21265703v3&count=horizontal&via=&text=Safety%20and%20efficacy%20of%20the%20two%20doses%20conjugated%20protein-based%20SOBERANA-02%20COVID-19%20vaccine%20and%20of%20a%20heterologous%20three-dose%20combination%20with%20SOBERANA-PLUS%3A%20double-blind%2C%20randomised%2C%20placebo-controlled%20phase%203%20clinical%20trial&counturl=https%3A//www.medrxiv.org/content/10.1101/2021.10.31.21265703v3" class="twitter-share-button service-links-twitter-widget" id="twitter_widget" title="Tweet This" rel="nofollow" data-icon-position="" data-hide-link-title="0">
                      <span class="element-invisible">
                       Tweet Widget
                      </span>
                     </a>
                    </li>
                    <li>
                     <a href="http://www.facebook.com/plugins/like.php?href=https%3A//www.medrxiv.org/content/10.1101/2021.10.31.21265703v3&layout=button_count&show_faces=false&action=like&colorscheme=light&width=100&height=21&font=&locale=" id="facebook_like" title="I Like it" class="service-links-facebook-like" rel="nofollow" data-icon-position="" data-hide-link-title="0">
                      <span class="element-invisible">
                       Facebook Like
                      </span>
                     </a>
                    </li>
                    <li class="last">
                     <a href="https://www.medrxiv.org/content/10.1101/2021.10.31.21265703v3" id="google_plus_one" title="Plus it" class="service-links-google-plus-one" rel="nofollow" data-icon-position="" data-hide-link-title="0">
                      <span class="element-invisible">
                       Google Plus One
                      </span>
                     </a>
                    </li>
                   </ul>
                  </div>
                 </div>
                </div>
               </div>
               <div class="panel-separator">
               </div>
               <div class="panel-pane pane-highwire-article-collections">
                <h2 class="pane-title">
                 Subject Area
                </h2>
                <div class="pane-content">
                 <div class="highwire-list-wrapper highwire-article-collections">
                  <div class="highwire-list">
                   <ul class="highwire-article-collection-term-list">
                    <li class="first last odd">
                     <span class="highwire-article-collection-term">
                      <a href="/collection/infectious_diseases" class="highlight" data-icon-position="" data-hide-link-title="0">
                       Infectious Diseases (except HIV/AIDS)
                       <i class="icon-caret-right">
                       </i>
                      </a>
                     </span>
                    </li>
                   </ul>
                  </div>
                 </div>
                </div>
               </div>
               <div class="panel-separator">
               </div>
               <div class="panel-pane pane-panels-mini pane-biorxiv-subject-collections block-style-col2">
                <div class="pane-content">
                 <div class="panel-flexible panels-flexible-new clearfix" id="mini-panel-biorxiv_subject_collections">
                  <div class="panel-flexible-inside panels-flexible-new-inside">
                   <div class="panels-flexible-region panels-flexible-region-new-center panels-flexible-region-first panels-flexible-region-last">
                    <div class="inside panels-flexible-region-inside panels-flexible-region-new-center-inside panels-flexible-region-inside-first panels-flexible-region-inside-last">
                     <div class="panel-pane pane-snippet">
                      <div class="pane-content">
                       <div class="snippet biorxiv-subject-areas-table-title" id="biorxiv-subject-areas-table-title">
                        <div class="snippet-content">
                         <b>
                          Subject Areas
                         </b>
                        </div>
                       </div>
                      </div>
                     </div>
                     <div class="panel-separator">
                     </div>
                     <div class="panel-pane pane-snippet">
                      <div class="pane-content">
                       <div class="snippet biorxiv-subject-areas-view-papers" id="biorxiv-subject-areas-view-papers">
                        <div class="snippet-content">
                         <a href="/content/early/recent">
                          <strong>
                           All Articles
                          </strong>
                         </a>
                        </div>
                       </div>
                      </div>
                     </div>
                     <div class="panel-separator">
                     </div>
                     <div class="panel-pane pane-highwire-subject-collections">
                      <div class="pane-content">
                       <ul id="collection" class="collection highwire-list-expand">
                        <li class="outer collection depth-2 child first">
                         <div class="data-wrapper">
                          <a href="/collection/addiction-medicine" class="" data-icon-position="" data-hide-link-title="0">
                           Addiction Medicine
                          </a>
                          <span class="article-count">
                           (218)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/allergy-and-immunology" class="" data-icon-position="" data-hide-link-title="0">
                           Allergy and Immunology
                          </a>
                          <span class="article-count">
                           (496)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/anesthesia" class="" data-icon-position="" data-hide-link-title="0">
                           Anesthesia
                          </a>
                          <span class="article-count">
                           (106)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/cardiovascular-medicine" class="" data-icon-position="" data-hide-link-title="0">
                           Cardiovascular Medicine
                          </a>
                          <span class="article-count">
                           (1121)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/dentistry-and-oral-medicine" class="" data-icon-position="" data-hide-link-title="0">
                           Dentistry and Oral Medicine
                          </a>
                          <span class="article-count">
                           (198)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/dermatology" class="" data-icon-position="" data-hide-link-title="0">
                           Dermatology
                          </a>
                          <span class="article-count">
                           (141)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/emergency-medicine" class="" data-icon-position="" data-hide-link-title="0">
                           Emergency Medicine
                          </a>
                          <span class="article-count">
                           (275)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease" class="" data-icon-position="" data-hide-link-title="0">
                           Endocrinology (including Diabetes Mellitus and Metabolic Disease)
                          </a>
                          <span class="article-count">
                           (510)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/epidemiology" class="" data-icon-position="" data-hide-link-title="0">
                           Epidemiology
                          </a>
                          <span class="article-count">
                           (9829)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/forensic-medicine" class="" data-icon-position="" data-hide-link-title="0">
                           Forensic Medicine
                          </a>
                          <span class="article-count">
                           (5)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/gastroenterology" class="" data-icon-position="" data-hide-link-title="0">
                           Gastroenterology
                          </a>
                          <span class="article-count">
                           (484)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/genetic-and-genomic-medicine" class="" data-icon-position="" data-hide-link-title="0">
                           Genetic and Genomic Medicine
                          </a>
                          <span class="article-count">
                           (2344)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/geriatric-medicine" class="" data-icon-position="" data-hide-link-title="0">
                           Geriatric Medicine
                          </a>
                          <span class="article-count">
                           (225)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/health-economics" class="" data-icon-position="" data-hide-link-title="0">
                           Health Economics
                          </a>
                          <span class="article-count">
                           (465)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/health-informatics" class="" data-icon-position="" data-hide-link-title="0">
                           Health Informatics
                          </a>
                          <span class="article-count">
                           (1574)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/health-policy" class="" data-icon-position="" data-hide-link-title="0">
                           Health Policy
                          </a>
                          <span class="article-count">
                           (738)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/health-systems-and-quality-improvement" class="" data-icon-position="" data-hide-link-title="0">
                           Health Systems and Quality Improvement
                          </a>
                          <span class="article-count">
                           (609)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/hematology" class="" data-icon-position="" data-hide-link-title="0">
                           Hematology
                          </a>
                          <span class="article-count">
                           (239)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/hiv-aids" class="" data-icon-position="" data-hide-link-title="0">
                           HIV/AIDS
                          </a>
                          <span class="article-count">
                           (510)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/infectious_diseases" class="" data-icon-position="" data-hide-link-title="0">
                           Infectious Diseases (except HIV/AIDS)
                          </a>
                          <span class="article-count">
                           (11686)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/intensive-care-and-critical-care-medicine" class="" data-icon-position="" data-hide-link-title="0">
                           Intensive Care and Critical Care Medicine
                          </a>
                          <span class="article-count">
                           (617)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/medical-education" class="" data-icon-position="" data-hide-link-title="0">
                           Medical Education
                          </a>
                          <span class="article-count">
                           (242)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/medical-ethics" class="" data-icon-position="" data-hide-link-title="0">
                           Medical Ethics
                          </a>
                          <span class="article-count">
                           (67)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/nephrology" class="" data-icon-position="" data-hide-link-title="0">
                           Nephrology
                          </a>
                          <span class="article-count">
                           (259)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/neurology" class="" data-icon-position="" data-hide-link-title="0">
                           Neurology
                          </a>
                          <span class="article-count">
                           (2170)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/nursing" class="" data-icon-position="" data-hide-link-title="0">
                           Nursing
                          </a>
                          <span class="article-count">
                           (134)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/nutrition" class="" data-icon-position="" data-hide-link-title="0">
                           Nutrition
                          </a>
                          <span class="article-count">
                           (340)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/obstetrics-and-gynecology" class="" data-icon-position="" data-hide-link-title="0">
                           Obstetrics and Gynecology
                          </a>
                          <span class="article-count">
                           (427)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/occupational-and-environmental-health" class="" data-icon-position="" data-hide-link-title="0">
                           Occupational and Environmental Health
                          </a>
                          <span class="article-count">
                           (521)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/oncology" class="" data-icon-position="" data-hide-link-title="0">
                           Oncology
                          </a>
                          <span class="article-count">
                           (1188)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/ophthalmology" class="" data-icon-position="" data-hide-link-title="0">
                           Ophthalmology
                          </a>
                          <span class="article-count">
                           (368)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/orthopedics" class="" data-icon-position="" data-hide-link-title="0">
                           Orthopedics
                          </a>
                          <span class="article-count">
                           (129)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/otolaryngology" class="" data-icon-position="" data-hide-link-title="0">
                           Otolaryngology
                          </a>
                          <span class="article-count">
                           (221)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/pain-medicine" class="" data-icon-position="" data-hide-link-title="0">
                           Pain Medicine
                          </a>
                          <span class="article-count">
                           (148)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/palliative-medicine" class="" data-icon-position="" data-hide-link-title="0">
                           Palliative Medicine
                          </a>
                          <span class="article-count">
                           (50)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/pathology" class="" data-icon-position="" data-hide-link-title="0">
                           Pathology
                          </a>
                          <span class="article-count">
                           (315)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/pediatrics" class="" data-icon-position="" data-hide-link-title="0">
                           Pediatrics
                          </a>
                          <span class="article-count">
                           (702)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/pharmacology-and-therapeutics" class="" data-icon-position="" data-hide-link-title="0">
                           Pharmacology and Therapeutics
                          </a>
                          <span class="article-count">
                           (304)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/primary-care-research" class="" data-icon-position="" data-hide-link-title="0">
                           Primary Care Research
                          </a>
                          <span class="article-count">
                           (269)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/psychiatry-and-clinical-psychology" class="" data-icon-position="" data-hide-link-title="0">
                           Psychiatry and Clinical Psychology
                          </a>
                          <span class="article-count">
                           (2201)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/public-and-global-health" class="" data-icon-position="" data-hide-link-title="0">
                           Public and Global Health
                          </a>
                          <span class="article-count">
                           (4705)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/radiology-and-imaging" class="" data-icon-position="" data-hide-link-title="0">
                           Radiology and Imaging
                          </a>
                          <span class="article-count">
                           (786)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/rehabilitation-medicine-and-physical-therapy" class="" data-icon-position="" data-hide-link-title="0">
                           Rehabilitation Medicine and Physical Therapy
                          </a>
                          <span class="article-count">
                           (462)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/respiratory-medicine" class="" data-icon-position="" data-hide-link-title="0">
                           Respiratory Medicine
                          </a>
                          <span class="article-count">
                           (626)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/rheumatology" class="" data-icon-position="" data-hide-link-title="0">
                           Rheumatology
                          </a>
                          <span class="article-count">
                           (276)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/sexual-and-reproductive-health" class="" data-icon-position="" data-hide-link-title="0">
                           Sexual and Reproductive Health
                          </a>
                          <span class="article-count">
                           (227)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/sports-medicine" class="" data-icon-position="" data-hide-link-title="0">
                           Sports Medicine
                          </a>
                          <span class="article-count">
                           (214)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/surgery" class="" data-icon-position="" data-hide-link-title="0">
                           Surgery
                          </a>
                          <span class="article-count">
                           (254)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/toxicology" class="" data-icon-position="" data-hide-link-title="0">
                           Toxicology
                          </a>
                          <span class="article-count">
                           (43)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/transplantation" class="" data-icon-position="" data-hide-link-title="0">
                           Transplantation
                          </a>
                          <span class="article-count">
                           (121)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child last">
                         <div class="data-wrapper">
                          <a href="/collection/urology" class="" data-icon-position="" data-hide-link-title="0">
                           Urology
                          </a>
                          <span class="article-count">
                           (94)
                          </span>
                         </div>
                        </li>
                       </ul>
                      </div>
                     </div>
                    </div>
                   </div>
                  </div>
                 </div>
                </div>
               </div>
              </div>
             </div>
            </div>
           </div>
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </section>
  </div>
  <div class="region region-page-bottom" id="region-page-bottom">
   <div class="region-inner region-page-bottom-inner">
   </div>
  </div>
  <script type="text/javascript" src="https://www.medrxiv.org/sites/default/files/advagg_js/js__VNH5GD8Zz7g6_hGCOZjVjdMndxxC6naiExSSJKX3k_A__kzmEdtbqCsJx5Z9yg2Qy0PptB__ufXm-TxUOl0KZzUw__yDRjOTiBnSnu2tzh2xbnVTigKcZk0CFMqnf6m8vMg3M.js">
  </script>
  <script type="text/javascript" src="https://www.medrxiv.org/sites/default/files/advagg_js/js__2WRbxlwOW0MEUc_hSWU5MBepQg6Lch6O5SZwefpJ6IE__HCL0YQJqLkOhrLPZZYGqosGvtFsEHMGghHIkSx4y9vA__yDRjOTiBnSnu2tzh2xbnVTigKcZk0CFMqnf6m8vMg3M.js" defer="defer">
  </script>
  <script type="text/javascript" src="https://www.medrxiv.org/sites/default/files/advagg_js/js__N7ERJBYsOWyRnJgyoM125_Aiez2MOJGaUofG1JdWWBg__2cpwCQ7-xzTVeVvg_KOzwA1jka23oWApDPpgjoZKDCY__yDRjOTiBnSnu2tzh2xbnVTigKcZk0CFMqnf6m8vMg3M.js">
  </script>
  <script type="text/javascript" src="https://d33xdlntwy0kbs.cloudfront.net/cshl_custom_medrxiv.js">
  </script>
  <script type="text/javascript" src="https://www.medrxiv.org/sites/default/files/advagg_js/js__BmqjBnkz3MgYCAoc25s1lDRMEjLhC3mEPVonUFIHi08__Unwv5-ZIuHBfFwytsjEx1niBVJ7n1T4lPws7VrkHXM4__yDRjOTiBnSnu2tzh2xbnVTigKcZk0CFMqnf6m8vMg3M.js">
  </script>
  <script type="text/javascript">
   &lt;!--//--&gt;&lt;![CDATA[//&gt;&lt;!--
function euCookieComplianceLoadScripts() {}
//--&gt;&lt;!]]&gt;
  </script>
  <script type="text/javascript">
   &lt;!--//--&gt;&lt;![CDATA[//&gt;&lt;!--
var eu_cookie_compliance_cookie_name = "";
//--&gt;&lt;!]]&gt;
  </script>
 </body>
</html>
